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SUMMARY 
The kidney is a vital organ, which plays an essential role in health, disease and overall 
development and growth. The main function of kidney is to maintain total body fluid 
volume, its composition and acid base balance. A number of environmental variables 
including certain drugs influence these functions (Mahmood and Water, 1994; Begg 
and Barcaly, 1995; Priyamvada et al, 2009). Platinum-based drugs are widely used 
anticancer agents with a broad range of antitumor activities (Alois et al, 2007). These 
platinum antitumor agents are unique, coordination complexes and the parent 
compound of this class cis-diammine-dichloroplatinum (II) (cisplatin, CP), 
contributes to the curative treatment of various cancers such as testicular teratoma, 
ovarian, head, neck, bladder, cervical and lung cancers. The compound is also highly 
toxic with a list of side effects including renal damage, severe nausea, vomiting, 
myelosuppression, ototoxicity and neurotoxicity (McKeage, 1995, Markman, 2003). 
The optimal use of cisplatin as a chemotherapeutic drug has been limited by its 
nephrotoxicity. Following administration, CP is widely distributed into body fluids 
and tissues. The highest concentration can be seen in the kidney, liver and intestine 
although it has also been found in all other tissues (McEvoy, 1992). Induction of 
nephrotoxicity is assumed to be a rapid process involving reactions with proteins in 
renal tubules. Light and electron microscopy have shown that the CP-induced injury 
and necrosis in rat kidney are predominantly localized in the S3 segment of proximal 
tubules in the corticomeduUary region (Townsend et al, 2003). CP toxicity in 
proximal tubular epithelial cells is morphologically characterized by tubular necrosis, 
loss of microvilli, alterations in the number and size of lysosomes and mitochondrial 
vacuolization accompanied by functional disturbances of various cell organelles 
(Kuhlmann et al, 1997). The mechanism by which cisplatin kills the proximal tubule 
cells in the kidney has been the focus of intense investigation for many years. In 
tumors and other dividing cells, cisplatin-DNA crosslinks are thought to be the 
cytotoxic lesion (Fink and Howell, 2000). Nonproliferating cells are less sensitive to 
the toxicity of DNA-damaging agents, yet the quiescent proximal tubules cells are 
selectively killed by cisplatin (Lieberthal et al, 1996). Experimental evidence has 
suggested that CP deteriorates renal function (Arany and Safirstein, 2003) and 
glomemlar filtration rate (GFR) in a dose-dependent manner (Yao et al, 2007). 
Summary 
The mechanism underlying the side effects induced by cisplatin is not understood 
clearly, however it was considered to be attributed to the combination of multi-ways 
(Hong et al, 2005; Ramesh and Reeves, 2002; Nowmak, 2002; Townsend and 
Hanigen, 2002; Xiao et al, 2003) such as the generation of reactive oxygen species 
(ROS), which could interfere with the antioxidant defense system and result in 
oxidative damage in different tissues (Kuhlman et al, 1991 \ Matsushima et al, 1998; 
Kuhad et al, 2007; Khan et al, 2009 ) and reaction with thiols in protein and 
glutathione, which could cause cell dysfunction. Various studies have focused on the 
ways for prevention of cisplatin associated side effects via supplementation of 
preventive agents simultaneously. These include antioxidants, modulators of nitric 
oxide, diuretics, and cytoprotective and apoptotic agents (Ali and Al Moundhri, 
2006). However, none of them have been found safe/suitable for clinical practice. 
In past few years, much interest has been centered on the role of naturally occurring 
dietary substances for the control and management of various chronic diseases such as 
cancer and cardiovascular disorders (Connor, 2000; Hardman, 2002; Larsson et al, 
2004; Williams et al, 2007; Kakar et al, 2008; Leaf, 2008). From ancient times the 
physicians and scholars in Asia have understood that food have both preventive and 
therapeutic value and are integral part of health. Omega-3 polyunsaturated fatty acids 
((0-3 PUFA) enriched fish oil provides one such dietary source of biologically active 
components that has been shown to be co-preventative and co-therapeutic in a wide 
variety of ailments (Doughman et al, 2007). 
A number of investigations have already demonstrated that diet supplemented with 
fish oil (FO) enriched in 00-3 PUFA has profound beneficial health effects against 
various pathologies including cancers, cardiovascular disorders, diabetes, depression, 
arthritis, asthma and inflammatory and immune disorders of the kidney and intestine 
(De Caterina et al, 1994; Tsujikawa et al, 2000; Barbosa et al, 2003; Bhattacharya 
et al, 2006). Recently, (o-3 PUFA from some plants/seeds e.g. flaxseed oil (FXO) 
showed many similar health benefits as demonstrated by (o-3 PUFA from FO (Freese 
and Mutanen 1997; Ide et al, 2000; Kim and Choi, 2001; Nannicini et al, 2006; 
Paschos et al, 2007). Alpha Linolenic acid (ALA, 18:3 n:3, co-3 FA) from vegetable 
sources including grains and oils, offer an alternative source for those who are unable 
to regularly consume fish for religious or other reasons (Harper and Jacobson, 2001). 
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Summary 
Dietary flaxseed oil affects the biochemistry of fatty acid metabolism and thus the 
balance of proinflammatory mediators and atherogenic lipids, holding a great promise 
for modulating inflammatory diseases (Chilton et al, 2008). 
. In view of numerous beneficial health effects of co-3 PUFA "we hypothesized that: 
dietary FO and FXO enriched in 0)-3 PUFA would be able to prevent/reduce single 
as well as multiple CP dose induced nephrotoxic and other adverse effects in the rat 
kidney," 
To address this hypothesis the present work was undertaken to study the detailed 
biochemical events/cellular response/mechanism of CP induced nephrotoxic and other 
adverse effects in rat kidney. The effects of dietary a)-3 PUFA enriched FO and FXO 
were also determined to observe any protection provided by them against CP 
nephrotoxicity. The following parameters were determined: 
(a) Certain biochemical parameters in serum/urine. 
(b) The activities of BBM and lysosomal marker enzymes in renal cortical and 
medullary homogenates and BBM marker enzymes in isolated BBM preparations 
from renal cortex. 
(c) The activities of certain enzymes of carbohydrate metabolism involved in 
glycolysis, TCA cycle, gluconeogenesis and HMP-shunt pathway in renal cortex 
and medulla. 
(d) The enzymatic and non-enzymatic parameters of antioxidant defense system in 
renal cortex and medulla. 
# THE RESULTS OBTAINED ARE SUMMARIZED AS FOLLOWS: 
O PART-IA: EFFECT OF DIETARY FISH OIL (FO) ON SINGLE CP DOSE 
INDUCED ACUTE NEPHROTOXIC AND OTHER ADVERSE EFFECTS 
(a) Serum/Urine Parameters: 
Single CP injection resulted in marked nephrotoxicity as manifested by increased 
serum creatinine and BUN. However, serum cholesterol, phospholipids, inorganic 
phosphate and glucose were significantly declined by CP treatment compared to 
control rats. These changes were associated with massive phosphaturia, proteinuria 
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and glucosuria accompanied by decreased creatinine clearance. FO supplementation 
alone caused increase in serum glucose and Pi but decrease in BUN, serum creatinine, 
PLP and cholesterol. Urinary glucose, Pi and protein excretions declined significantly 
accompanied by increased creatinine clearance. CP elicited increase in serum 
creatinine and BUN was markedly lowered by dietary FO supplementation to CP co-
administered rats. CP induced alterations in other serum and urine parameters were 
also prevented by FO supplementation. 
(b) Marker enzymes ofBBM and Ivsosomes: 
CP treatment to control rats caused significant reduction in the specific activities of 
ALP, GGTase and LAP in cortical homogenate. The activities of BBM enzymes as in 
the cortex were also lowered in medulla by CP administration. Feeding of FO diet 
alone, however, caused increase in GGTase activity both in renal cortex and medulla. 
The consumption of FO in combination with CP treatment prevented/reduced CP 
induced decrease in ALP, GGTase and LAP in the cortex as well as in the medulla. 
The effects of CP and FO were more apparent in BBMVs isolated from renal cortex 
than observed in the respective cortical homogenates. The magnitude of enzyme 
activities increased (4-8 folds) in the membrane preparations compared with 
respective values in the homogenates in control and treated groups for renal cortex 
indicating that the quality of the membrane prepared by the procedure was uniform 
for the various experimental groups. 
The effect of CP, FO alone and in combinations was also determined on the activity 
of lysosomal enzyme, ACPase in renal homogenates. The activity of ACPase was 
significantly increased by CP treatment in cortical and medullary homogenates, 
however the increase was significantly reduced/prevented by FO diet. 
(c) Enzymes of carbohydrate metabolism: 
CP treatment to control rats significantly increased LDH, a marker of anaerobic 
glycolysis and HK whereas decreased MDH, an enzyme of TCA cycle, G6Pase, 
FBPase (gluconeogenesis) and G6PDH (source of NADPH). When CP treatment was 
extended to FO-fed rats, CP-induced alterations in the metabolic enzyme activities are 
prevented. FO alone caused increase in MDH, G6Pase, FBPase and G6PDH activities 
in cortex as well as in medulla. The activities of LDH, MDH, G6Pase and FBPase in 
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medullary homogenates were similarly affected by CP treatment albeit to different 
extent than in the cortical homogenates. Similar to cortex, G6PDH activity decreased 
whereas ME and HK activity increased by CP in the medulla. Feeding of FO 
containing diet to CP treated rats prevented CP induced alterations in various enzyme 
activities in the cortex and medulla. 
(d) Enzymatic and non-enzvmatic parameters of antioxidant defense mechanism: 
CP caused significant decrease in the activities of SOD, catalase and GSH-Px in the 
cortex and medulla which was associated with marked increase in LPO and decrease 
in total-SH levels, indicating that CP caused severe damage to the renal tissues by 
generating free radicals and/or by suppressing the activities of antioxidant enzymes. 
CP treatment caused marked decrease in SOD, GSH-Px activities but slight decrease 
in catalase activity in the renal cortex. In medulla the activity of SOD, catalase and 
GSH-Px also showed significant decline by CP administration alone. CP induced 
increase in LPO and decrease in total-SH was prevented by feeding FO diet to CP 
treated rats. Dietary FO consumption protected well against CP induced perturbation 
of oxidants/antioxidants or CP induced oxidative damage. CP induced decrease in 
SOD, catalase and/or GSH-Px activity was markedly reversed/reduced by FO 
consumption in the renal cortex and medulla. CP induced increase in LPO was also 
lowered by FO supplementation in the renal tissues. 
OPART-IB: EFFECT OF DIETARY FISH OIL fFO) ON MULTIPLE CP 
DOSE INDUCED NEPHROTOXIC AND OTHER ADVERSE EFFECTS 
(a) Serum Parameters: 
Multiple dose CP administration caused severe nephrotoxicity as characterised by 
significant increase in serum creatinine, cholesterol, phospholipids and BUN 
accompanied by significant decrease in serum glucose and Pi. Prolonged FO 
consumption prior to and along with CP treatment significantly lowered CP induced 
increase in serum creatinine and BUN, indicating reduction in CP nephropathy. FO 
given to CP treated rats markedly prevented/retarded CP-induced increase of serum 
creatinine, cholesterol, and BUN. 
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(b) Marker enzymes ofBBM and lysosomes: 
CP treatment to control rats caused significant decrease in the activity of ALP, 
GGTase and LAP in the homogenates of renal cortex and medulla and in BBMV 
isolated from renal cortex. FO consumption in general significantly increased the 
activities of GGTase and LAP in both cortex and medulla. CP induced decrease in 
most BBM enzymes in the cortex and medulla was markedly prevented/reduced by 
FO supplementation to CP treated rats. The activity of ACPase, a lysosomal enzyme 
was significantly increased by CP treatment. CP-induced increase in ACPase activity 
was significantly reduced by FO diet both in cortical and medullary homogenates 
albeit to different extent. 
(c) Enzymes of carbohydrate metabolism: 
The activities of various enzymes involved in glycolysis, TCA cycle, gluconeogenesis 
and HMP-shunt pathways were variably affected by CP, FO and CP+FO in rat 
kidney. CP treatment to control rats significantly increased LDH, HK and ME 
activities whereas decreased MDH, an enzyme of TCA cycle and G6PDH (source of 
NADPH). When CP treatment was extended to FO-fed rats, CP-induced decrease of 
metabolic enzyme activities was prevented. CP elicited decrease of MDH activity was 
normalized to near control values by FO supplementation. However, FO alone caused 
increase in MDH, G6Pase, FBPase and G6PDH activities. 
The activities of LDH, MDH, G6Pase and FBPase in medullary homogenates were 
similarly affected by CP treatment albeit to different extent than in the cortical 
homogenates. Similar to cortex, G6PDH activity decreased whereas ME and HK 
activities were increased by CP in the medulla. Prolonged feeding of FO 
supplemented diet to CP treated rats prevented CP induced alterations in various 
enzyme activities in medulla. 
(d) Enzymatic and non-enzvmatic parameters of antioxidant defense mechanism: 
CP caused significant decrease in the activities of SOD, catalase and GSH-Px in 
cortex and in catalase and GSH-Px in medulla which was associated with marked 
increase in LPO and decrease in total-SH, indicating that CP caused severe damage to 
these tissues by generating free radicals and by suppressing the activities of 
antioxidant enzymes. Prolonged FO consumption protected well against CP induced 
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perturbation of oxidants/antioxidants or CP induced oxidative damage. CP induced 
decrease in SOD, catalase and GSH-Px was markedly reversed/reduced by FO 
consumption in both renal cortex and medulla. CP induced increase in LPO was also 
lowered by FO in the renal tissues. 
fy" Interpretation: In general, CP caused severe adverse effects on various 
serum/urine parameters and on the enzymes of BBM, carbohydrate metabolism and 
antioxidant defense system in rat kidney. FO similarly protected against single and 
multiple CP dose induced nephrotoxic and other adverse effects most likely due to its 
intrinsic biochemical and antioxidant properties. 
OPART-IIA: EFFECT OF DIETARY FLAXSEED OIL (FXO) ON SINGLE 
CP DOSE INDUCED ACUTE NEPHROTOXIC AND OTHER ADVERSE 
EFFECTS 
(a) Serum/Urine Parameters'. 
Single dose CP administration caused severe nephrotoxicity as characterized by 
significant increase in serum creatinine, BUN, cholesterol and PLP but decrsease in 
glucose and inorganic phosphate accompanied by massive glucosuria, proteinuria, 
phosphaturia, poljmria and decreased creatinine clearance.Dietary FXO 
supplementation to CP treated rats markedly prevented/retarded CP-induced increase 
of serum creatinine, cholestrol and BUN. CP-induced polyuria, phosphaturia and 
glucosuria were significantly prevented by FXO diet. 
(b) Marker enzymes of BBM and lysosomes: 
CP treatment to control rats caused significant decrease in the activities of ALP, 
GGTase and LAP in renal cortex and medulla indicating CP induced damage to the 
kidney. However, dietary FXO consumption caused significant reversal in CP induced 
decrease in BBM enzyme activities in the cortex and medulla. The activity of ACPase 
(a lysosomal enzyme) was variably increased by CP in the renal cortex and medulla 
whereas FXO consumption prevented the CP-induced increase in ACPase. 
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(c) Enzymes of carbohydrate metabolism: 
C? treatment caused significant decline in the activities of MDH, G6Pase,FBPase and 
G6PDH whereas activities of LDH,HK and ME increased significantly in renal cortex 
and medulla. However, the effect of CP on HK and LDH activities was more marked 
in medulla while the effect on MDH activity was greater in cortex than medulla. As 
shown in "Part-IIA", some of these enzyme activities were enhanced by FXO alone. 
FXO supplementation similarly prevented/retarded CP-induced decrease of MDH, 
G6Pase and G6PDH activities in the cortex and medulla. 
(d) Enzymatic and non-enzvmatic parameters of antioxidant defense mechanism: 
CP treatment significantly decreased the activities of SOD, catalase and GSH-Px 
activities, accompanied with marked elevation of LPO and decrease in total-SH levels 
in the cortex and medulla. FXO alone significantly increased SOD, catalase and GSH-
Px activities in the renal cortex and catalase activity in the renal medulla. FXO-diet 
when given to CP treated rats significantly ameliorated the CP-induced imbalance in 
the antioxidant defense system. LPO was decreased, whereas total-SH increased and 
the activities of the antioxidant enzymes remained significantly higher in FXO fed-CP 
treated rats compared to CP treated rats. 
O PART-IIB: EFFECT OF DIETARY FLAXSEED OIL (FXO) ON MULTIPLE 
CP DOSE INDUCED NEPHROTOXIC AND OTHER ADVERSE EFFECTS 
(a) Serum/Urine Parameters: 
Multiple dose CP treatment to control rats resulted in significant increase in serum 
creatinine (Scr), BUN, cholesterol and phospholipids but decrease in glucose and 
inorganic phosphate (Pi). These changes where associated with profound 
phosphaturia, proteinuria and glucosuria, accompanied by decrease in creatinine 
clearance. Feeding of FXO diet to CP administered rats resulted in significant reversal 
of various CP elicited deleterious effects on serum and urine parameters. 
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(b) Marker enzymes ofBBMand lysosomes: 
Multiple doses of CP caused significant decrease in the activities of BBM marker 
enzymes viz ALP, GGTase and LAP while FXO supplementation alone increased the 
activities of ALP and GGTase in renal cortical and medullary homogenates. FXO diet 
fed to CP treated rats prevented/reduced the CP induced decrease in the BBM 
enzymes while the activities were significantly higher in CPFXO than the CP group. 
The effect of CP was much more apparent in isolated BBMV preparations than 
observed in the respective homogenates. The activity of ACPase was however 
increased by CP in both cortical and medullary homogenates and FXO diet was able 
to prevent/retard the CP-induced increase in ACPase activity in a similar manner. 
(c) Enzymes of carbohydrate metabolism: 
CP treatment to control rats significantly increased LDH, HK and ME while 
decreased MDH, G6Pase, FBPase and G6PDH activities. However, FXO alone 
caused increase in MDH, G6Pase and FBPase activities. The activities of LDH, HK, 
MDH, G6Pase and FBPase in medullary homogenates were similarly affected by CP 
treatment albeit to different extent than in the cortical homogenates. Similar to cortex, 
G6PDH activity decreased whereas ME and HK activities were increased by CP in 
the medulla. Prolonged FXO feeding to CP treated rats prevented the CP-induced 
alterations in the metabolic enzyme activities. 
(d) Enzymatic and non-enzymatic parameters of antioxidant defense mechanism: 
Multiple CP doses caused significant decrease in the activities of SOD, catalase and 
GSH-Px in the cortex and medulla which was associated with marked increase in 
LPO and decrease in total-SH levels. The dietary supplementation of FXO was able to 
ameliorate the CP induced oxidative damage in both renal cortex and medulla. CP 
induced increase in LPO and decrease in total-SH were prevented/reduced by feeding 
FXO diet to CP treated rats. The activities of SOD, catalase and GSH-Px both in the 
cortex and medulla were significantly ameliorated by FXO supplementation to CP 
treated rats. These results indicate marked protection by FXO diet against single and 
multiple CP dose induced oxidative damage to renal tissues. 
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Hy Interpretation: Single as well as multiple CP dose treatments caused severe 
damage to the kidney as reflected by increase in serum creatinine and BUN and 
decrease in biomarker BBM enzymes. There appeared to be a shift from aerobic to 
anaerobic metabolism most likely due to CP induced mitochondrial damage. CP also 
increased oxidative stress as indicated by increased LPO and decreased total-SH 
levels associated with suppressed antioxidant enzyme activities. FXO supplementation 
diet similarly prevented/retarded single and multiple CP dose induced alterations in 
various biochemical parameters and enzyme activities most likely by empowering the 
antioxidant defense system and improving cellular membrane integrity. 
In conclusion, single or multiple dose CP administration elicited deleterious 
nephrotoxic effects by causing major damage to mitochondria, lysosomes and in 
particular to BBM of renal proximal tubules as reflected by significant decrease in the 
activities of the specific biomarker enzymes, confirming the morphologic and 
toxicogenomic observations that showed these organelles as prime CP target. CP 
seems to enhance glycolytic enzyme LDH in order to increase energy dependence on 
glycolysis due to mitochondrial damage and depressed TCA cycle enzymes. 
Gluconeogenic enzymes, G6Pase and FBPase also appeared to decrease due to 
mitochondrial dysfunction as oxaloacetate produced by MDH is not available. These 
nephrotoxic and other adverse effects appeared to be mediated in part due to CP 
elicited oxidative damage. The significant lowering of LPO by FO/FXO in renal 
cortex and medulla suggests that (o-3 PUFA enriched FO/FXO play a major role in 
reducing oxidative damage induced by CP. The decrease in oxidative damage by 
dietary FO/FXO supplementation appears to be due to the synergistic increase in the 
activity of both SOD and catalase and GSH-Px. The present results imply that 
FO/FXO exhibited a nephroprotective effect probably by empowering the biological 
defense system. Dietary (o-3 PUFA enriched fish oil and flaxseed oil to a larger extent 
prevented CP-induced nephrotoxicity parameters by enhancing nutrition/energy 
metabolism, by strengthening antioxidant defense mechanism and by altering 
membrane organization. Further FO and FXO offered renoprotection similarly 
against single and multiple dose CP treatments. Based on our present observations 
and already known numerous health benefits, we propose that co-3 PUFA enriched 
FO/FXO may provide a cushion for a prolonged therapeutic option against CP 
induced nephropathy without harmftil side effects. Similar protective effects of FO 
and FXO provide a much needed relief for millions of vegetarians who do not eat 
fish/fish oil for religious or other reasons. 
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INTRODUCTION 
1. GENERAL: 
The kidney is a vital organ, which plays an essential role in health, disease and overall 
development and growth. The main flinction of kidney is to maintain total body fluid 
volume, its composition and acid base balance. A number of environmental variables 
including certain drugs influence these functions (Mahmood and Water, 1994; Begg 
and Barcaly, 1995; Priyamvada et al, 2009). Platinum-based drugs are widely used 
anticancer agents with a broad range of antitumor activities (Alois et al.. 2008). These 
platinum antitumor agents are unique coordination complexes and the parent 
compound of this class cis-diammine-dichloroplatinum (II) (cisplatin, CP), 
contributes to the curative treatment of various cancers such as testicular teratoma, 
ovarian, head, neck, bladder, cervical and lung cancers. However, its therapeutic 
utility is limited by acute and chronic nephrotoxicity alongwith some untoward side 
effects including nausea, vomiting, diarrhea, myleosuppression, ototoxicity and 
neurotoxicity (McKeage, 1995, Markman, 2003). The kidney accumulates cisplatin 
(CP) to a greater degree than other organs and is the major route for its excretion (Yao 
et al., 2007). Dose dependent nephrotoxicity is the major limitation of this compound, 
sometimes requiring a reduction in dose or discontinuation of treatment (Schrier, 
2002). Approximately 25-35% of patients develop evidence of nephrotoxicity 
following a single dose of cisplatin (Saad et al, 2007). Cisplatin nephrotoxicity is 
chiefly characterized by tubular damage, primarily affecting the proximal tubules. 
Tubular damage may range from a mere loss of brush border of epithelial cells to an 
overt tubular necrosis in severe cases (Meyer and Madias, 1994). Light and electron 
microscopy have shown that the CP-induced injury and necrosis in the rat kidney are 
predominantly localized in S3 subsegments of proximal tubule (Townsend et al.. 
2003). Mitochondria, lysosomes and microsomes are critical CP targets (Zhang et al, 
1993; Leibbrandt et al., 1995). Functional alterations are characterized by change in 
urine volume, increase in blood urea nitrogen and serum creatinine (Khan et al, 
2009). In addition to kidney, the structure and function of other major tissues e.g 
intestine and liver are also reported to be affected (Naqshbandi et al., 2011; 2012a, b; 
Khan et al.. 2009; Bearcroft et al., 1999; Neife et al., 2007). Continued aggressive 
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high-dose CP chemotherapy necessitates the investigation of ways for prevention of 
the dose-h'mitmg side effects that inhibit the CP administration at tumoricida! doses. 
As man has moved over the centuries from a hunter-gatherer diet to greater intaice of 
saturated and trans-fatty acids, the world appears to be now increasingly interested in 
the health benefits of foods and have begun to look beyond the basic nutritional 
benefits of food stuffs to disease prevention and health enhancing ingredients of the 
same. Dietary fat is one environmental variable that affects our health in different 
ways. Saturated fats mostly from animal based foods have been blamed for various 
forms of cancers and heart disease (Simopoulos, 2002a) whereas unsaturated fats in 
the diet were shown to have numerous health benefits (Deckelbaum et al, 2006). 
Evidences supporting the possible importance of unsaturated fatty acids especially 
polyunsaturated fatty acids (PUFA) came from studies showing that young humans 
and experimental animals experienced impaired growth when all fatty acids were 
removed from the diet. Small amounts of co-3 (a-linolenic acid) or o)-6 (linoleic acid) 
fatty acids prevented that impaired growth and thus were termed as "essential" (Burr 
and Burr, 1930). Highly unsaturated/polyunsaturated fatty acids (HUFA/PUFA) were 
relatively found to be several-fold more effective (Turpeinen, 1937). 
Epidemiological and clinical trial evidence suggests that both ©-3 and (o-6 PUFA 
have numerous health benefits. However, co-3 PUFAs especially from fish/marine 
foods were found to be more effective in lowering incidence of various pathologies 
compared to co-6 PUFA rich diets (Simopoulos, 2001). This stems from the 
observations of the different prevalence of coronary heart disease and other chronic 
diseases (including psoriasis, bronchial asthma, diabetes mellitus and thyrotoxicosis) 
in the Greenland Inuit (Eskimo) population relative to Western populations (Kromann 
and Green. 1980). PUFA from marine fish and mammals were indicated as the main 
dietary factor responsible for such differences (Dyerberg et al, 1975; Bang et al., 
1976). The consumption of fish has now been linked with the rate of depression 
among various populations. In countries where people eat the least fish the rate of 
depression is highest, and vice versa (Hibbein, 1998; Small, 2002). This correlation 
holds true across the world. The most dramatic change in what we eat has happened in 
the past century, with industrialization and development of the food industry, the 
intake of saturated fat. trans fat and especially to-6 enriched refined oils have 
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enormously increased whereas the consumption of (0-3 PUFA has considerably 
declined. These dietary imbalances in fat intake, in fact, are prime cause of modem 
sufferings like cancer, hypertension, diabetes, depression, cardiovascular and renal 
disorders. 
Nutritional recommendations have recently promoted the increased need to consume 
omega-3 (co-3/n-3) polyunsaturated fatty acids (PUFAs) (Simopoulos, 2000). The 
most common way to consume omega 3 fatty acids has been in the fomi of marine 
oils like fish oil. Recently flaxseed has been identified as a significant alternative 
source of omega 3 fatty acids. Role of co-3 PUFA enriched fish oil has been 
extensively investigated and has received a great deal of attention in recent times as 
therapeutic options in a variety of clinical situations ranging fi^om cardiovascular 
disorders (CVD) to hyperlipidemia, cancer, inflammatory and immune disorders, 
respiratory diseases, depression and diabetes (De Caterina et al, 1994; Kakar et ai, 
2008). Lately, ©-3 PUFA from certain plants/seeds e.g. walnut, canola and most 
notably from flaxseed (linseed) showed many similar health benefits as demonstrated 
by co-3 PUFA from fish/fish oil (Nannicini et al, 2006; Vijaimohan et ai, 2006). 
Although (0-3 PUFA have been shown as deterrents for environmental pollutants, 
studies on their possible beneficial effects against drug/chemical induced 
nephrotoxicity are very limited (Watkins et ai, 2007; Priyamvada et al, 2008). 
Considering profound beneficial health effects of co-3 PUFA from marine or plant 
foods against various pathologies, the present work embodied in tliis thesis was 
undertaken to study the detailed mechanisms of CP induced nephrotoxic 
alterations and possible protection/prevention by a»-3 fatty acids enriched fish oil 
(FO) and/or flaxseed oil (FXO) diets against CP nephropathies and other 
alterations. The effect of dietary supplementafion of fish oil (FO) and flaxseed oil 
(FXO) was examined on single dose and multiple dose CP treatment induced 
alterations. 
2. OMEGA FATTY ACIDS - "FATS OF LIFE": 
"We are what we eat". This adage represents the force behind research efforts in diet 
manipulation as preventive measures and treatments of various diseased states. The 
nature of the relation between diet and disease is the subject of great controversy and 
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the last fifty years have been characterized by the understanding of the impact of 
nutrition and dietary patterns on health (Caballero, 2003). 
The dietary and body fat are essential for life. The concept of the essentiality of the 
long chain PUFA was made by Burr and Burr (1930) at the University of Minnesota 
Medical School (Holman, 1998). They were first to suggest that unsaturated fatty 
acids: linolenic and linoleic acids play a bioeffector role, in the growth and 
development of young humans and animals. Thus, the generic tenn 'essential fatty 
acid" was used for them. 
2.1 Definition, classification, distribution and sources of dietary polyunsaturated 
fatty acids (PUFA): 
Unsaturated fatty acids consist of monounsaturates (MUFA) and polyunsaturates 
(PUFA). PUFAs are further divided between two classes omega-3 and omega-6. The 
only fatty acids known to be essential for complete nutrition of many species of 
animals including humans are linoleic (LA) and a-linolenic acid (a -LA), as mammals 
lack the ability to synthesize them de novo and must obtain them in their diet. 
Moreover, if supplied in the diet these two can be elongated and further desaturated 
by the mammals. However, certain plants and marine mammals possess the ability to 
synthesize them (Simopoulos, 1991; Teitelbaum and Walker, 2001). Marcel et al. 
(1968) pioneered the cascade for LA and Klenk and Mohrhauer (1960) for ALA. Both 
LA and ALA are metabolized by the same microsomal enzyme system, by alternating 
desaturation and elongation to make two cascades of metabolic products upto 22 or 
more carbons long (Figure 1) which occur in tissue structural lipids in animals and in 
man(Donadio 1991; Holman, 1998). 
Nomenclature: PUFA are commonly classified according to a shorthand 
nomenclature which designates the chain length, number of double bonds and position 
of the double bond nearest to the terminal methyl group (Willis, 1987). This terminal 
carbon atom is often referred to as the omega (co) as it occurs at the opposite end of 
the molecule to carbon-1 which bears the carboxyl function. The use of the "omega" 
nomenclature was proposed by Holman (1964). Alternatively, the n-x notation is used 
instead of (o-x to describe the position nearest to the methyl group (Tinoco, 1982).to-3 
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u> - 3 PUFA 
a - Linolenate 
{C18:3A' '" ' ") 
elongation 
desaturation 
Eicosapentaenoic acid (EPA) 
(C20:5A^-«•"•"'") 
Docosahexaenoic acid (DHA) 
{C22:6 A"-' ' ' ' ' ' "• '"•") 
cyclooxygenase 
0) - 6 PUFA 
Linoleic acid 
(ClBrZA^'"^) 
desaturation 
y-linolenate 
elongation 
desaturation 
Arachidonate 
(C20:4A^'*'"'") 
lipooxygenase cyclooxygenase 
Prostaglandins Leukotrienes 
(3 double bond series) 
Prostaglandins Leukotrienes 
(2 double bond series) 
Figure 1: Metabolic cascade of co-3 and a)-6 fatty acids. 
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fatty acids are represented by alpha-linolenic acid ( ALA, C18:3 cisA''''~''') while ©-6 
fatty acids by linoleic acid (LA, CI8:2 cisA'*''^ ). 
The general formulas for ©-3 and co-6 fatty acids are, 
'CH3--CH2-^CH=CH-R 'CH3-^CH2-^CH2-'CH2--CH2-^CH=CH-R 
respectively. Where 'R' represents rest of the carbon chain and the number of 
conjugated double bonds may vary. 
Distribution: LA and ALA as well as their long chain derivatives (e.g. EPA and 
DHA), are important components of animal and plant cell membranes. LA is found in 
triglycerides, cholesterol esters and in very small amounts in phospholipids. EPA is 
found in cholesterol esters, triglycerides and phospholipids. DHA is found mostly in 
phospholipids and is one of the most abundant components of the brain's structural 
lipids (Teitelbaum and Walker, 2001). Both these essential fatty acid families have 
distinctive nutritional and metabolic effects and each has a direct precursor 
relationship with specific class of eicosanoids. Thus, all eicosanoids formed in the 
human body are generated from PUFA that must be derived from the diet (Willis, 
1987). 
Sources: The omega fatty acids are found in fish and marine foods, green leafy 
vegetables and in certain plant seeds and walnut. 
(a) Gifts from the sea: omega-3 fatty acids (EPA and DHA) 
The long chain ©-3 PUFA, eicosapentaenoic acid (EPA, C20:5 (o-3) and 
docosahexaenoic acid (DHA, C22:6 &~3) (Figure 2) are predominantly found in 
certain fish and sea mammals (tuna, trout, herring, salmon, sardine etc.). Infact, the 
origin of EPA/DHA in aquatic systems are the plants of the sea, microalgae and 
seaweed. They produce high levels of EPA and DHA which are acquired by the 
marine fish/mammals through the food chain. Fish oils are concentrated source of 
EPA and DHA (Simopoulos et al, 1986). Eggs can also provide small amount of 
DHA (<50 mg/egg) (Davis and Kris-Etherton, 2003). 
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(b) Gifts from the land: (i) omega-3 fatty acids (li) omega-6 fatty acids 
(i) Omega-3 fatt}' acids: ALA 
a-Linolenic acid (ALA, CI 8:3 co-3) (Figure 2) is found in chloroplast of green leafy 
vegetables (purslane, spinach etc.) and in oily seeds of canola, hempseed, walnuts and 
most notably in flaxseeds (richest source). (Davis and Kris-Etherton, 2003). Flaxseed 
{Linum usitatissimum or linseed) contains 32-45% of its mass as oil of which 51-55% 
is ALA and is the richest source of dietary fibre, both soluble and insoluble; and the 
highest content of phytoestrogenic lignans (Lay and Dybing, 1989; Harris and 
Haggerty, 1993; Prasad, 2000; Simopoulos, 2002b; Vijaimohan et al, 2006). The oils 
from these seeds are the only source of co-3 PUFA for vegetarians who do not eat fish 
for religious or other reasons. 
(ii) Omega-6 fatty acids: LA 
Linoleic acid (LA, CI8:2 co-6) (Figure 2) is plentifiil in nature and is found in the 
seeds of most plants except coconut, cocoa and palm. It is most predominant PUFA in 
western diet. Cooking oils with the greatest co-6 fatty acid content include safflower 
oil; grapeseed oil; sunflower oil; com oil; cottonseed oil and soybean oil. Processed 
foods, convenience foods and snack foods are also significant contributors to co-6 
intake (Davis and Kris-Etherton, 2003). 
Some of the major co-3 and co-6 sources of PUFA are summarized in Table 1 (Udo 
Erasmus, 1993; USDA nutrient data laboratory). 
Table 1: Fats and Oil Composition 
Fatty acid 
Components 
(%) 
ALA 
LA 
ALA+LA 
EPA 
DHA 
Sunflower 
1 
68 
69 
-
-
Vegetable Based* 
Corn 
1 
58 
59 
-
-
Canola 
11 
21 
32 
-
-
Walnut 
14 
58 
72 
-
-
Flax-seed 
57 
16 
73 
-
Marine Based* 
Herring 
0.6 
1.6 
2.2 
8.6 
7.6 
Menhaden 
-
1.2 
1.2 
11.0 
16.0 1 
•'The values are expressed as percent of total fatty acids. 
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(A) g-linolenic add (ALA) Cfi^micaffomuCa: C18:3A 9.12,15 
(B) Eicosapeiitaenoic acid (EPA) Cf^mkaffomuCa: C20:5A , , n . ; . . 5.8.11. H P 
(C) Docosahexaenoic add (DHA) Chemicalfomuk C22:6A 4.7.10.13.16.19 
H 
0) 
1 
4 7 10 13 16 19 
Figure 2: The structures of co-3 fatty acids 
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2.2 Beneficial health effects of co-3 PUFA from marine sources (EPA and 
DHA): ''Medicinal fatty acids'' 
The health benefits of fish oil have been extensively studied since the observation that 
incidence of cardiovascular diseases was lower among population that consumed 
large amounts offish (Kris-Etherton et ai, 2002). Fish oil contains a high proportion 
of co-3 PUFA e.g. eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). 
Efficacy and potential clinical utility of these fatty acids range from cardiovascular 
disorders (CVD) to hyperlipidemia, cancer, inflammatory disorders of renal and 
gastrointestinal systems, respiratory diseases, diabetes etc. (Connor, 2000; Kakar et 
ai, 2008). A number of investigations have demonstrated that co-3 fatty acids present 
in fish oil have profound beneficial effects on murine function including both cell and 
humoral mediated immunity in autoimmune diseases such as lupus nephritis (Grande 
and Donadio, 1998) and rheumatoid arthritis (Yusufi et ai, 2003). Recently it has 
been shown that FO may have a therapeutic potential as an adjunct therapy for human 
AIDS (Xi and Chen, 2000). DHA has been found to be essential in normal functional 
development of retina and brain (Simopoulos, 2000). The intake of co-3 PUFA/fish oil 
or consumption of fish was shown to have inverse association with growth and 
development and rate of depression and other mental deficiencies (Simopoulos, 
1991). Fish oil therapy has been used in cancer of the digestive tract, breast and 
prostate (Karmali, 1989). Intake of fish oil has been reported to have anti-ulcer 
actions (Lugea et ai, 1991). Several animal and human studies demonstrate that FO 
may act as free radical scavenger (Fisher an Levine, 1991; Chautan et al, 1990; 
Sarsilmaz et al., 2003; Barbosa et al, 2003). Thus dietary co-3 fatty acids have moved 
from speculation about their functions to solid evidence that they are not only 
essential nutrients but they also favorably lower the incidences and progression of 
various chronic diseases whereas co-6 PUFA are known to produce pro-inflammatory 
factors promoting inflammation, tumor growth and most degenerative disorders 
(Simopoulos, 2001; Berquin et al, 2008). Some of the beneficial effects of co-3 PUFA 
in detail arc described as follows: 
(A) Blood lipids and cardiovascular effects: The potential role of FO in CVD risk 
reduction first came fi-om the observation involving Inuits in Greenland (Mouratofife/ 
ai. 1967). Epidemiological data indicate a veiy low incidence of ischemic heart 
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disease in Eskimos and Japanese population that consume a diet ricli in seafood (Bang 
et al. 1976; Dyerberg and Bang, 1982). Burr et al. (1989) showed that patients who 
had myocardial infarcts had reduction in mortality over 2 years by eating 2 or 3 fish 
meals a week. It has been reported that fish consumption reduce the incidence of 
deaths from coronary artery disease via effects on blood pressure, atherosclerosis and 
thrombogenesis (Kinsella et al, 1990; Connor, 1994; Leaf, 2008). One of the most 
remarkable and consistent effects of a>-3 fatty acid supplementation in humans is their 
ability to decrease plasma concentration of triglycerides and VLDL (Harris, 1997; 
Foulon et al, 1999). PUFA have been shown to reduce total plasma cholesterol and 
improves LDL to HDL ratio (Dupont et al, 1990; Ruiz-Gutierrez et al, 1999). 
Numerous epidemiological studies suggest that people who subsist on PUFA rich 
diets have lower blood pressure than people whose diets have high content of 
saturated fatty acids (Smith-Barbaro and Pucak, 1983; lacono et al, 1984). Dietary »-
3 FAs retard the development of hypertension and related proteinuria (Rayner and 
Howe, 1995). Beneficial effects of co-3 fatty acids from both plant (flaxseed oil) and 
marine sources have been demonstrated on all coronary artery disease, fatal and non 
fatal myocardial infarction, stroke, sudden cardiac death (Schmidt, 1993; Lanzmann, 
2001; Nannicini et al. 2006; Posta et al, 2006). Thus, (o-3 fatty acids are "Hearf 
healthy'. 
(B) Dietary lipids and cancer: During the past several decades, research surveys and 
animal studies have indicated that high-fat diets are associated with increased 
incidence and accelerated development of certain tumors (Femandis and 
Venkatraman, 1993). However, unsaturated dietary fats are inversely related to the 
development and progression of various forms of cancers. Although dietary lipid itself 
is not usually considered a true carcinogen, it is postulated to enhance or promote 
development of tumor cells. Results from experiments with carcinogen-induced and 
transplant tumor models showed that diet containing higher levels of marine oil-
derived (i)-3 PUFA affects tumorigenesis in a different manner from equivalent 
vegetable oil-derived co-6 PUFA diets. In animal models atleast, co-6 PUFA diets have 
stimulated development of four types of solid tumors (breast, colon, pancreas and 
prostrate), whereas co-3 PUFA diets have diminished them (Cave, 1991). It has been 
found that o)-3 fatty acids prevent the worsening of colon cancer while o)-6 fatty acids 
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promote the growth of colon tumors (Anti et ai, 1994). (o-3 fatty acids in 
combination with other nutrients (namely vit C, vit E, beta-carotene, selenium) may 
prove to be of particular value for preventing and treating breast cancer (Zhu et ai, 
1995). DHA and EPA can inhibit the growth of prostate cancer (Aronson et ai, 2001). 
It has also been shown that changes in the lipid composition of the diet, readily induce 
fatty acid alteration in both the neoplastic and non-neoplastic cell membranes, hence 
the cell's subsequent physiological and pathological behaviour. EPA and DHA have 
been shown to inhibit carcinogenesis by several molecular mechanisms including 
^creased/increased^production of free radicals and ROS; suppression of arachidonic 
acid derived eicosanoid biosynthesis, gene expression (decreasing the expression of 
AP-1) and cell cycle regulation (Siddiqui et ai, 2003), influences on transcription 
factor, ^ittfy^, signal transduction pathway/ and alteration of estrogen metabolism 
(Hardman, 2002; Larsson et ai, 2004). 
(C) Depression and other mental disorders: There are several lines of evidence 
relating diet with depression and other mental conditions. After all, brain is all fat 
and fats in the brain could easily be altered by diet. At present in the western societies 
the diets contain 15-20 times as much co-6 as (o-3 PUFA and this imbalance was 
considered to be responsible for altered mental health. According to Hibbeln (1998) 
lack of co-3 PUFA early in life may forever alter the way the brain develops and 
operates. Low levels of DHA are linked to suboptimal visual acuity and reduced brain 
development in infants, for this reason DHA is now added to infant formula milk 
(Uauy et ai, 2001). Diminished levels of co-3 PUFA, especially DHA have been 
associated with several neurological and behavioral disorders, such as depression, 
schizophrenia, Alzheimer's disease and attention deficit hyperactivity disorder 
(Conquer and Holub, 1997; Zamaria, 2004; Bourre, 2005). Depressed patients showed 
significant progress within two weeks of taking fish oil. Most remarkably cross 
culture studies demonstrate a strong relationship between native's consumption of co-3 
PUFA and its level of depression. In countries where people eat the least fish the rate 
of depression is highest, and vice versa. The average New Zealander, for example, 
eats only 18 kg of fish a year and 6% of the population suffers from depression. In 
Japan, where they eat 64 kg of fish a year, depression accounts <1% of population. 
This correlation holds true across the world. Growing evidence support the essential 
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role of PIJFA in the development, growth and overall functions of neuronal cells, as 
20% of neuronal cell membranes are essential fatty acids. DHA and other a)-3 PUFA 
boost serotonin and affect mood (Small, 2002). In animal models, (0-3 deficiency 
caused memory deficit (Gamoh et a!., 1999), learning disability (Carrie et ciL, 1999) 
and visual acuity (Neuringer, 2000). Thus, while these long- chain fatty acids are not 
technically "essential" nutrients, it is important to ensure that they should be 
sufficiently present in the diet for "happy and healthy brain ". 
(D) Omega-3 fatty acids and renal diseases: Recent studies have demonstrated that 
dietary supplementation with co-3 PUFA retards disease progression in human and 
experimental renal disease (Donadio et al, 1994; Grande and Donadio, 2001; 
Donadio, 2001). Fish oil enriched in EPA and DHA has been shown to reduce blood 
pressure, serum lipid levels, decrease eicosanoid and cytokine production and reduce 
proteinuria in human and experimental renal disease (Goldstein et al, 1975; Engler 
and Engler, 2000). In IgA nephropathy, the most common glomerulonephritis 
worldwide (D'Amico, 1987), the rate of renal disease progression was significantly 
reduced in patients given a fish oil supplement (Donadio et al., 2001). Dietary (0-3 
competes for arachidonic acid oxygenation pathway resulting in formation of 
biologically [inactive end products thus exhibiting a favourable effect on glomerular 
injury, various forms of acute and chronic renal failure, allograft rejection, structural 
and functional renal damage in cyclosporine nephrotoxicity, hepatorenal syndrome, 
diabetic nephropathy, renal hypertension, vascular access thrombosis of end stage 
renal disease, idiopathic calcium urolithiasis, idiopathic immunoglobulin A 
nephropathy and lupus nephritis (Azar et al, 1989; De Caterina and Craven, 1993; 
De Caterina et al., 1994; Donadio, 2001; Baggio et al., 2002). Fish oil was also linked 
to the management of type 2 diabetes (Montori et al., 2000; Mostad et al., 2006). co-S 
PUFA are ''renoprotective" fatty acids and portray as potential new treatments for 
immune renal diseases. 
(E) Omega-3 fatty acids and sastrointestinal pathologies: In past few years there 
have been many advances in the area of small bowel physiology, pathology and 
therapy. Dietary PUFA influence the natural history of Inflammatory bowel diseases 
(IBD) including: Crohn's disease (CD) and ulcerative colitis. CD is a chronic, 
transmural, inflammatory process that results in bloody stools and malabsorption 
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problems whereas ulcerative colitis is a chronic relapsing inflammatory disease of the 
colonic and rectal mucosa resulting in ulceration, hemorrhage, edema, and 
regenerating epithelium, co-3 fatty acids found in fish oil have an anti-inflammatory 
activity and have given spectacular results in treatment of patients with CD (Belluzzi 
et ai, 1996; Tsujikawa et al, 2000) and shown marked clinical improvement of 
active, mild to moderate ulcerative colitis (Salomon et al, 1990; Asian and 
Triadafilopoulos, 1992; Barbosa et al, 2003). FO showed significant protecfive effect 
in different experimental models (Faust et al, 1989; Al-Harbi et al, 1995; 
Lichtenberger et al, 1998; Manjari and Das, 2000) of gastric ulceration by inhibition 
of offensive mucosal factors and oxidative stress, and augmentation of defensive 
mucosal factors (Bhattacharya et al, 2006). Dietary FO has been shown to protect 
against ethanol-induced gastric mucosal injury (Leung, 1992). Dietary co-3 fatty acids 
are preferentially incorporated into the mucosal phospholipids at the expense of ©-6 
fatty acids resulting in immunomodulatory effects including alteration of lymphocyte 
proliferation, neutrophil fianction, antigen presentation and induction of apoptosis in 
addition to changes in intestinal structure and function including changes in cellular 
glycoproteins and tight junctions. o)-3 fatty acids have been shown to influence the 
intestinal BBM uptake of glucose, galactose and cholesterol (Thompson et al, 1988; 
1989). 
2.3 Beneficial health effects of o>-3 PUFA from plant sources (ALA) in health and 
diseases -"Seeds of hope" for vegetarians: 
The health benefits of dietary consumption of food rich in marine o)-3 PUFA are well 
established. Whether plant 00-3 PUFAs are as beneficial as the co-3 PUFA from 
fish/marine food has not been investigated extensively. Lately, flaxseed, Linum 
usitatissimwn has been the focus of increased interest in the field of diet and disease 
research due to the potential health benefits (Abdel-Moneim et al, 201 la) associated 
with some of its biologically active components. It contains 32 to 45% of its mass as 
oil of which 51 to 55% is a-Linolenic acid (ALA) (18:3 n-3, omega-3 fatty acid), a-
Linolenic acid (ALA), is a major co-3 FA in plants (Hams, 2005). It is a precursor of 
EPA but not DHA and must be converted to EPA for its bioeffector role (Mantzioris 
et al, 1994). ALA is metabolized to EPA in humans to a significant extent (Valsta et 
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at., 1996). ALA from vegetable sources including grains and oils, offer an alternative 
source for those who are unable to regularly consume fish for religious or other 
reasons (Harper and Jacobson, 2001). Although plants, sea microalgae and seaweeds 
are primary source of EPA and DHA, but most are not concentrated sources. They do 
not contribute significantly to EPA intakes in the western world but are important 
sources where people use large quantities of seaweeds on a daily basis (e.g. Japan and 
other parts of Asia). Thus vegetarians can rely to some extent on eggs/microalgae 
supplements for the supply of essential fatty acids. 
ALA from vegetable oils and EPA and DHA from fish oil have several parallel 
beneficial health effects (Freese and Mutanen, 1997; Ide et ai, 2000; Kim and Choi. 
2001). Recent epidemiologic studies have shown that dietary ALA is associated with 
a lower risk of CVD in men and women (Djousse et al, 2001). ALA has been 
associated with a lower rate of fatal and non-fatal coronary events (Nannicini et ai, 
2006). Hypotensive effect of flaxseed oil have been documented lately thus 
constituting another mechanism for cardioprotective effect of ALA (Paschos et al, 
2007). The consumption of ALA rich FXO offers protective effects against 
cardiovascular disorders compared to LA-rich sunflower oil via their ability to 
decrease the tendency of platelet to aggregate (Allman, 1995) and inhibition of 
progression of arterial atherosclerosis (Lorgeril and Salen, 2004; Mozaffarian, 2005). 
co-3 ALA has been shown to have greater hypolipidemic effect than ©-6 LA (Kim and 
Choi, 2001). Role of ALA in flaxseed oil in prevention of colon cancer has also been 
demonstrated (Kelley et ai, 1991; Williams et al, 2007). Utility of flax and flaxseed 
oil in lupus nephritis and renal failure have also been accounted (Kelley et al, 1991; 
Basch et al, 2007). Dietary supplementation with flaxseed oil affects the 
biochemistry of fatty acid metabolism and thus the balance of proinflammatory 
mediators and atherogenic lipids, holding a great promise for modulating 
inflammatory diseases (Chilton et al, 2008). Flaxseed oil has been shown to increase 
life span of irradiated mice suggesting its prophylactic potential against radiation-
induced degenerative changes in liver (Bhatia et al, 2007). Recent researches have 
shown that long temi flaxseed oil supplementation diet protects BALB/c mice against 
streptococcus pneumoniae infection (Archana et al, 2010). Flaxseed oil has received 
attention for its potential role in lead acetate induced kidney and liver damage and in 
preventing lipid disorders (Abdel-Moneim et al. 2010, 2011a, 2011b). Dietary 
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supplementation of flaxseed was found to inhibit the growth and development of 
prostate cancer in the transgenic adenocarcinoma mouse prostate model (Lin et al., 
2002). Flaxseed has also been reported to inhibit human breast cancer growth and 
metastasis and down-regulate expression of insulin-like growth factor and epidermal 
growth receptor (Chen et al, 2002). Another study using rat suggested that exposure 
to flaxseed during suckling inhibited chemically induced mammary tumorigenesis 
(Chen et al., 2003). Moreover, previous studies have shown that the 
cyclophosphamide-induced decUne in the blood levels of glutathione (GSH), 
glutathione peroxidase (GSH-Px) and alkaline phosphatase were also significantly 
reduced by flaxseed oil in mice (Bhatia et al., 2006). 
Taken together, it appears that a)-3 PUFA both from marine and plant sources have 
many similar beneficial effects and that plant to-3 PUFA are a great relief for those 
who are largely vegetarians. 
3. STRUCTURE AND FUNCTION OF KIDNEY: 
The kidney is a vital organ that plays an essential role in health and disease. The main 
function of the kidney is to maintain total body fluid volume, its composition and pH 
within physiologic range. This is achieved collectively by the presence of several 
millions of architectural and functional units of the kidney, known as '"nephron". A 
nepliron consists of glomerulus with an extended tubular structure. A rat kidney 
contains 30,000-35,000 nephrons whereas a human kidney is made up of about 
1,30,000 nephrons. All these nephrons contribute to maintain renal functions by 
selective reabsorption of various ions and solutes. 
The structure of the mammalian kidney apparently looks very homogenous, however, 
can be viewed as a composite of several tissue organs, geometrically, functionally and 
metabolically (Schmidt and Guder, 1976) (Figure 3). Thus each nephron consists of 
group of organs arranged in series coursing-through four concentric tissue planes, the 
cortex, outer and inner zones of the outer medulla and the inner medulla (papilla) 
(Schmidt and Guder, 1976) (Figure 4). Each tissue plane also has individual "organ" 
characteristics with respect to their ionic contents and metabolic rates (Guder, 1973; 
Schmidt and Guder, 1976). 
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The luminal brush border membrane (BBM) of renal proximal tubule is the major site 
for reabsoiption of various solutes including amino acids, sugars and 0uy^ nutrients, 
9^ | t^ ions and minerals such as Na^ and inorganic phosphate (Pi) (Evan et al., 
1983). Reabsorption of most ions and solutes from the tubular lumen is coupled by an 
active transport with sodium (Na^) via a carrier located on apical side and is driven by 
an electrochemical gradient of Na^ generated by Na^/K^-ATPase located on 
basolateral side (McCrory et al, 1952; Massary and Fleisch, 1980; Bonjour and 
Caverzasio, 1984). Thus the transport of Na^ is considered to be a major work 
function of the kidney upon which all other transports are dependent (Ullrich et ai, 
1974; 1977). The energy for the sodium transport is mainly provided by the 
hydrolysis of ATP at antilurainal membrane site involving NaVK^ATPase (Balagura-
Baruch et al, 1973; Evan et ai, 1983). Since the production of ATP is usually 
coupled to oxidative metabolism occurring in mitochondria, Na^ transport appears 
to be linked with the oxidative metabolism or oxygen tension (p02) of the renal 
tubular ceils. A direct linear relationship between O2 uptake/utilization and Na^  
reabsorption has been found (Thurau, 1961; Torelli et al, 1986). There appears to be 
a reverse cortico-medullary gradient for tissue oxygen tension (pOa) i.e., pOi in inner 
medulla is far lower than in cortical tissue (Aukland and Krog, 1960; 1961; Aukland, 
1962; Aperia and Liebow, 1964). 
According to several studies, fatty acids, glutamine, lactate, citrate and in particular 
glucose are the major substrates which support the transport work of the kidney (Leal-
Pinto, 1973; Park et ai, 1974; Pitts and Macleod, 1975; Mandel and Balaban, 1981). 
It is well established that various nephron subsegments located in different ^f^b^ 
zones of the kidney have different functions in solute and fluid transport, as well as in 
substrate metabolism. For example, the renal cortex is characterized mostly by 
aerobic oxidative metabolism (Lee et ai, 1962) while the renal medulla is the site of 
anaerobic metabolism and glycolysis. Moreover, the renal cortex is also capable of 
producing.glucose (Guder, 1973; Burch et ai, 1978; Maleque, I980).The oxidation of 
glucose in kidney may occur by several different metabolic pathways depending on 
the location and type of a particular nephron segment in the kidney: (i) the 
tricarboxylic acid (TCA) cycle, in which glucose is first converted to pyruvate by 
glycolysis which intum is completely oxidized to CO2 and H2O (ii) the hexose-
monophosphate (HMP) shunt pathway; and (iii) the glycolysis m which glucose is 
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partially oxidized to lactate (Figure 5). On the other hand glucose is known to be 
produced in the kidney by gluconeogenesis perhaps in the proximal tubule of the 
cortex (Schmidt and Guder, 1976; Maleque, 1980; Burch et al., 1978). The enzymes 
belonging to the above pathways are found to be present and distributed differentially 
in the kidney. 
The renal medulla is the major region for the production of lactate from glucose by 
glycolytic enzymes (Hems and Gaja, 1972; Guder, 1973) while the oxidative 
conversion of glucose to CO2 was shown in renal cortex (Lee et al., 1962; Cohen, 
1979). 
Nephron, which consists of various subsegments, shows distinct structural and 
ftinctional differences (Figure 4). Thus, nephron heterogeneity also adds to the 
variation m the kidney functions. Both inter- and intra-nephronal heterogeneity exists 
in the mammalian kidney that depends on the origin and location of the nephrons in 
the cortical region of the kidney (Use et al., 1987; Francois and Danielle, 1985). The 
nephron which originates from the glomerulus located in superficial cortex is known 
as "superficial nephron" while the nephron which originates from deep cortical region 
is called as "deep" or "juxtamedullary nephron". These populations of nephrons have 
been found to be distinct structurally and functionally (Francois and Danielle, 1985). 
In inter-nephronal heterogeneity, proximal convoluted tubules of superficial nephrons 
always touch the surface of the kidney. In intra-nephron or axial heterogeneity, the 
proximal tubules have been divided into three distinct morphological subsegments 
namely Si, S2, and S3. The early proximal convoluted tubules (PCT) both in 
superficial and juxtamedullary nephrons is defined as Spsegment and can be 
identified by its attachment with glomeruli on one side. S2 is defined as the late 
superficial proximal convoluted tubule, early superficial proximal straight tubule and 
late juxtamedullary proximal convoluted tubule. S3 is located principally in the outer 
stripe of outer medulla and consist of terminal superficial proximal straight tubule 
and entire juxtamedullary proximal straight tubule. S3 is identified by its medullary 
location and by its connection with thin limbs on distal part. All S3-subsegments (pars 
recta), as they descend from cortex into the outer stripe of the outer medulla, change 
from S2 to S3 cell type. Thus, the outer stripe of the outer medulla contains proximal 
tubular ceils but only the S3 type (Woodhall et al., 1978). These segments can be 
characterized by their biomarker enzymes (Yusufi et al., 1994). 
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3.1 Acute Kidney Injury: 
Acute kidney/renal injury (AKI), previously called acute renal failure f ARF), is a 
process rather than a state. Often it denotes a reversible insufficiency of the 
glomerular and tubular excretory functions which may be triggered by renal or extra-
renal mechanisms. AKI denotes a dramatic clinical situation in which both the 
kidneys stop their function within a short period of time or immediately depending on 
the severity of AKI. It is best characterized by increase of waste products, such as 
serum creatinine and blood urea nitrogen and appearance of proteinic and enzymic 
components in the urine. 
AKI can be grossly divided into three phases; pathogenic phase, manifestation phase 
and recovery phase. In the first phase, a progressive disintegration and necrosis 
especially of tubular epithelial cells has been observed, leading to the functional loss 
of the kidney which is manifested by the reduction of inulin clearance (Steinhausen 
and Parekh, 1984). In the second phase, long lasting effects are observed that severely 
affect the clearance of both creatinine and inulin and which can continue for several 
days after recovery begins, depending on the degree of renal damage. In the recovery 
phase, there is an increase in concentrating ability of the kidney with eventual 
normalization of kidney functions. 
A number of environmental variables viz heavy metals chromium, mercury, cadmium, 
lead, uranium (Bank e! ai, 1967; Cronin, 1986; Banday et al, 2008b) and chemicals 
(Yagil, 1990; Weinberg et al, 1990) including drugs like aminoglycosides, 
cephalosporin, cisplatin etc. (Porter and Bennett, 1981; Harris et al, 1990; Basnakian 
et al, 2002; Banday et al, 2008a) affect the structure and fiinction of the kidney 
leading to AKI. Generally, AKI caused by drugs and chemicals is much more severe 
and iireversible and the recovery sometimes is not possible (Steinhausen and Parekh, 
1984). The pathophysiologic mechanism of AKI has been investigated extensively in 
the last few decades. Four major possible causes of AKI have been generalized which 
include renal vasoconstriction, glomerular permeability, tubular obstruction and 
tubular leakage (Mason, 1986). For many causes of AKI, ROS have been invoked as a 
pathway for renal injury. The kidney has been studied as an organ that can generate 
ROS and is vulnerable to the damaging effects of ROS. That ROS contribute to the 
pathogenesis of AKI is supported by the presence of oxidative stress in models of 
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AKl, the amelioration of renal injury in these models by antioxidant maneuvers, and 
the worsening of renal injury in such models by manipulations that exacerbate 
sustained oxidative stress (Mason, 1986; Penelope et al., 2011). Oxygen radicals are 
important mediators of renal damage in AKI causing lipid peroxidation of cell and 
organelle membranes, disrupting the structural integrity and capacity for cell transport 
and energy production (Greene and Paller, 1991). Several preventive measures have 
also been utilized but a definite answer for the pathogenesis and control of acute renal 
injury, however, remains the topic of future studies. 
4. CISPLATIN : PATHOPHYSIOLOGY 
Cisplatin (cis-diamminedichloroplatinum II) is an inorganic complex of platinum 
whose cytotoxicity was first discovered by Rosenberg et al. in 1965. Cisplatin is one 
of the most potent anti-cancer drugs currently in use and is effective against a wide 
spectrum of solid cancers. Despite its effectiveness, the dose of cisplatin (CP) that can 
be administered is limited by its nephrotoxicity. Several other platinum analogues 
(e.g. carboplatin, explatin, nedaplafin) had entered clinical trials in order to improve 
the effectiveness and to lesser the toxicity of CP. Cisplatin was first synthesized by 
Michael Peyrone in 1845, and is historically known as Peyrone's chloride. The 
structure was first elucidated by Alfi-ed Werner in 1893 (Figure 6). Cisplatin is a 
heavy metal plafinum co-ordination complex containing a central atom of platinum 
surrounded by chloride and amrttoni'am(^tom^ih the cis position of a horizontal plane. 
Cisplatin and other related drugs form strong electrophillic intermediates that act via 
nucleophillic substitution reaction to form inter and intra strand DNA cross-links. CP 
remained a major antineoplastic drug for the treatment of solid tumors such as 
metastatic testicular cancer, advanced ovarian carcinoma (Taguchi et al., 2005), 
advanced bladder carcinoma and squamous cell carcinoma of head and neck 
(Nakashimae?a/., 1990). 
CI Pt NH3 
CI 
Figure 6: Structure of Cisplatin (CP) 
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It is given intravenously or intraperitoneally, binds to serum protein by about 90%, 
distributes to most tissues and is cleared unchanged from the kidney (Royer et al.. 
2005). Free CP in the plasma, by virtue of its low molecular weight and uncharged 
character, is freely filtered at the glomerulus (Safirstein et al, 1984). CP and its 
analogs accumulate in the kidney to higher degree than other organs probably through 
energy-mediated transport (Arany and Safirstein, 2003; Kawai et al, 2005). CP 
concentrations in proximal tubular epithelial cells exceeds plasma concentrations by a 
factor of five. The disproportionate accumulation of cisplatin in kidney tissue 
contributes to cisplatin-induced nephrotoxicity (Arany and Safirstein, 2003). 
Intracellularly, the highest concenfration of CP is found in the cytosol, mitochondria, 
nuclei and microsomes (Kuhlmann et al, 1997). 
4.1 Effect of Cisplatin on Kidney: 
The toxic effect of the drug in mammals and animals include nephrotoxicity, 
ottotoxicity, neurotoxicity and bone marrow suppression but its chief dose-limiting 
side effect is nephrotoxicity (Arany and Safirstein, 2003; Boulikas and Vougiouka, 
2003; Sastry and Kellie, 2005). Morphologically, the nephrotoxicity induces necrosis 
of the terminal portion of the proximal tubule and apoptosis, predominantly in cells in 
the distal nephron. CP treatment also induces extensive death of cells in proximal and 
distal tubules and loop of Henle (Arany et al, 2004; Taguchi et al, 2005). Light and 
electron microscopy have shown that the CP induced injury and necrosis in the rat 
kidney are predominantly localized in the S3 segment of proximal tubule in the 
corticomedullary region with or without accompanying distal changes (Townsend et 
al, 2003). Pathological changes were rarely observed in the SI and S2 segments of 
pars convoluta of the proximal tubule. Cisplatin toxicity in proximal tubular epithelial 
cells is morphologically characterized by tubular_jiecrosis,_-loss of microvilli, 
alterations in number and size of lysosomes, and (mitochondrial vacuolization!. These 
^ T t e ^ - - -
structural alterations are accompanied by functional disturbance of(^arious cell 
organene§>(Kuhlmann et al, 1997). Very few changes were noted 1 to 2 days after the 
injection of drug, although a focal loss in brush border, increased cytoplasmic vesicles 
and a necrotic cell were seen occasionally in the proximal tubules in the outer stripe 
region. More severe lesions became evident after 3 days, and the S3 segment showed 
a spectrum of morphologic alterations (Dobyan et al, 1980). In some cells, the bmsh 
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border was almost completely obliterated with only a few microvilli remaining. 
Clumping of nuclear cliromatin and increased number of cytoplasmic vesicles could 
be seen in many of the injured cells (Nonclercq et al, 1989). 
Functionally, the nephrotoxicity causes reduced renal perfusion and a concentrating 
defect, and changes in renal hemodynamics. Biochemical, morphological and 
functional alterations induced by CP in renal mitochondria supports the idea that 
mitochondria could be the primary target of toxicity as the S3 segment of the 
proximal tubule has a large number of mitochondria as compared to other parts of the 
kidney (Santos et al., 2007). 
The alterations induced by CP in the kidney functions are characterized by change in 
urine volume, increase in BUN and serum creatinine levels (Dauggard, 1990). Some 
biochemical changes due to CP treatment include generation of free radicals, lipid 
peroxidation (Hannemann and Baumann, 1988; Matsushima et al., 1998; Sadzuka et 
al, 1992), loss of renal sulfhydryl groups, damage to mitochondria (Zhang and 
Lindup, 1993) impaired antioxidant enzyme activities (Ulubas et al, 2003) and 
inhibition of DNA synthesis (Gomeva et al, 1993). 
Although the exact mechanism of cisplatin nephrotoxicity remains unclear, 
biotransformation of cisplatin could play an important role (Fillastre and Raguenez-
Viotte, 1989). Conversion of cisplatin to nephrotoxic molecule in the proximal tubule 
cells is required for cell injury (Townsend and Hanigan, 2002). CP undergoes ligand 
binding reactions which are virtually irreversible (Daley-Yates and McBrien, 1982). 
CP is biotransformed through binding to low molecular mass substances such as 
glutathione, methionine, cysteine and to high molecular mass substances such as o 
albumin and nucleic acids and the resulting metabolites are known as(mobile and 
fixed metabolites respective!^ (Farris et al, 1985). It has been shown that cisplatin is 
conjugated to glutathione and then metabolized through a y-glutamyl transpeptidase 
(GGTase) and a cysteine S-conjugate P-lyase ^^oedjlejj^ pathway to reactive thiols, a 
potent nephrotoxin (Yao et al, 2007; Townsend et al, 2003). A series of studies on 
the role of the enzyme y-glutamyl transpeptidase in cisplatin toxicity revealed that in 
tumor cells GGTase expression increased resistance to cisplatin, while in kidney 
GGTase expression made the cells sensitive to cisplatin toxicity (Hanigan et al, 1999; 
Hanigan el al, 2001). The disparate roles of GGTase in the antitumor activity and 
nephrotoxicity of cisplatin suggest that the mechanism by which cisplatin kills tumor 
Page I 23 
Introduction 
cells is distinct from the mechanism by which it kills the proximal tubular cells in the 
kidney. 
Once cisplatin is administered to cancer patients intravenously as a sterile saline 
solution, there are three possible mechanisms involved in CP toxicity. Upon entering 
the bloodstream, it remains intact due to the relatively high concentration of chloride 
ions (~100mM). Cisplatin enters cells by diffusion where it is converted to its active 
form. Inside the cell the neutral cisplatin molecule undergoes hydrolysis in which a 
chlorine ligand is replaced by a molecule of water, generating a positively charged 
y~) species (Figure 7). These aquated forms qte highly reactive with nucleophiles and can 
. vloseTi^rogen ions to form cytotoxic hydroxyl radical^ Once inside the cell, cisplatin 
has a number of possible targets: DNA; RNA; sulfur containing enzymes such as 
^^^metailothionein. glutathioneXand mitochondrii) The principal target of cisplatin is 
i - ^ ^ — ^ - - .-^ — — ^ 
DNA (Cohen and Lippard, 2001). It causes intrastrand cross-linking probably 
between N7 and 06 of the adjacent guanine molecules, which results in local 
denaturation of DNA chain. CP also damages cell mitochondria, arrest cell cycle in 
the G2 phase, inhibits ATPase activity, alters the cellular transport system, eventually 
causing apoptosis, inflammation, necrosis and cell death (Boulikas and Vougiouka, 
2003;Taguchie/a/., 2005). 
Inside the Cell: 
Pt (NH3)2Cl2+H20 > [ Pt(NH3)2 CI (H20)]^ + Cr 
[Pt (NH3)2 C1(H20)] V H2O > [Pt(NH3)2(H20)2]^^ 
^~y~* SI I -^p •"*— 
\ 
H A NH 
Figure 7: Cellular uptake of cisplatin and its target 
(From: Encyclopedia of cancer by Pil and Lippard, 1997) 
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There are two distinct genomes in the cell; mitochondrial and nuclear. It has been 
postulated that mitochondrial DNA damage induced by CP causes nephrotoxicity 
(Singh, 1989), the reasons being, that, mitochondrial DNA is less closely associated 
with proteins than nuclear DNA (Salazar et ai, 1982) and thus will be more 
accessible to attack by aquated species of CP. Secondly, DNA repair mechanisms 
play a major role in nucleus than in mitochondria. Damage of the mitochondrial 
DNA, would result in the inhibition of the de novo synthesis of mitochondrial 
proteins, leading to the degeneration of the organelles. Cisplatin nephrotoxicity has 
been demonstrated to be mediated by DNasel (Basnakian et ai, 2005). 
Another mechanism proposed is that cisplatin induces renal damage by free-radical 
generation, by altering arginine metabolism and by increasing the activity of calcium 
independent nitric oxide synthase (Devipriya and Shyamaladevim, 1999). Glutathione 
is one of the most important antioxidant systems. The interaction of CP with 
sulphydryl groups is an important factor in promoting cytotoxicity. Due to the 
compounds high affinity to SH groups, its chloride moieties are replaced by 
sulphydryl groups (Kuhlmann et ai, 1997). The formation of stable protein-S-CP 
adducts results in dysftinction of membrane associated and cytoplasmic proteins e.g. 
Na^/phosphate and NaVglucose cotransporters (Courjault-Gautier et a/., 1995) and 
decreases the activity of important enz>Tne systems such as glutathione-S transferase, 
reductase and peroxidase (Bompart, 1989). In addition, stable glutathione-CP adducts 
lead to a decrease in the amount of reduced glutathione available to scavenge free 
reactive oxygen metabolites (Mistry et ai, 1991). This may effectively harm the 
cellular oxidant defense systems, eventually leading, to lipid peroxidation. The 
depletion of renal glutathione level has been observed in rats in response to oxidative 
stress caused by CP (Nakano and Gemba, 1989). A recent study suggests that 
apoptosis may also play an important role in development of CP induced acute renal 
injury (Lee et ai. 2001). CP has been reported to induce apoptosis in renal epithelial 
cells (Lieberthal et ai, 1996; Zhan et al, 1999; Lau 1999). Metabolic responses, cell 
cycle events and the inflammatory cascade seem to be important determinants of the 
degree of renal injury induced by cisplatin (Arany and Safirstein, 2003). Different 
studies have demonstrated that the cytotoxicity of CP is probably due to peroxidation 
of cell membrane, mitochondrial dysfunction, inhibition of protein synthesis and 
DNA damage in kidney thereby inducing renal dysfunction (Santos et al.. 2007). 
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4.2 Protection or Prevention against Cisplatin toxicity: 
Cisplatin (CP) is an antineoplastic agent that has a remarkably broad spectrum of 
clinical activity in the treatment of solid tumors (Cohen and Lippard, 2001). However, 
CP nephrotoxicity limits its use in cancer therapy. Hundreds of platinum compounds 
have been tested over the last two decades in order to improve the effectiveness and to 
lesser the toxicity of CP (AH and Al-Moundhri, 2006). Several agents have been 
tested to ameliorate the nephrotoxicity of platinum drugs (Ali and Al-Moundhri, 
2006). The agents that have been shown to prevent/reduce experimental CP 
nephrotoxicity include antioxidants, modulators of nitric oxide, agents interfering CP 
metabolism, diuretics and cytoprotective and apoptotic agents. Only few of these have 
been tested in humans. 
Administration of GSH was protective against lethal CP toxicity (Anderson et al., 
1990). The antioxidant ^de^jji that have been reported to either ameliorate or prevent 
the nephrotoxicity of cisplatin include melatonin (Sener et al., 2000; Hara et al, 2001; 
Saad and Al-Rikabi, 2002), selenium (Hu et al, 1997), vitamin E (Naziroglu et al., 
2004), N-acetylcysteine (Wu et al., 2005)'7 sodium selenite (Baldew et al, 1989; 
Franseccato et al. 2001), vitamin C (Appenroth et al, 1997; Antunes et al, 2000), 
curcumin (Antunes et al, 2000) and^aroteiioi^bixinXSilva et al, 2001). Among the 
antioxidants that have been tried against nephotoxicity of cisplatin, include those that 
have been extracted from natural products (Conklin, 2004) and medicinal plants such 
as Nigella Sativa (Ezzats and El-Daly, 1996). An ethyl acetate extract of Phellinus 
rimosus, fungus, has been shown to protect mice against cisplatin nephrotoxicity 
(Ajith et al, 2002). Shirwaiker et al, (2003) reported that treatment of rats with 
extract of the flowers of the plant Pongamia pinnata ameliorated cisplatin 
nephrotoxicity in a dose-dependent manner. It has been recently reported that 
treatment of rats with capsaicin, was effective in protecting against cisplatin-induced 
nephrotoxicity (Shimeda et al, 2005). The flavanoid naringenin has been shown to 
have in vitro and in vivo antioxidant and antiproliferative actions, which may be the 
basis of its protective effect against cisplatin nephrotoxicity (Totta et al. 2004). An 
angiotensin-converting enzyme (ACE) inhibitor containing sulfliydryl (-SH) group, 
captopril can protect against cisplatin-induced neplirotoxicity (El-Sayed et al, 2008). 
Recent studies have shown that green tea ameliorated CP-induced nephrotoxic effects 
due to its associated biochemical/antioxidant properties (KJian et al, 2009). 
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It has been suggested that NO is involved in CP nephrotoxicity (Snvastava et ai, 
1995, 1996) and it has been reported that the inhibitor o f ^ O synthase, NG-nitro-1-
arginine methyl ester, was effective in mitigating lipid peroxidation and other 
biochemical changes associated with nephrotoxicity caused by cisplatin (Saad et ai, 
2000). L-Arginine (precursor of iSfO) was also shown to have nephroprotective effects 
on CP nephrotoxicity. It has recently been shown that nephrotoxicity of cisplatin can 
be blocked by inhibiting either of the two enzymes expressed in the proximal tubules, 
y-glutamyl transferase or cysteine-S-conjugate-P-lyase (Townsend et ai, 2003). 
Erythropoietin (EPO) has been shown to exert cytoprotective and antiapoptotic effects 
in experimental cisplatin-induced nephrotoxicity and ischaemic acute renal injury 
(Yalcin et ai, 2003; Vessey et al, 2004). 
The in vivo mechanisms of cisplatin nephrotoxicity are complex and involve oxidative 
stress, apoptosis, inflammation, and fibrogenesis. High concentrations of cisplatin 
induce necrosis in proximal tubule cells, whereas lower concentrations induce 
apoptosis through a caspase-9-dependent pathway (Lieberthal et al, 1996). Treatment 
of rats with anti-inflammatory agent, salicylate reduced cisplatin nephrotoxicity (Li et 
al, 2002). The broad-spectrum cytoprotective agent, amifostine, has been approved 
by the US Food and Administration for use in patients receiving cisplatin, with the 
aim of reducing its nephrotoxicity. Both human and animal studies have shown that 
the use of diuretics (furosemide, mannitol and others) and hydration substantially 
mitigate cisplatin nephrotoxicity (Comelison and Reed, 1993; Yoshizawa et al, 1998; 
Santoso et al, 2003; Hanigan et al, 2005). 
In past few years, much interest has been centered on the role of naturally occurring 
dietary substances for the control and management of various chronic diseases such as 
cancer and cardiovascular disorders (Connor, 2000; Anurag et al, 2007; Estella et al, 
2006). From ancient times the physicians and scholars in Asia have understood that 
foods have both preventive and therapeutic value and are integral part of health. 
Renewed interest has been observed in the recent years in co-3 FA enriched dietary 
sources. However, studies on the protective effect of (o-3 PUFA enriched diet on drug 
induced toxicity are limited. Fish oil enriched in Q)-3 PUFA has been found to exert 
protection against gentamicin and uranyl-nitrate induced nephrotoxicity (Priyamvada 
et al, 2008, 2009). co-3 PUFA enriched FO and FXO have been shown to offer 
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significant protection from cisplatin induced oxidative damage in rat liver and 
intestine (Naqshbandi et al., 201 l,2012a,2012b). However, it is important that the 
prospective nephro-protective agent should not affect the drug efficacy while reducing 
its side effects. 
In light of these findings, the present investigation was undertaken to find an 
appropriate approach to reduce/prevent cisplatin'^s^/autkj^nephrotoxic effects. 
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SCOPE OF THESIS 
"Let food he thy medicine and medicine be thy food" this philosophy of Hippocrates 
(460 B.C.) is the underlying concept for the development of functional foods. The 
concept of functional food is novel to the west and is viewed as a revolution but in 
Asia, in contrast, functional foods have been part of the culture for centuries. From 
ancient times the physicians and scholars in Asia have understood that food have both 
preventive and therapeutic value and are integral part of health. 
Diets or "pharmacologically acting nutrients" are garnering more attention and are a 
potentially important approach to modulate the therapeutic uses of drugs. The recent 
few years have been rich in information coming from laboratories all around the 
worid concerning the positive impact of nutrition and dietary patterns on human 
health (Caballero, 2003). Chemoprevention has emerged as a practical approach in 
reducing risk of various ailments. The concept of chemoprevention of certain diseases 
using naturally occurring substances that could be included in the diet consumed by 
human population is gaining attention. At the same time, the factors both endogenous 
and exogenous that influence the incidence and progression of many chronic diseases 
are being better defined and understood. 
The kidneys play an essential role in the maintenance of total body fluid volume, its 
composition and acid-base balance by selective reabsorption. A number of 
environmental contaminants, chemicals and drugs including antibiotics and anticancer 
drugs dramatically alter the structure and function of various tissues and produce 
multiple adverse effects in the liver, kidney, heart and intestine (Soberon et al, 1979; 
Ozturk et al, 1997; Kohn et al, 2005). The antineoplastic nature of liganded platinum 
compounds, such as cisplatin (CP) has led to its increasing clinical use for the 
treatment of malignancies (Safirstein, 1984). The therapeutic use of cisplatin however 
is limited by myelotoxicity, ototoxicity, intestinal toxicity, and most notably renal 
toxicity (Filiastre and Ranguenez-Viotte, 1989; Mahmood and Waters, 1994). 
Although the mechanism underlying the side effects induced by cisplatin are not 
understood cleariy, it was considered to be attributed to the combination of multi-
ways (Hong et al, 2005; Ramesh and Ravees, 2002; Nowak, 2002; Townsend and 
Hanigan, 2002; Xrao et al, 2003), such as the generation of reactive oxygen species 
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(ROS), which could interfere with the antioxidant defense system and result in 
oxidative damage in different tissues (Pratibha et ai, 2006; Iraz et al., 2006) and 
reaction with thiols in protein and glutathione, which could cause cell dysfunction. In 
general, brush border membrane (BBM) and other major organelles e.g. mitochondria, 
lysosomes and microsomes are critical CP targets. CP is known to cause alterations in 
the structure and ftinctions of these organelles that can be demonstrated by 
determining the associated biomarker enz>mes. Evidence points out that CP induces 
nephrotoxicity partly via oxidative stress due to free radical generations. Considering 
vital clinical use of CP, it was used as a model of toxic injury in the present studies. 
For the effective use of CP, it is necessary that it should exert minimum side effects. 
Several approaches utilizing different mechanism have been attempted to reduce CP 
toxicity. Many different agents and strategies have been reported to ameliorate CP 
toxicity in experimental animals (Liao et al., 2008). Cisplatin induced toxicity in 
experimental animals has been shown to be protected by prior treatment with various 
antioxidants such as ebselleen (Yoshida et al., 2000), selenium (Francescato et al., 
2001; Naziroglu et al., 2004), vitamin C (Antunes et al., 2000; Fatima et ai, 2007), 
green tea (Khan et al., 2009) and methionine (Kroning et ai, 2000; Campbell et ai, 
2003). It has also been reported that NAC (N-acetyl cysteine), low molecular weight 
antioxidant can protect the cisplatin associated nephro and ototoxicity (Mishima et 
al., 2006; Nisar and Feinfeld, 2002). However, none of these strategies were found to 
be suitable/safe for clinical practice. 
The quest for protective dietary nutrients for the control and management of various 
chronic diseases has spanned generations of scientific research. Of late, renewed 
interest and vigor has been showered on the role of co-3 fatty acids. Fish oil enriched 
in 00-3 PUFA (EPA and DHA) provide one such dietary source of biologically active 
components that has been shown to be co-preventative and co-therapeutic in a wide 
variety of ailments (Doughman et al., 2007). 
A number of investigations have already demonstrated that diet supplemented with 
fish oil (FO) enriched in co-3 PUFA has profound beneficial health effects against 
various pathologies including cancers, cardiovascular diseases, diabetes, depression, 
arthritis, asthma and inflammatory and immune disorders of kidney and intestine. 
Recently co-3 PUFA from some plants/seeds e.g. flaxseed oil (FXO) showed many 
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similar health benefits as demonstrated by ©-3 PUFA from FO. Dietary fatty acids are 
known to be incorporated in cellular membranes especially plasma membranes 
affecting membrane fluidity and the organization of various membrane enzymes and 
transport proteins (Kogteva and Bezuglov, 1998) influencing the functional aspects of 
various organs especially of kidney; leading to "positive" end points relating to health 
and disease (Seo, 2005). 
Although ro-3 PUFA have been shown as environmental deterrents (Watkins et ai, 
2007) for environmental contaminants, studies on their possible beneficial effects 
against drug/chemical induced nephrotoxicity are especially very limited. Recently 
research in our lab has shown that FO could prevent gentamicin and uranyl nitrate 
induced nephrotoxicity (Priyamvada et ai, 2008, 2009). Considering the profound 
beneficial health effects of co-3 PUFA we hypothesized that: dietary FO and FXO 
enriched in co-3 PUFA would be able to prevent/reduce CP induced nephrotoxic 
and other adverse effects in rat kidney. 
To address this hypothesis the present work was undertaken to study detailed 
biochemical events/cellular response/mechanism of CP induced nephrotoxic and other 
adverse effects in rat kidney. The effects of dietary co-3 PUFA were also determined 
to observe any protection provided by them against CP nephrotoxicity. The specific 
objectives of the planned research included:-
In the first part: 
Experiments were conducted to study the effect of (0-3 FA enriched dietary fish oil 
(FO) and cisplatin (CP) alone and in combination on various biochemical parameters 
in serum/urine and on the enzjones of carbohydrate metabolism, brush border 
membrane (BBM), lysosomes and antioxidant defense system in the renal cortex and 
medulla. Both single (acute) and multiple dose (chronic) effects of CP administration 
were evaluated and the efficacy of dietary co-3 PUFA in ameliorating there effects was 
assessed. 
In the second part: 
Experiments were earned out to detennine the effects of o)-3 FA enriched dietary 
flaxseed oil (FXO) and cisplatin (CP) alone and in combination on various 
biochemical parameters in serum/urine and on the enzymes of carbohydrate 
metabolism, brush border membrane (BBM), lysosomes and antioxidant defense 
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system in the renal cortex and medulla. The possible protective effect of FXO was 
analyzed both in single and multiple dose CP treatment protocol. 
To understand the mechanism of CP induced nephrotoxicity and its possible 
protection by dietary (o-3 PUFA, the following parameters/biomarkers of energy 
metabolism/mitochondria/lysosomes/BBM/ and oxidative stress were detemiined to 
ascertain their role in drug induced nephropathy and possible protection by dietary FO 
and FXO. 
a) Serum parameters such as cholesterol, creatinine, blood urea nitrogen (BUN), 
inorganic phosphate, glucose and phospholipids were estimated to determine the 
effect of CP toxicity. 
b) Various enzymes of carbohydrate metabolism e.g. LDH, HK, MDH, G6Pase, 
FBPase, G6PDH and ME were determined as representative enzymes of 
glycolysis (LDH and HK), gluconeogenesis (G6Pase and FBPase) and HMP-
shunt pathways (G6PDH). 
c) Activities of ALP, GGTase and LAP were measured as these enzymes are 
biomarkers of BBM and were used to assess structural/functional integrity of 
renal BBM, which is major CP target. 
d) ACPase was measured to assess lysosomal dysfunction, as lysosomes are major 
targets of CP toxicity. 
e) The activities of the indicators of oxidative stress such as SOD, catalase, GSH-
Px, LPO and total-SH were evaluated to ascertain the role of GSH, which is a 
major cellular defense mechanism in CP induced oxidative stress. 
The results of the present studies showed that single as well as multiple CP dose 
administration caused specific alterations in various biochemical parameters in 
serum/urine and in the enzyme activities of various systems in renal tissues 
confirming nephrotoxic effects caused by CP. The results further demonstrate that 
dietary FO and FXO, largely prevented/ameliorated CP induced alterations in various 
parameters. The studies would help us in furthering our understanding of CP induced 
nephropathy and its possible prevention or protection by dietary co-3 PUFA from fish 
oil and flaxseed oil for the safe use of CP as an important antineoplastic agent. The 
studies put forth a good basis for the clinical use of omega-3 fatty acids both as 
dietary components and future drugs/adjuvants which are relatively safe and 
inexpensive, confirming the dicta-" Nutrition is the foundation for all health ". 
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A: MATERIALS 
Animals: 
Adult male Albino rats (Wistar strain) were purchased from Central Animal House 
Facility, Jamia Hamdard University, New Delhi, India. 
Substrates for carbohydrate metabolism and lysosomal enzymes: 
Sodium pyruvate for lactate dehydrogenase, oxaloacetate for malate dehydrogenase, 
L-malic acid for malic enzyme, D-glucose-6-phosphate for glucose-6-phosphate 
dehydrogenase and glucose-6-phosphatase, fructose-1,6-diphosphate for fructose-1,6-
bisphosphatase and p-nitrophenyl phosphate for acid phosphatase were purchased 
from Sisco Research Laboratory (SRL, Mumbai, India). 
Substrates for BBM marker enzymes of kidney: 
p-nitrophenyl phosphate for alkaline phosphatase, y-glutamyl-p-nitroanilide for y-
glutamyl transferase and L-leucine-p-nitroaniline for leucine aminopeptidase were 
purchased from Sigma Chemical Co. (St. Louis, MO, USA). 
Substrates for enzymes involved in free radical scavenging: 
Pyrogallol for superoxide dismutase and hydrogen peroxide for catalase were 
purchased from SRL (Mumbai, India). Glutathione reductase required in assay of 
glutathione peroxidase was purchased from Sigma Chemical Co. (St Louis, MO, 
USA). 
Diet: 
The standard rat pellet diet was obtained from Aashirwaad Industries, Chandigarh, 
India. 
Oil: 
Fish oil: Menhaden, Sigma Chemical Co. (St. Louis, MO, USA). 
Flaxseed oil: Omega Nutrition, Canada Inc., Vancouver. 
Miscellaneous: All chemicals used were of the finest quality commercially available 
and their sources are indicated against them. Glass double distilled water was used in 
all experiments. 
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SRL, India: Acetic acid, Ammonium molybdate, Bovine serum albumin, Calcium 
chloride (CaCl?), Cholesterol, Copper sulphate (CUSO4), Creatinine, 5. 5'-Dithio-bis 
2-nitrobenzoic acid, Ferric chloride (FeCls), Ferrous sulphate (FeS04), Folin's 
phenol reagent. Glucose, Glutathione reduced (GSH), Glycine, Glycylglycine, 
Hydrochloric acid (HCl), Maleic acid, Mannitol, Nicotinamide adenine dinucleotide 
phosphate, Nicotinamide adenine dinucleotide phosphate reduced, Nicotinamide 
adenine dinucleotide reduced, Sodium acetate, Sodium azide, Sodium carbonate 
(NaiCOs), Sodium chloride (NaCl), Sodium hydroxide (NaOH), Sodium potassium 
tartarate. 
Sigma Chemical Co., USA: Cisplatin, Glutathione reductase. Adenosine 
triphosphate (ATP), Cysteine hydrochloride, N-2-Hydroxyethyl-piperazine-N-2-
ethane Sulphonic acid (HEPES), p-nitroaniline, Sodium dodecyl sulphate, 
Thiobarbituric acid (TBA). 
Quaiigens, India: Barium hydroxide {Ba(0H)2}, Calcium carbonate, Chloroform, 
Di-potassium hydrogen orthophosphate (K2HPO4), Di-sodium hydrogen 
orthophosphate (Na2HP04), Ethylene diamine tetra-acetic acid (EDTA), Ethanol, 
Hyrdogen peroxide. Magnesium chloride (MgCl2), Perchloric acid. Picric acid. 
Potassium dihydrogen orthophosphate (KH2PO4), Sodium arsenate, Sodium 
dihydrogen orthophosphate, dihydrogen orthophosphate (KH2PO4), Sodium 
arsenate. Sodium dihydrogen orthophosphate , Sodium fluoride (NaF), Succinic 
acid. Sulphuric acid (H2SO4), Trichloroacetic acid (TCA), Tris-(Hydroxymethyl) 
aminomethane (Tris-base), Zinc sulphate (ZnS04). 
Others: 
3, 5-Dinitro salicylic acid 
Vitamin E 
p-nitrophenol 
Lancaster, England. 
Merck Ltd., India. 
Loba Chem. Co., India. 
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B: METHODS 
1. Animal Protocol: 
Male Wistar rats weighing 150-200 gm were used in all studies. Animals were 
acclimatized for a week prior to the experiment on standard rat pellet diet with free 
access to water. The animal experiments were conducted according to the guidelines 
of Committee for Purpose of Control and Supervision of Experiments on Animals 
(CPCSEA), Ministry of Environment and Forests, Government of India. Body 
weights of rats were recorded at the start and completion of the experiment. 
Diet-
A nutritionally adequate laboratory pellet diet was obtained from Aashirwaad 
Industries, Chandigarh (India). Normal diet (ND) was prepared by crushing the pellets 
finely and adding vitamin E as DL-a-tocopherol (270 mg/kg chow) to the crushed 
diet. Fish oil (FO) and flaxseed oil (FXO) diets were prepared by adding 15% fish oil 
and 15% flaxseed oil by diet weight to the normal diet respectively. The diet was 
stored in airtight containers. Vitamin E was added in order to meet the increased 
metabolic requirement for antioxidants on a diet high in polyunsaturated fatty acids. 
The oil diets were prepared in small batches (for 3d consumption) and supplied 
everyday to ensure freshness, the left over diet from each cage was discarded. With 
the exception of the dietary oils, all components of the diet were identical. 
General Experimental desien-
After acclimatization (7 days) the animals were divided into different dietary groups 
fed on (a) Normal diet (control rats) and (b) co-3 PUFA supplemented diet (FO rats 
and FXO rats). 
(i) In first series of experiments, effect of dietary consumption of o}-3 fatty acid 
enriched fish oil was observed on single and multiple doses of CP treatment. 
(ii) In second series of experiments, effect of dietary consumption of (o-3 fatty 
acid enriched flaxseed oil was obser\'ed on single and multiple doses of CP 
treatment. 
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Body weights of rats were recorded before and after inducing specific experimental 
conditions. The rats were anesthetized with anesthetic ether and sacrificed. Blood and 
urine samples were collected. Kidneys were harvested and processed for the 
preparation of homogenates and BBMV, utilized for further analyses as described in 
"Methods'". 
Blood collection: Before sacrifice of the rats, blood was withdrawn from the left 
jugular vein with the help of a disposable syringe. Serum was obtained by 
centrifugation at 2000 x g for 10 min. , .w«^^'\>^>^-
Urine collection: \2-3 rat^of each group were placed in standard metabolic cages and 
the urine was collected for 3' hrs prior to the day of sacrifice. Urine volumes were 
recorded and the urine samples were frozen and stored at -80°C for subsequent 
analyses. 
2. Analysis of Serum and Urine Parameters : 
The serum samples were deproteinated with 3% TCA in a ratio of 1:3. After 
incubation for 10 min at room temperature, the samples were centrifuged at 4000 rpm 
(Remi Centrifuge, India) for 10 min. The protein free supernatant was used to 
quantitate serum creatinine (Scr) and inorganic phosphate (Pi) and the precipitate was 
saved to quantitate total phospholipids. Cholesterol was determined directly in the 
serum samples. 
(i) Quantitative determination of creatinine: Creatinine was determined by the 
method of Levinson and MacFate (1969). To 0.5 ml of the deproteinated 
serum supernatant, 50 |J,1 of 10% NaOH and 200 |il of saturated picric acid 
were added and incubated for exactly 20 min at room temperature. A 
calibration curve was simultaneously prepared using known concentrations of 
creatinine solution ranging between 2.0-5.0 |^ g. The sample and the standards 
were read at 520 nm in Cintra 5, GBC, Scientific Equipment. Pty. Australia. 
Creatinine was determined in urine samples after a dilution of 1:10 with 
distilled water following the same procedure. 
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(ii) Determination of inorganic phosphate: The inorganic phosphate (Pi) was 
measured in protein free (TCA precipitated) serum supernatant by the method 
ot Tausky and Shorr (1953). The serum supernatant (0.5 ml) was diluted to 3 
ml with 1.3 ml of glass distilled water and 1.2 ml of FeS04 reagent (5 gm 
FeS04 was dissolved in 10 ml, of lO^ /o w/v ammonium molybdate in 10 N 
H2SO4 and diluted to 100 ml with glass distilled water) was added. A 
calibration curve was prepared simultaneously with test samples using known 
concentrations of KH2PO4 (0.018pmoles-0.28^moles). The blue color 
obtained was read at 820 nm after 20 min incubation at room temperature in 
Cintra 5, GBC, Scientific Equipment Pty. Australia. Pi was determined in 
urine samples after a dilution of 1:10 with distilled water following the same 
procedure. 
(iii) Quantitative determination of phospholipids: Phospholipids are determined 
in the serum TCA-precipitates by the method of Bartlett (1959) as modified by 
Marinetti (1962). The precipitates were digested with 1 ml of 70% perchloric 
acid on an electric digestion unit. On cooling to room temperature 3 ml of 
glass distilled water was added. The phosphate (inorganic) released was 
estimated by adding 2 ml of FeS04 reagent by the method of Tausky and 
Shorr (1953) as described above in Pi estimation. The phospholipid values 
were obtained after multiplying the phospholipid phosphorus by a factor of 25. 
(iv) Quantitative determination of cholesterol: Cholesterol was determined by 
the method of Zlatkis et ai, (1953). To 3 ml acetic acid, 30 ^1 serum sample 
was added. To this, 2 ml of FeCls reagent (prepared by diluting 1 ml of 10% 
FeCb w/v in glacial acetic acid to 100 ml with concentrated H2SO4) was 
added careftilly from the side to allow the formation of a brown ring. The 
samples were shaken thoroughly, cooled and colour density was read in Cintra 
5, GBC, Scientific Equipment Pty. Australia, at 560 nm against a reagent 
blank. A calibration curve was simultaneously prepared using known 
concentration (0.02 - 0.2 mg) of cholesterol. 
(v) Determination of blood urea nitrogen and glucose: Levels of urea and 
glucose were assayed by standard colorimetric procedures, urea by reaction 
with diacetyl monoxime and glucose by reaction with o-toluidine using kits 
from Span diagnostics (Surat, India). Glucose was also assayed in the urine 
samples by reaction with o-toluidine using kit from Span diagnostics (Surat, 
India). 
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(vi) Determination of urinary protein: The urine collected was filtered, 
precipitated by 13% (final concentration) TCA and was then centrifuged at 
3000 rpm for 10 min. The protein content was assayed by the method of 
Lowry e? fl/., (1951). \ pV^ ' 2 
3. Preparation of renal cortical and medullary homogenates: 
(i) Homogenate for the determination of metabolic enzymes: After the 
completion of treatment schedule, the kidneys were carefiilly separated from 
the treated and control animals, decapsulated and kept in ice-cold buffered 
saline (154 mM NaCl, 5 mM Tris-HEPES, pH 7.4). The cortical and 
medullary regions were carefully separated as described by Yusufi et al. 
(1994) and homogenized in 50mM mannitol, 2mM Tris buffer pH 7.5 by a 
glass-teflon homogenizer (Thomas PA, USA) by passing 5 pulses; at 4°C to 
make a 15% w/v homogenate. The homogenate was then subjected to high 
speed Ultra-Turrex Kunkel homogenizer (Type T-25, Janke & Kunkel GMBH 
& Co. KG. Staufen) for 3 pulses of 30s each with an interval of 30 s between 
each stroke. Homogenate was centrifuged at 2000 rpm at A°C for 10 min in 
Beckman J2-M1 (Beckman instruments. Inc Palo Alto, C.A. USA) high-speed 
refrigerated centrifuge to remove the cell debris. The supernatant was saved in 
aliquots and stored at -20°C for analyses of metabolic enzymes. 
Homogenate for enzymatic and non-enzymatic antioxidant parameters: A 
10% homogenate of cortex and medulla was prepared in 50mM mannitol, 
2mM Tris buffer, pH 7.5, in a glass-teflon homogenizer with 5 complete 
strokes. The homogenate was then subjected to high speed Ultra-Turrex 
Kunkel homogenizer for 3 pulses of 30s each with an interval of 30s between 
each stroke. One part of the homogenate was saved at -20°C for estimation of 
total-SH and lipid peroxidation and other was centrifiaged at 5000 rpm for 15 
min at 4^0 and supernatant was stored at -20°C for analyses of free-radical 
sca\ enging enzymes. 
4. Preparation of brush border membrane(s) (BBM): 
The renal E}BM vesicles (BBMV) were prepared by the method of Schmitz et al.. 
(1973) using MgCh for precipitation of membranes other than BBM as described by 
Yusufi and Dousa (1987) and as outlined in schematic diagram (Figure 8). For each 
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preparation, tissues fron/2-3 animals^in each group was pooled to obtain a sufficient 
amount of starting materiatrAltTKesteps involved were strictly carried out at 0-4"C 
unless otherwise specified. 
a) The cortical tissue for the preparation of BBMV was homogenized in a 
buffered solution containing 50 mM mannitol, 5 mM Tris base/HEPES, pH 
7.5 (5ml/gm tissue) with four complete passes by glass-teflon homogenizer. 
b) The homogenate (10% w/v) was diluted with the above solution (20ml/gm 
tissue) followed by high speed homogenization (Ultra-Turrex Kunkel 
homogenizer) with three pulses of 30 s each with 30 s interval between each 
pulse. Aliquots of cortical homogenates were saved and quickly frozen for 
fiarther analyses. 
c) 1 M MgCl2 was added to the homogenate (to a final concentration of 10 mM) 
and kept on ice for 20 min with intermittent shaking. 
d) The homogenate was then centrifuged at 5000 rpm (2000 x g) for 10 min in a 
Beckman J2-M1 refirigerated centrifiage using JA-17 rotor. 
e) The pellet was discarded and the supernatant was recentrifuged at 17,000 rpm 
(35,000 X g) for 30 min. 
f) The pellet thus obtained was resuspended in a solution containing 300 mM 
mannitol, 5 mM Tris base/ HEPES, pH 7.5 with four passes by a loose fitting 
Dounce homogenizer (Wheaton IL, Thomas PA, USA) and centrifuged at 
17,000 rpm (35,000 x g) for 30 min in 15 ml corex glass tube using JA-20 
rotor. 
g) The supernatant was discarded and the white outer portion of the fluffy pellet 
was resuspended carefully in a small volume of buffered 300 mM mannitol, 
leaving the dark brown centre of the pellet undisturbed (mitochondrial 
contamination). 
h) The white outer fluffy portion of the pellet was resuspended in 300 mM 
sodium maleate, pH 6.8, buffer leaving the dark brown center of pellet 
undisturbed (mitochondrial contamination). 
i) The suspension thus obtained was homogenized by hand held Douncer or 
passed tlirough a gauge needle number 21. This BBM suspension was quickly 
frozen in small aliquots and used for enzyme analysis. 
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RENAL CORTEX 
CORTICAL HOMOGENATE 
50 Mm Mannitol, 5mM Tris-HEPES. 
pH 7.5 High speed Homogenization 
(Ultra-Turrex) 
BBMV IN HOMOGENATE 
Mg precipitation 
PELLET 
DISCARDED 
Centrifugation at 2000 x 
for 10 min 
BBMV IN SUPERNATENT 
BBMV purification by 
• centrifugation at 
35000 X g 
SUPERNATENT 
DISCARDED 
BBMV IN PELLET 
Centrifugation at 
35000 X g for 30 min 
SUPERNATENT 
DISCARDED 
BBMV IN PELLET 
Suspended in 300Mm Mannitol 
5Mm Tris-HEPES Ph 7.4 
Figure 8: Schematic representation of renal BBMV 
preparation. 
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5. Enzyme Assays: 
>^  All enzymes were assayed at zero order kinetics unless otherwise specified. 
^ The activities of each enzyme from various comparing groups were determined 
simultaneously under similar conditions by using same solutions to avoid day to 
day experimental variations. 
"^ One unit of enzyme activity is defined as the amount of enzyme required to 
catalyze the formation of 1 (amole of product per min or hour under the 
specified experimental conditions. 
^ Specific activity is defined as the enzyme unit per mg protein. 
^ The enzymes of carbohydrate metabolism, enzymatic and non-enzymatic 
antioxidant parameters were assayed in cortical, medullary homogenates and 
marker enzymes of brush border membrane were measured in homogenates and 
cortical BBMV. 
(A) Assay of marker enzymes of brush border membrane: The enzymes were 
assayed simultaneously in kidney {cortical homogenate (CH) and cortical 
BBMV (CBBMV)}, under similar conditions by using same solutions to avoid 
day-to-day experimental variations. Aliquots of CH and CBBMV were diluted 
with 10 mM Tris-HCl buffer, pH 7.5 to obtain suitable enzyme protein 
concentration. 
(i) Alkaline phosphatase (ALP, E.C. 3.1.3.1): The activity of ALP was 
determined according to the method of Shah et al, (1979) as modified 
by Kempson et ai, (1979). The reaction mixture contained 1.4 ml assay 
buffer (55 mM glycine; 36 mM NaCI and 45 mM NaOH, pH 10.5) and 
100 \i\ enzyme protein (10-25 fig protein for CH, IH and 4-8 |ag for 
BBMV). The reacUon was started by adding 15 \x\ p-nitrophenyl 
'^ phosphate (final concentration 5.8 mM in 1.5 ml) and incubated at 37°C 
^y** fof the required t i m ^ - 2 0 miiU. The reaction was stopped by adding 50 
X* J^ \x\ of 5 N NaOH. A calibration curve was prepared simultaneously by 
using known concentration of p-nitrophenol (0.01-0.2 |amoles). The 
colour was read at 405 nm against a reagent blank. 
Page 1 41 
Material & Methods 
(ii) y-Glutamyl transferase (GGTase, E.G. 2.3.2.2): The activity of 
GGTase was determined according to the method of Glossman and 
Neville (1972) as described by Kempson et ai, (1985). The reaction was 
started by adding 100 |xl enzyme protein (15-20 i^ g for CH; 100 jig for 
IH; 2-5|ag for cortical BBMV) to 1.9 ml substrate buffer (20 mM MgCb, 
2 niM y-glutamyl-p-nitroanilide, 4 mM glycylglycine, 100 mM Tris-
base, pH 8.2) and incubated in a shaking water bath maintained at 37°C 
for the required time u 5-30 minV. The reaction was stopped by adding 
100 |al of 15 M acetic aciHTA calibration curve of known concentration 
of standard p-nitroaniline (0.025-0.2 lamoles) was prepared 
simultaneously. The yellow colour developed was read at 405 nm against 
a reagent blank. 
(iii) L-Leucine aminopeptidase (LAP, E.G. 3.4.11.2): This enzyme was 
assayed by the method of Goldmann et al, (1976). The reaction was 
started by the addition of 100 f^ l cortical and medullary homogenates or 
BBMV (40-60 Jig protein for homogenate and 10-15 i^g for BBMV) to 
1.9 ml substrate buffer (50 mM sodium phosphate buffer, 0.33 mM L-
leucine p-nitroanilide, pH 7.2) and incubated at 25°C for the required 
time /l5-30 minj). The reaction was stopped with 100 ^1 of 15 M acetic 
acid. A calibration curve of standard p-nitroaniline (0.025-0.20 ^moles) 
was also prepared simultaneously. The yellow color obtained was read at 
405 nm against a reagent blank. 
(B) Assay of lysosomal marker enzymes: 
Acid phosphatase (AGPase, E.G. 3.1.3.2): The activity of acid phosphatase 
(AC'Pase) in cortical and medullary homogenates was determined by the 
method of Verjee (1969). The reaction mixture contained 2.4 ml acetate buffer 
(0.05 M sodium acetate, pH 4.5) and 100 \x\ enzyme (35-40 (Jg). The reaction 
was started by the addition of 0.5 ml p-nitrophenyl phosphate (final 
concentration 0.8 mM in 3ml) and incubated for 15 min at 30°C. The reaction 
was stopped by adding 2ml, 2 N NaOH. A calibration curve of known 
concentrations of p-nitrophenol (0.05-0.4 f.imoles) was prepared 
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simultaneously. The yellow colour developed was read at 405 nm against a 
reagent blank. 
(C) Assay of carbohydrate metabolism enzymes: The assays were carried out in 
kidney {cortical homogenate (CH) and medullary homogenate (MH)} by 
measuring the extinction changes in a Cintra 5 (GBC, Scientific Equipment 
Pty. Australia) in a final volume of 3 ml at room temperature (28-30"C). The 
net reaction rate was measured by difference of the extinction values obtained 
from addition of the substrate only and for actual enzymatic reaction following 
the addition of substrate. The molar extinction coefficient of NADH and 
NADPH used in calculation of reaction rate was 6.22 mM"'cm"' at 340 nm. 
G6Pase and FBPase were assayed at 37°C. 
(i) Lactate dehydrogenase (L-Lactate: NAD oxidoreductase; LDH; E.C. 
1.1.1.27): The activity of LDH was measured by the method of 
Komberg (1955). The reaction mixture, in a total volume of 3 ml, 
contained 150 jimoles Tris-HCl buffer pH 7.4; 10 |imoles MgCl2; 5 
|j.moles sodium pyruvate; 0.24 lamoles NADH and 4.0-6.0 |ug protein. 
The activity was measured as decrease in absorbance, by pyruvate 
dependent NADH oxidation to NAD^ for 5 min at 340 nm. 
(ii) Malate dehydrogenase (L-Malate: NAD oxidoreductase; MDH; E.C. 
1.1.1.37): The activity of MDH was measured by the method of Meyer 
et al, (1948). The reaction mixture, in a total volume of 3 ml, contained 
100 lamoles Tris-HCl buffer, pH 7.4; 2.5 ^moles oxaloacetate (OAA, pH 
neutralized to 7.4); 0.24 fimoles NADH and 2.0-3.0 |ug protein. The 
activity was measured as decrease in absorbance, by OAA dependent 
NADH oxidation to NAD"^  for 5 min at 340 nm. 
(iii) Malic enzyme (L-Malate: NADP oxidoreductase; ME; E.C. 
1.1.1.40): ME was assayed according to the method of Ochoa et al, 
(1948). The reaction mixture, in a total volume of 3 ml, contained Tris-
HCl buffer, pH 7.4, 100 |.imoles; 10 |umoles MnCb; 5 |.imolcs L-malic 
acid (pH adjusted to 7.4); 0.24 i^moles NADP^ and 0.6-1.2 mg protein. 
The activity was measured as increase in absorbance, by monitoring the 
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malic acid dependent reduction of NADP^ to NADPH for 5 min at 340 
nm. 
(iv) Glucose-6-phosphate dehydrogenase (D-Glucose-6-phosphate: 
NADP oxidoreductase; G6PDH; E.G. 1.1.1.49): G6PDH was assayed 
by the method of Shonk and Boxer (1964). The reaction mixture, in a 
total volume of 3 ml, contained Tris-HCl buffer, pH 7.4, 150 lamoles; 10 
fimoles MgCl2; 5 famoles glucose-6-phosphate; 0.24 ).imoles NADP^; 
and 0.6-1.2 mg protein. The activity was measured by monitoring 
increase in absorbance, by glucose-6-phosphate dependent reduction of 
NADP^ to NADPH for 5 min at 340 nm. 
(v) Hexokinase (ATP:glucose phospho transferase; HK; E.G. 2.7.1.1): It 
was assayed according to the method of Crane and Sols (1953). The 
reaction mixture in a total volume of 1ml contained Tris-HCl buffer, pH 
7.4, 50 iLimoles; 2 i^moles KH2PO4; 10 fimoles MgCl2; 5 fimoles ATP; 2 
inmoles glucose and 1-1.5 mg protein. The reaction was carried out at 
37°C and stopped with 0.5 ml of 10% ZnS04 and Ba(OH)2 each, after 60 
min. The samples were centrifuged at 4000 rpm (Remi centrifuge, 
Mumbai, India) and the remaining glucose was estimated in the protein 
and phosphorylated derivatives firee supernatant by the method of Nelson 
(1944). A calibration curve was simultaneously prepared using a known 
concentration of glucose solution ranging between 5-45 jag. 
(vi) Glucose-6-phosphatase (D-gIucose-6-phosphate phosphohydrolase; 
G6Pase; E.G. 3.1.3.9): It was assayed according to the method of Shull 
et al, (1956). The reaction mixture in a total volume of 1.5 ml contained 
Tris-HCl buffer pH 7.4, 50 |amoles; 10 |amoles MgCl2; 10 f^ moles 
glucose-6-phosphate and 2-3 mg protein. The reaction was carried out at 
37"C and stopped with 1ml of 10% TCA after 60 min. The samples were 
centrifuged at 4000 rpm (Remi Centrifuge, Mumbai, India) and 
phosphorus was estimated in the protein free supernatant by the method 
of Tausky and Shorr (1953). 
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(vii) Fructose-l,6-Bisphosphatase(D-fructose-l,6-bisphosphate-l-
phosphohydrolase FBPase; E.C. 3,1.3.11): It was assayed according to 
the method of Freedland and Harper (1959). The reaction mixture in a 
total volume of 1.5 ml contained Tris-HCl buffer pH 8.4, 50 i^moles; 10 
fimoles MgCh', 12 lamoles cysteine-HCl; 10 |j,moles fructose-1,6-
diphosphate; 0.6-0.8 mg protein. The reaction was carried out at 37"C 
and stopped with 1 ml of 10% TCA after 60 min. The samples were 
centrifiiged at 4000 rpm (Remi Centrifuge, Mumbai, India) and 
phosphate released was estimated in protein free supernatant by the 
method of Tausky and Shorr (1953). 
(D) Assay of enzymatic antioxidant parameters: The activities of the three key 
enzymes of the antioxidant defense system i.e. superoxide dismutase, catalase 
and glutathione peroxidase were measured simultaneously in the homogenates 
of cortex and medulla under similar conditions by using same solutions to 
avoid day-to-day experimental variations. 
(i) Superoxide dismutase (SOD, E.C. 1.15.1.1): It was assayed by the 
method of Marklund and Marklund (1974). To 0.08 ml of supematant 
2.82 ml of 0.05 mM Tris-succinate buffer, pH 8.2 was added, mixed 
well and incubated at 25°C for 20 min. The reaction was started by 
adding 0.1 ml of 8 mM pyrogallol solution. Change in absorbance per 
minute was immediately recorded for the initial 3 min at 420 nm. A 
reference set, containing 0.08 ml distilled water instead of supematant 
solution, was also run simultaneously. 
(ii) Catalase (E.C. 1.11.1.6): This enzyme was assayed according to the 
method of Claiborne (1985) as described by Giri et al., (1996). The 
assay mixture consisted of 1.95 ml of 0.05 M potassium phosphate 
buffer pH 7.0, 1 ml of 0.019 M hydrogen peroxide and 0.05 ml 
homogenate (50-100 \yg protein), in a final volume of 3 ml. The 
decrease in absorbance at 240 nm was immediately noted after every 30 
seconds for 3 min. Enzyme activity was calculated using the molar 
extinction coefficient of H2O2 (436 M"' cm'' at 240 nm). 
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(iii) Glutathione peroxidase (GSH-Px, E.G. 1.11.1.9): The activity of 
GSH-Px was determined by the method of Flohe and Gunzler (1984). 
The assay mixture contained 500 |J.1 of 0.1 M potassium phosphate/1 
mM EDTA buffer (pH 7.0), 50 i^l of 1 mM of sodium azide, 50 |al of 
homogenate (100-200 |ag protein), 100 |a.l glutathione reductase (0.24 
U), and exactly 100 |j,l of 10 mM GSH. The mixture was preincubated 
for 10 min at 37°C. Then 100 j^ l of 1.5 mM NADPH solution was added 
and the hydrogen peroxide independent consumption of NADPH was 
monitored for 3 min. The overall reaction was started by adding 100 \i\ 
of prewarmed 1.5 mM hydrogen peroxide solution and the decrease in 
absorbance at 340 nm was monitored for 5 min. Enzyme activity was 
calculated using the molar extinction coefficient of NAPDH (e = 6.22 x 
10^M"'cm"'). 
(E) Assay of non-enzymatic antioxidant parameters: 
(i) Total-SH groups: Total-SH groups were determined by the method of 
Sedlak and Lindsay (1968). To 0.4 ml of 10% tissue homogenate, 2.1 ml 
of 0.1 M Tris-HCl (pH 8.2), 0.5 ml of 10% SDS and 0.3 ml of 0.1 M 
EDTA were added. The reaction was incubated in a boiling water bath 
for 5 min. Then, 0.1 ml DTNB (40 mg/100 ml methanol) was added. 
After 30 min at room temperature, the absorbance was read at 412 nm. A 
calibration curve with different amounts of cysteine (20-160 runoles) 
was constructed by the same procedure as described above and used to 
calculate the total-SH groups in the samples. 
(ii) Lipid Peroxidation: Lipid peroxidation (LPO) in various tissue 
homogenates was determined spectrophotometrically by the method of 
Ohkawa et a/.,(1979). To 0.1 ml of tissue homogenate 1.5 ml of 20% 
trichloroacetic acid, 0.2 ml of 8% SDS, 0.7 ml of distilled water and 1.5 
ml of 0.8% thiobarbituric acid were added and after mixing incubated at 
95"C for 20 min. After cooling to room temperature and centrifugation at 
10,000 qim for 10 min the absorbance of the supernatant was read at 532 
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nm a against reagent blank. Amount of malondialdehyde (MDA, end 
product of LPO) was calculated using the molar extinction coefficient of 
thiobarbituric acid (s = 1.56 x 10^  M"' cm"'). 
6. Protein Estimation: 
Protein was measured by the method of Lowry et al, (1951) with minor modifications 
as described by Yusufi et al, (1983). The samples were made to 0.8 ml with 0.5% 
SDS. Then 2 ml alkaline copper reagent was added and after 10 min incubation at 
room temperature 0.2 ml Folin's reagent (1 N) was added with brisk shaking and 
incubated for 30 min at room temperature. A calibration curve of standard BSA (5-80 
)ag) was prepared simultaneously. The blue colour obtained was read at 660 nm. 
7. Statistical Analysis: 
All data are expressed as Mean ± SEM for at least 4-5 different preparations. 
Statistical evaluation was conducted by one-way ANOVA and by unpaired Student's 
Mest using SPSS 7.5 software. A probability level of p < 0.05 was selected as 
indicating statistical significance. Most of the changes between various groups were 
compared with control values for better understanding and clarity. However, specific 
differences and statistical significance between other groups were evaluated 
separately e.g. CP vs. CPF; CP vs. CPFXO. 
i U ^ 1 
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O HYPOTHESIS! A: 
a)-3 fatty acids from marine (fish oil, FO) sources would protect against single CP 
dose induced acute nephrotoxic and other deleterious effects in the rat kidney. 
O EXPERIMENTAL DESIGN-IA (SHORT TERM PROTOCOU: 
To test the above hypothesis, Adult male Wistar rats ((10-12 rats/group) weighing 
between 150-200 g were used in the study. Animals were acclimatized for a week on 
standard rat chow and allowed water ad libitum under controlled conditions of 
25±2°C temperature, 50±15% relative humidity and normal photoperiod (12 hour dark 
and light). Four groups of rats entered the study after acclimatization (Figure 9). They 
were fed on either normal diet (control and CP groups) or diet containing 15% fish oil 
(CPF and FO groups). After 10 days rats in two groups (CP and CPF) were 
administered a single dose of CP intraperitoneally (6 mg/kg bwt) in 0.9% saline. 
Animals in the control and FO group received an equivalent amount of normal saline. 
Since CP induced renal injury is gradual and usually occurs 3-5 days after CP 
administration (Arany and Safirstein, 2003), hence the animals were sacrificed 4 days 
after CP administration under/light ether anesthesia} Blood was withdrawn from left 
jugular vein and serum was separated by centrifiigation at 2000 x g for 10 min. Urine 
samples were collected for 4 h in standard metabolic cages a day before the sacrifice 
of rats. The kidneys were pctracte$and processed for the preparation of homogenates 
and brush border membrane vesicles (BBMV) as described in "Methods". Each 
preparation of BBM was made by pooling the cortical tissue from 2-3 animals. Thus, 
the number of animals mentioned above contributed to 4-5 different preparations for 
each group. Body weight of rats were recorded at the start and completion of the 
experimental procedures. 
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Results & Discussion 
O RESULTS-1 A: 
To test the above hypothesis, the effect of fish oil (FO) consumption and cisplatin 
(CP) treatment alone and in combination was determined on various parameters in rat 
serum and kidney. In general the rats remained active and alert throughout the study. 
The daily food and fluid intakfi-mas similar in various experimental group of rats (data 
not shown). There was (significant lo s s^ body weight in CP treated rats (CP and CfF 
,0-
groups) as compared to control rats (Table 1). V'tTt^ ^^ " 
O Effect of dietary fish oil on single CP dose induced alterations in serum and 
urine parameters: 
Single dose CP treatment to control rats resulted in significant increase in serum 
creatinine (Scr, +101%), and blood urea nitrogen (BUN, +138%) but decrease in 
cholesterol (-10%), phospholipids (PLP, -30%) inorganic phosphate (-17%) and 
glucose (-74%)) compared to control rats (Table 2). These changes were associated 
with massive phosphaturia, proteinuria and glucosuria accompanied by decreased 
creatinine clearance (Table 3). FO-diet alone caused increase in serum glucose and Pi 
but decrease in BUN, Scr, PLP and Serum cholesterol. Urinary glucose, Pi and 
protein excretions declined significantly accompanied by increased creatinine 
clearance. 
Feeding of FO-diet to CP administered rats (CPF group) resulted in amelioration of 
various CP elicited nephrotoxic alterations in serum and urine parameters. FO 
prevented CP induced increase in Scr and BUN and decrease in glucose. CP induced 
phosphaturia, proteinuria and glucosuria were prevented/reduced by FO feeding to CP 
treated rats. CP-induced phosphaturia, proteinuria and glucosuria was 
prevented/reduced in CPF compared to CP rats. 
O Effect of dietary fish oil on single CP dose induced alterations on BBM 
enzymes in the renal homogenates and in isolated BBMV: 
To assess the structural integrity of plasma membrane (BBM) and certain organelles 
i.e. lysosomes, the effect of CP and FO alone and in combination was detenuined on 
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Table 1: Effect of dietary fish oil (FO) on body weight (in gms) of rats 
with/without single dose CP treatment. 
Groups Before Treatment After Treatment % change 
Control 150 ±6.30 156.33 ±7.60 +4 
CP 155.75 ±6.10 128.25 ±8.2 -18 
CPF 150.25 ±6.1 134.3 ±5 -11 
FO 150 ±7.50 144.6 ±4.9 -4 
Results are expressed as Mean ± SEM for 10-12 rats/group. 
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Results & Pfscwss/on 
biomarker enzymes of BBM and lysosomes in the homogenates of renal cortex and 
medulla and in isolated BBM preparations from renal cortex. 
a) Effect of CP alone and with FO diet on biomarkers of BBM and lysosomes in 
the cortical/medullary homogenates: 
The activities of alkaline phosphatase (ALP), y-glutamyl transpeptidase (GGTase), 
leucine aminopeptidase (LAP) and acid phosphatase (ACPase) were determined 
simultaneously for different experimental groups in the homogenates of renal cortex 
and medulla (Table 4). A single dose CP treatment to control rats caused significant 
reduction in the specific activities of ALP (-36%), GGTase (-37%) and LAP (-30%) 
in cortical homogenate. Feeding of FO diet alone, however caused increase in 
GGTase activities whereas ALP and LAP activity was slightly decreased compared to 
control rats. Feeding FO supplementation diet to CP treated rats prevented CP elicited 
decrease in BBM enzyme activities (Table 4a, Figure 10a) 
The activities of BBM enzymes similar to the cortex were also lowered in the medulla 
by CP administration (Table 4b). The consumption of FO in combination with CP 
treatment prevented the CP induced decrease in ALP (-42%), GGTase (-37%) and 
LAP (-24%) activities in the medulla. The effect of CP and FO alone and in 
combination was also determined on the activities of ACPase in cortical and 
medullary homogenates. The activity of ACPase was significantly increased in 
cortical (+32%) and medullary (+35%) homogenates by CP treatment. CP-induced 
increase in ACPase activity was significantly reduced/prevented by FO diet both in 
cortical and medullary homogenates albeit to different extent. 
b) Effect of dietary fish oil on single CP dose induced alterations on BBM enzymes 
in the isolated BBMVpreparations: 
The effect of CP, FO and their combination was further analyzed on the specific 
activities of BBM marker enzymes in isolated BBMV preparations (Table 5, Figure 
10b). Results show a similar activity pattern of the enzymes as observed in cortical 
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Table 4: Effect of dietary fish oil (FO) on biomarkers of BBM and ly sosomes in 
homogenates of a) cortex and b) medulla with/without single dose CP 
treatment. 
Groups 
a) Cortex 
Control 
CP 
CPF 
FO 
b) Medulla 
Control 
CP 
CPF 
FO 
ALP 
(fimol/mg 
protein/h) 
7.48 ± 0.54 
4.8 ±0.215* 
(-36%) 
5.50 ±0.286*^ 
(-27%) 
6.65 ± 0.504 
(-11%) 
5.33 ± 0.331 
3.08 ±0.246* 
(-42%) 
3.75 ±0.849* 
(-30%) 
4.49 ± 0.920 
(-16%) 
GGTase 
(|amol/mg 
protein/h) 
10.18 ±5.91 
6.44 ±1.29* 
(-37%) 
6.92 ±1.068^ 
(-32%) 
12.07 ±1 
(+19%) 
12.91 ±1.205 
8.12 ±0.552* 
(-37%) 
9.13 ±1.33^ 
(-29%) 
14.61 ±2.66 
(+13%) 
LAP 
(l^mol/mg 
protein/h) 
12.34 ±1.45 
8.64 ±1.12* 
(-30%) 
11.07+1.36^ 
(-10%) 
11.86 ±2.23 
(-4%) 
11.8±1.14 
9.01 ± 0.690* 
(-24%) 
9.19 ±0.503* 
(-22%) 
9.79 + 0.173* 
(-17%) 
ACPase 
(nmol/mg 
protein/h) 
3.39 ±0.088 
4.48±0.194* 
(+32%) 
3.52 + 0.142^ 
(+4%) 
3.03+0.314 
(-11%) 
2.51 ±0.196 
3.40 + 0.096* 
(+35%) 
2.69 + 0.177^ 
(+7%) 
2.53 + 0.0914 
(+0.8%) 
Results (specific activity expressed as |imoles/mg protein/h) are Mean ± SEM for five 
different preparations. 
*Significantly different from control, tsignificantly different fi-om CP at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 5: Effect of dietary fish oil (FO) on activities of biomarker enzymes of 
BBM in cortical BBMV with/without single dose CP treatment. 
Groups ALP (}imol/mg 
protein/h) 
GGTase 
(fj,mol/mg 
protein/h) 
LAP 
(|j.mol/mg 
protein/h) 
Control 
CP 
CPF 
FO 
45.41±5.53 
20.76 ±1.46* 
(-54%) 
23.76 ±2.51* 
(-48%) 
42.74 ±1.52 
(-6%) 
81.22 ±4.19 
56.28 ± 3.44* 
(-31%) 
78.1 ±2.49*^ 
(-4%) 
94.15 ±0.815* 
(+16%) 
66.56 ± 2.5 
52.07 ± 2.2* 
(-22%) 
66.17 ±9.5^ 
(-0.6%) 
75.38 ±3.01 
(+13%) 
Results (specific activity expressed as |umoles/mg protein/h) are Mean ± SEM for five 
different preparations. 
*Significantly different from control, fsignificantly different from CP at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Figure 10. Effect of dietary fish oil (FO) on the activities of ALP, GGTase and 
LAP in (a) cortical homogenate (b) cortical BBMV with/without 
single dose cisplatin (CP) treatment. 
Above figure is drawn using values from Table 4a and 5. 
^Significantly different from control, tsignificantly different from CP; at 
p<0.05 by one way ANOVA. 
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homogenates, however the magnitude of the effects under different experimental 
conditions was more apparent. The decrease or increase in the activities of ALP, 
GGTase and LAP by CP or FO respectively was significantly higher in BBMVs as 
compared to renal cortical homogenate. The damaging effect of CP on BBM was 
clearly ameliorated by FO, as decrease in the activities of ALP, GGTase and LAP by 
CP was prevented significantly by FO supplementation diet. 
O Effect of dietary fish oil on single CP dose induced alteration in metabolic 
enzymes in renal cortex and medulla: 
The effect of CP, FO and CP+ FO was determined on the activities of various 
enzymes of carbohydrate metabolism involved in glycolysis, TCA cycle, 
gluconeogenesis and HMP shunt pathway in renal cortex and medulla (Tables 6, 7). 
(a) Effect on carbohydrate metabolism in renal cortex: 
CP treatment to control rats significantly increased LDH, a marker of anaerobic 
glycolysis (+86%), HK (glycolysis) (+69%) and NADP-malic enzyme (ME) (+24%) 
whereas decreased MDH, an enzyme of TCA cycle (-16%), G6Pase (-20%), FBPase 
(-40%)) (gluconeogenesis) and G6PDH (source of NADPH)(-32%) (Table 6). When 
CP treatment was extended to FO-fed rats, CP-induced decrease of metabolic enzyme 
activities was prevented by FO. CP elicited decrease of MDH activity was reversed to 
near control value by FO diet. However, FO consumption alone caused increase in 
LDH, HK, MDH, G6Pase, G6PDH and ME activities. 
b) Effect on carbohydrate metabolism in renal medulla: 
The activities of LDH, MDH, G6Pase and FBPase in medullary homogenates were 
similarly affected by single dose CP treatment albeit to different extent than in the 
cortical homogenates (Table 6). Feeding FO supplementation diet to CP treated rats 
prevented CP induced alterations in various metabolic enzyme activities. Similar to 
cortex, G6PDH activity decreased whereas ME and HK activity increased in the 
medulla by CP treatment (Table 7). Dietary FO supplementation to CP treated rats 
decreased ME and HK activities. 
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Results & Discussion 
O Effect of dietary fish oil on single CP dose induced alterations in 
antioxidant defense parameters in renal cortex and medulla: 
To ascertain the role of antioxidant system in CP-induced toxicity, the effect of CP 
was observed on oxidative stress parameters. CP enhanced hpid peroxidation (LPO) 
and significanriy altered antioxidant enzymes both in cortex and medulla, albeit 
differently (Table 8). 
As reported earlier (Khan et al, 2009), CP suppressed antioxidant enzymes and 
increased lipid peroxidation (LPO) both in the cortex and medulla (Table 8). LPO 
measured in terms of malondialdehyde (MDA levels) was significantly enhanced in 
the cortex (+64%) and medulla (+29%) whereas total-SH groups were declined in 
cortex (-30%) and medulla (-33%). CP treatment caused significant decrease in 
superoxide dismutase (SOD, -46%), catalase (-20%) glutathione peroxidase (GSH-Px, 
-41%) activities in the renal cortex. In medulla also the activities of SOD (-52%), 
catalase (-59%) and GSH-Px (-39%) were significantly declined by CP 
administration. However, CP administration to FO fed rats greatly reduced the CP 
induced increase in LPO and decrease in total-SH groups. CP administration to FO 
fed rats also prevented the decline in superoxide dismutase (SOD), catalase and 
glutathione peroxidase (GSH-Px) both in the cortex and medulla. Dietary FO 
consumption alone, significantly enhanced the antioxidant parameters in the renal 
tissues. 
The results indicate that FO diet was able to ameliorate the CP induced oxidative 
damage in both renal cortex and medulla and thus indicate a marked protection by FO 
against CP induced oxidative damage to renal tissues. 
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PART- IB 
O HYPOTHESIS-I B: 
O co-3 fatty acids from marine (fish oil, FO) sources would also protect against 
multiple CP dose induced nephrotoxic and other deleterious effects in the rat 
kidney. 
O EXPERIMENTAL DESIGN-IB (LONG TERM PROTOCOL): 
Since cancer chemotherapy involving cisplatin requires administration of CP in 
multiple doses over a long duration, therefore to investigate whether the protection 
offered by FO in single dose CP treatment also extends for multiple dose CP therapy, 
the following experiment w^sjdesigied. 
Adult male Wistar rat^ (10-12 rats/group) weighing between 150-200 g were used in 
the study. Animals wereacchmatized for a week on standard rat chow and allowed 
water ad libitum under controlled conditions of 25±2°C temperature, 50±15% relative 
humidity and normal photoperiod (12 hour dark and light). Four groups of rats entered 
the study after acclimatization (Figure 11). They were fed on either normal diet 
(control and CP groups) or diet containing 15% fish oil (CPF and FO groups). After 
10 days rats in the two groups (CP and CPF) were administered rmiltiple dosejJ of CP 
^;^intraperitoneally (3 mg/kg bwt) in 0.9% saline on every fourth day for 20 days. 
Animals in the control and FO group received an equivalent amount of normal saline. 
The rats were sacrificed on fifth day after the last CP/saline injection under light ether 
anesthesia. Blood was withdrawn fi-om left jugular vein and serum was separated by 
centriftigation at 2000 x g for 10 min. Urine samples were collected for 4 h in 
standard metabolic cages a day before the sacrifice of rats. The kidneys were 
extracted and processed for the preparation of homogenates and brush border 
membrane vesicles (BBMV) as described in "Methods". Each preparation of BBM 
was made by pooling the cortical tissue from 2-3 animals. Thus, the number of 
animals mentioned above contributed to 4-5 different preparations for each group. 
Body weight of rats were recorded at the start and completion of the experimental 
procedures. 
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Results & Discussion 
^ RESULTS-I B: 
To test the above hypothesis, the effect of fish oil (FO) consumption and cisplatin 
(CP) treatment alone and in combination was determined on various parameters in rat 
serum and kidney. In general the rats remained active and alert throughout the study. 
The daily food and fluid intake was similar in various experimental group of rats (data 
not shown). There was significant loss in body weight in CP treated rats (CP and CPF 
groups) as compared to control rats (Table 1). 
O Effect of dietary fish oil on multiple CP dose induced nephrotoxicity in serum 
parameters: 
CP treatment to control rats resulted in significant increase in serum creatinine (Scr, 
+60%), and blood urea nitrogen (BUN, +96%), cholesterol (+37%) and phospholipids 
(PLP,+50%) but decrease in inorganic phosphate (-26%) and glucose (-10%) as 
compared to control rats (Table 2). Feeding of FO-diet to CP administered (CPF) rats 
appeared to lower the severity of various CP elicited nephrotoxic alterations in serum 
parameters. Dietary FO supplementation prevented CP induced increase of Scr, BUN, 
PLP and cholestrol and decrease in Pi. and glucose in CPF rats. Dietary 
supplementation of FO alone decreased BUN, Scr, PLP and cholesterol whereas 
glucose and Pi were further increased in FO as compared to control group. 
O Effect of dietary fish oil on multiple CP dose induced alterations on BBM 
enzymes in the renal homogenates and in isolated BBMV: 
To assess the structural integrity of plasma membrane (BBM) and certain organelles 
i.e. lysosomes, the effect of CP and FO alone and in combination was determined on 
biomarker enzymes of BBM and lysosomes in the homogenates of renal cortex and 
medulla and isolated BBM preparations from renal cortex. 
a) J^Xf*!ct of CP alone and with FO diet on biomarkers of BBM and lysosomes in 
the cortical and medullary homogenates: 
The activitcs of alkaline phosphatase (ALP), y-glutamyl transpeptidase (GGTase), 
leucine aminopeptidase (LAP) and acid phosphatase (ACPase) were determined in the 
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Table 1: Effect of dietary fish oil (FO) on body weight (in gms) of rats 
with/without multiple dose CP treatment. 
Groups Before Treatment After Treatment % change 
Control 130 ±8.30 133.33 ±10.60 ±3 
CP 131.25 ±6.10 118.75 ±9.20 -10 
CPF 131.25± 10.60 126.25±4.50 -4 
FO 130 ±7.50 128.11 ±6.90 -1 
Results are expressed as Mean ± SEM for 10-12 rats/group. 
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Results & Discussion 
homogenates of renal cortex and medulla (Table 3) for different experimental groups. 
CP treatment to control rats caused significant reduction in the specific activities of 
ALP (-37%), GGTase (-30%) and LAP (-56%) in cortical homogenate (Table 3a, 
Figure 12a). Feeding of FO diet alone, however, caused increase in GGTase and LAP 
activities while ALP activity decreased slightly compared to control rats. However, 
feeding FO diet to CP treated rats prevented CP elicited decrease in BBM enzyme 
activities. The activity of lysosomal enzyme, acid phosphatase (ACPase) was 
increased (+23%) by CP in cortical homogenates and FO diet was able to prevent the 
CP elicited increase (Table 3a). 
The activities of BBM enzymes similar to the cortex were also lowered in the renal 
medulla by CP administration (Table 3b). The consumption of FO in combination 
with CP treatment resulted in reducing the CP induced decrease in ALP (-55%), 
GGTase (-34%) and LAP (-65%) activities in the medulla. The effect of CP and FO 
alone and in combination was also determined on the activities of ACPase in 
medullary homogenates. ACPase activity was more profoundly increased (+63%) by 
CP treatment in medulla. CP-induced increase in ACPase activity was significantly 
reduced by FO diet in cortical as well as in medullary homogenates albeit to different 
extent. 
b) Effect of dietary fish oil on multiple CP dose induced alterations in BBM 
enzymes in isolated BBMVpreparations: 
The effect of CP, FO and their combination was flirther analyzed on the specific 
activities of BBM marker enzymes in isolated BBMV preparations (Table 4, Figure 
12b). Results show a similar activity pattern of the enzymes as observed in cortical 
homogenates however the magnitude of the effects under different experimental 
conditions were more apparent. The decrease/increase in the activity by CP/FO 
respectively was significantly higher in BBMVs as compared to the respective 
cortical homogenates. The damaging effect of CP was clearly ameliorated by FO, as 
decrease in the activities of ALP, GGTase and LAP by CP was prevented/retarded 
significantly by FO consumption. 
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Table 3: Effect of dietary fish oil (FO) on biomarkers of BBM and lysosomes in 
homogenates of a) cortex and b) medulla with/without multiple dose 
CP treatment. 
Groups 
a) Cortex 
Control 
CP 
CPF 
FO 
a) Medulla 
Control 
CP 
CPF 
FO 
ALP 
(l-imol/mg 
protein/h) 
7.38 ±0.14 
4.63 ±1.24* 
(-37%) 
5.4 ± 0.22*^ 
(-27%) 
6.89±0.86 
(-7%) 
52.53 ±2.28 
23.88 ± 2.22* 
(-55%) 
38.28 ±0.81*' 
(-27%) 
45.61± 1.23 
(-13%) 
GGTase 
(lamol/mg 
protein/h) 
22.36 ±0.76 
15.6 ±2.04* 
(-30%) 
20.64 ±1.28' 
(-8%) 
29.13±1.09* 
(+30%) 
30.95 ± 2.09 
20.51 ±0.86* 
(-34%) 
24.9 ± 0.07*^ 
(-20%) 
38.46± 0.067* 
(+24%) 
LAP 
(p.mol/mg 
protein/h) 
19.23 ±0.29 
8.4 ±1.59* 
(-56%) 
16.94 ±3.42^ 
(-12%) 
21.48±0.54 
(+12%) 
19.16 + 0.92 
6.78 + 0.33* 
(-65%) 
17.54 ±0.94^ 
(-8%) 
20.12±0.76 
(+5%) 
ACPase 
()Lj.mol/mg 
protein/h) 
4.36 + 0.20 
5.38 + 0.12* 
(+23%) 
4.63 + 0.13^ 
(+6%) 
3.89+0.12 
(-11%,) 
1.41+0.08 
2.3 + 0.12* 
(+63%) 
1.89 + 0.08 
(+34%) 
1.44+0.03 
(+2%) 
Results (specific activity expressed as |amoles/mg protein/h) are Mean + SEM for five 
different preparations. 
*Significant!y different from control, fsignificantly different from CP at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 4: Effect of dietary fish oil (FO) on activities of biomarker enzymes of 
BBM in cortical BBMV with/without multiple dose CP treatment. 
Groups ALP (fimol/mg 
protein/h) 
GGTase 
(^mol/mg 
protein/h) 
LAP 
(famol/mg 
protein/h) 
Control 
CP 
CPF 
FO 
67.36 ±4.64 
28.89 ±2.29* 
(-57%) 
52.47 ±L87*^ 
(-22%) 
69.86 ±0.98 
(+4%) 
77.07 ± 4.65 
50.98 ± 3.76* 
(-34%) 
63.55 ±3.37^ 
(-17%) 
86.78 ±1.21* 
(+13%) 
43.21 ±3.83 
25.2 ±2.28* 
(-42%) 
37.87 ± 1.71 
(-12%) 
51.12 ±0.25* 
(+18%) 
Results (specific activity expressed as ^moles/mg protein/h) are Mean ± SEM for five 
different preparations. 
*Significantly different from control, jsignificantly different from CP at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change fi-om control. 
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(a) 
ALP GGTase LAP 
(b) 
Q Control BCP QCPF BFO 
100 
ALP GGTase LAP 
Figure 12. Effect of dietary fish oil (FO) on the activities of ALP, GGTase and 
LAP in (a) cortical homogenate (b) cortical BBMV with/without 
multiple dose cisplatin (CP) treatment. 
Above figure is drawn using values from Table 3a and 4. 
* Significantly different from control, tsignificantly different from CP: at p <0.05 
by one way ANOVA. 
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O Effect of dietary fish oil on multiple CP dose induced alterations on 
metabolic enzymes in renal cortex and medulla: 
The effect of CP, FO and CP+FO was determined on the activities of various enzymes 
of carbohydrate metabolism involved in glycolysis, TCA cycle, gluconeogenesis and 
HMP shunt pathway in renal cortex and medulla (Tables 5,6). 
(a) Effect on carbohydrate metabolism in renal cortex: 
CP treatment to control rats significantly increased LDH, a marker of anaerobic 
glycolysis (+70%), HK (glycolysis) (+22%), G6Pase (+7%) and FBPase (+3%) 
(gluconeogenesis) whereas decreased MDH, an enzyme of TCA cycle (-44%). When 
CP treatment was extended to FO-fed rats, CP-induced alterations in metabolic 
enzymes were prevented. CP elicited decrease in MDH activity was normalized to 
near control value by FO diet consumption. However, FO alone caused significant 
increase in MDH and G6Pase activities (Table 5). 
The effect of FO and CP alone and in combination was also determined on glucose-6-
phosphate dehydrogenase (G6PDH) and NADP-malic enzyme (ME), source of 
NADPH needed in various anabolic reactions. CP treatment to control rats 
significantly decreased G6PDH (-43%) but increased ME (+35%) activity. CP elicited 
decrease in G6PDH activity was completely prevented and the value was normalized 
back to the control value. CP induced ME activity increase was arrested by dietary FO 
supplementation. 
b) Effect on carbohydrate metabolism in renal medulla: 
The activities of LDH and MDH in medullary homogenates were similarly affected 
by CP treatment albeit to different extent than in the cortical homogenates (Table 6). 
Similar to cortex, G(5PDH activity decreased whereas ME and HK activity increased 
by CP in the medulla. Feeding of FO enriched diet to CP treated rats prevented CP 
induced alterations in various enzyme activities. FO consumption to CP treated rats 
reduced/prevented the increase in LDH, HK and ME activities and decrease in MDH, 
G6PDH, G6Pase and FBPase activities. 
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Results & Discussion 
O Effect of dietary fish oil on multiple CP dose induced alterations in 
antioxidant defense parameters in renal cortex and medulla: 
As reported earlier (Khan et al, 2009), CP suppressed antioxidant enzymes and 
increased lipid peroxidation (LPO) both in the cortex and medulla (Table 7). LPO 
measured in terms of malondialdehyde (MDA levels) was significantly enhanced in 
the cortex (+215%) and medulla (+82%) whereas total-SH groups were declined in 
the cortex (-30%) and medulla (-22%) by CP treatment. However, CP induced cellular 
damage was much more apparent in renal cortex than in medulla as reflected by 
greater increase in LPO and decrease in total-SH in the cortical tissue. CP treatment 
caused marked decrease in superoxide dismutase (SOD, -36%), catalase (-25%) and 
glutathione peroxidase (GSH-Px, -33%) activities in the renal cortex. In medulla, the 
activity of SOD (-19%), catalase (-33%) and GSH-Px (-47%) also showed significant 
decline by CP administration. However, CP administration to FO fed rats prevented 
the decline in SOD, catalase and GSH-Px activities. Dietary FO supplementation to 
CP treated rats also prevented CP elicited increase in LPO and decrease in total-SH 
groups. Dietary FO consumption alone significantly enhanced the activities of 
antioxidant enzymes in both cortex and medulla and the activities of these enzymes in 
FO group were found to be higher than in the CP or control groups. The results 
indicate marked protection by FO diet against CP induced oxidative damage to renal 
tissues. 
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DISCUSSION-I 
Cisplatin (cis-diamminedichloroplatinum II, CP) one of the most effective 
chemotherapeutic agent plays a major role in the treatment of variety of human solid 
tumors including those of the head, neck, testis, ovary and breast (Lebwohl and 
Canetta, 1998). However, the most common adverse effect, nephrotoxicity, limits its 
application in clinical oncology (Antonio et ai, 2002). Experimental evidence has 
suggested that CP deteriorates renal function (Arany and Safirstein, 2003) and 
glomerular filtration rate (GFR) in a dose-dependent manner (Yao et al., 2007). The 
alterations in the kidney functions induced by cisplatin are closely associated with an 
increase in lipid peroxidation and reactive oxygen species (ROS) in renal tissue 
(Baligha et al., 1998; Silici et al., 2010). The pathological changes consequent to 
cisplatin administration consist essentially of tubular disease. Cisplatin appears to be 
directly toxic to the renal cortex affecting the proximal tubules most severely, 
although the distal tubule and collecting ducts are also damaged (Chopra et al., 1982; 
Choie et ai, 1981). Tubular damage may range fi-om a mere loss of brush border of 
epithelial cells to an overt tubular necrosis in severe cases (Meyer and Madias, 1994). 
The mechanism by which cisplatin kills the proximal tubule cells in the kidney has 
been the focus of intense investigation for many years. In tumors and other dividing 
cells, cisplatin-DNA crosslinks are thought to be the cytotoxic lesion (Fink and 
Howell, 2000). Nonproliferating cells are less sensitive to the toxicity of DNA-
damaging agents, yet the quiescent proximal tubule cells are selectively killed by 
cisplatin (Lieberthal et al., 1996). The metabolic activation of CP to a more potent 
nephrotoxin in proximal tubular cells is considered as a prerequisite for its 
nephrotoxicity and the enzyme GGTase plays a crucial role in the pathway involved 
(Townsend et al., 2003). 
Recent studies suggest that cisplatin nephrotoxicity is a complex and multifaceted 
process in which cisplatin triggers cellular response involving multiple pathways that 
culminate in renal damage (Hong et al., 2005; Ramesh and Reeves, 2002; Nowmak, 
2002; Townsend and Hanigen, 2002; Xiao et ai, 2003). By inducing mitochondrial 
injury, cisplatin stimulates the production of reactive oxygen species (ROS), which 
could interfere with the antioxidant defense system and result in oxidative damage in 
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tissues (Sugiyama et ciL, 1989; Chirino and Perzada-Chaverri, 2009). It may react 
with thiols in protein and glutathione, which could cause cell dysfunction (Kuhlman 
et a!., 1997; Matsushima et al, 1998; Kuhad et al., 2007; Khan et al., 2009). Since 
cisplatin's development, research has centered on mitigating nephrotoxicity to allow 
cisplatin to be delivered at therapeutic doses without adversely affecting the kidneys. 
Various studies have focused on the ways for prevention of cisplatin associated side 
effects via supplementation of preventive agents simultaneously. These include 
antioxidants, modulators of nitric oxide, agents interfering with metabolic pathways 
and cytoprotective and antiapoptotic agents (Ali and Al Moundhri, 2006). However, 
none of these approaches have been found safe/suitable for clinical practice. 
The past 3 decades have been a period of rapid expansion in the scientific knowledge 
of G)-3 PUFAs. Several epidemiological and clinical studies have demonstrated that 
ci)-3 fatty acids from marine sources like fish oil (FO) retard(s) progression of various 
forms of cancers, depression, arthritis, asthma, cardiovascular and renal disorders (De 
Caterina, 1994; Tsujikawa et al., 2000; Barbosa et al.. 2003; Bhattacharya et al.. 
2006; Kakar et al.. 2008). Watkins et al., (2007) have also suggested the therapeutic 
use of co-3 PUFA and flavonoids against inflammation that is mediated by 
environmental pollutants. The exact mechanism of action to explain the benefits of (o-
3 fatty acids against various pathologies has not been clearly established. It has been 
reported that cardio-protective effects may be mediated by reduction in triglyceride 
(Harris, 1997; Craig, 1999), total plasma cholesterol and improvement in LDL to 
HDL ratio (Dupont et al. 1990; Cunnane et al. 1993; Ruiz-Gutierrez et al. 1999). 
co-3 fatty acids have distinct and important bioactive properties and influence gene 
expression. It has been shown that dietary PUFA regulates the expression of several 
enzymes involved in hepatic carbohydrate and lipid metabolism and act as fine 
regulators of glucose metabolism (Jump et al, 1994; Yoshida et al. 2001; Sampath 
and Natambi, 2004; Yilmaz et al. 2004). 
Oxidative stress is caused when the pro-oxidant challenge overwhelms the antioxidant 
defenses and leads to cellular damage which in turn can be influenced by nutritional 
intervention (Huang et al, 1994). It has been suggested that co-3 FA/fish oil may act 
as free radical scavenger and prevent the suppression of tissue endogenous 
antioxidant defense capability (Xi and Chen, 2000; Barbosa et al, 2003). Dietary fish 
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oil markedly increased the activity of GSH-Px in lymphoid organs and liver 
(Naqshbandi et al., 2011; Guimaraes and Curi, 1991). Erdogan et al. (2004) 
demonstrated that co-3 FA lead to decreased LPO and increased activity of SOD thus 
increasing plasma total antioxidant capability. Venkataraman et al., (1994) reported 
that 00-3 fatty acids increase the expression of hepatic and renal antioxidant defense 
enzymes in autoimmune-prone mice resulting in increased life span and delay of 
disease progression as compared to saturated or (o-6 fatty acids. However studies on 
possible beneficial effects of FO on drug/chemical induced nephrotoxicity are very 
limited. Recently, it has been documented that FO protects against gentamicin and 
uranyl nitrate-induced nephrotoxicity (Priyamvada et al, 2008, 2009). 
In view of the above, the present work was undertaken to test the hypothesis whether 
dietary fish oil rich in 00-3 FA would be able to protect against CP induced 
nephrotoxicity and other adverse effects and to find out the efficacy of such protection 
for single and multiple CP dose regimes. 
As shown in the "Results I", two sets of experiments were conducted. In the first set 
(Part lA), single injection of CP was administered, while in the second set (Part IB), 
multiple CP injections were administered to normal (CP group) and FO (CPF group) 
diet consuming rats. Serum parameters and the activities of various enzymes of 
carbohydrate metabolism, brush border membrane, mitochondria, lysosomes and 
antioxidant system were analyzed to ascertain potential beneficial effects of FO. CP 
administration as a single or multiple dose was found to cause marked renal 
dysfunction as evident by increased serum creatinine and urea, diagnostic indicators 
of nephrotoxicity, accompanied by the significant decrease in serum glucose and 
inorganic phosphate (Pi). However, the magnitude of increase in nephrotoxic 
parameters such as serum creatinine and BUN were more pronounced in single dose 
as compared to multiple dose CP treatment. Serum phospholipid and cholesterol were 
decreased by a single dose CP administration. In contrast, mulfiple dose CP exposure 
significantly increased serum cholesterol and phospholipids. The results show a 
typical pattern of CP-induced (Khan et al., 2009) nephrotoxicity as indicated by 
massive proteinuria, glucosuria and phosphaturia. The feeding of FO prior to and 
after/alongwith CP treatment in the short and long temi protocols respectively 
prevented CP induced deleterious effects in various blood/urine parameters. CP-
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induced alterations in serum creatinine, blood urea nitrogen (BUN), serum 
cholesterol, phospholipids and proteinuria, glucosuria and phosphaturia were 
prevented in FO-fed CP treated rats. This renoprotective effect was possible by the 
fact that short (2 weeks) as well as long term (4 weeks) FO consumption alone was 
able to increase serum glucose, phosphate and reduce serum cholesterol, creatinine 
and BUN. Dietary FO supplementation for 2 weeks caused reduction in urinary 
excretion of glucose, phosphate and proteins. 
The brush border membrane (BBM) of renal proximal tubules have been shown as an 
early and prominent site of CP induced renal injury (Ikuno et al, 1995; Vijayalakshmi 
et al, 2006). As a step towards understanding the biochemical mechanism of CP 
toxicity as well as its effect on the structural and functional integrity of the plasma 
membrane, the activity of BBM enzymes was studied in cortical and medullary 
homogenates, as well as in isolated BBMV preparations. Both the single and multiple 
dose CP treatment caused significant decrease in the activities of ALP, GGTase and 
LAP in cortical homogenates and isolated BBM vesicles, however the extent of 
decline was more in BBMV than in the respective cortical homogenates. A similar 
decrease was observed in medulla, suggesting an overall CP induced damage to the 
kidney. The decrease in enzyme activities could be due to the direct modification and 
consequent inactivation of enzymes by CP generated free radicals and ROS. There 
could also have been leakage or loss of these enzymes into the tubular lumen 
following ROS induced damage to the epithelial cells, especially the membrane. The 
decrease in BBM enzymes in the kidney suggest a severe damage to the structural 
architecture of the renal tissue as reported by morphological studies (Dobyan et al., 
1980). However, a differential effect on BBM enzymes activities was observed by 
single and multiple dose CP exposure. The activities of ALP and GGTase were 
affected almost to the similar extent in the renal tissues by single and multiple dose 
CP treatment, however the extent of damage/decline in LAP activity was more 
pronounced in multiple dose CP treatment. In contrast to CP, FO consumption alone, 
however significantly enhanced the activities of BBM enzymes in comparison to the 
control group in the homogenates and BBMV indicating an overall improvement in 
renal BBM integrity. Dietary fatty acids are known to be incorporated in the 
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membrane causing changes in the Upid composition which in turn affect the 
biophysical characteristics of the membrane and the activities of certain membrane 
associated enzymes (Stenson et al, 1989; Kaur et ai, 1996; Thakkar et ai, 2000; 
Carrillo-Tripp M and Feller, 2005). A variable effect on the activity of ALP/GGTase 
in the renal cortex and medulla can be considered due to their localization in the 
thickness of BBM or due to differential access/accumulation of FO in these tissues 
(Yusufi er a/., 1994). 
FO consumption in combination with CP treatment resulted in the attenuation of CP 
induced alterations in the BBM enzymes in renal tissues. The results convincingly 
demonstrate that FO consumption prevented the CP elicited decrease in the activities 
of certain BBM enzymes. The activities of BBM enzymes in the cortical/medullary 
homogenates and in BBM remained significantly higher in CPF compared to CP 
group in both the short and the long term protocols, indicating a marked prevention of 
CP effect on these enzymes by FO consumption. The activity of lysosomal enzyme, 
ACPase was significantly increased in the cortex and medulla by CP treatment. 
Alterations in ACPase activity demonstrate CP-induced loss of lysosomal function 
(Courjault-Gautier et ai, 1995; Kuhlmann et al, 1997). In contrast, FO consumption 
prevented this loss either by lessening the damage caused by CP or by increasing the 
regeneration process or both. 
Reabsorption of important ions and molecules is the major fiinction of kidney, that 
intum depends on the structural integrity of BBM and available energy (ATP) 
supplied by various metabolic pathways. Thus, it is imperative that any alteration to 
these metabolic pathways caused by toxic insult (or otherwise modified) would affect 
the functional capabilities of kidney. To assess the functional aspects, the activities of 
various enzymes of carbohydrate metabolism were determined for different 
experimental groups. As shown in the "Results", the activities of various enzymes 
involved in glycolysis, TCA cycle, gluconeogenesis and HMP shunt pathway were 
differentially altered by CP treatment and/or by FO consumption. A single as well as 
multiple CP injections caused significant increase in LDH activity but decrease in 
MDH (TCA cycle) activity in both renal cortex and medulla which was associated 
with simultaneous increase in HK activity in the renal tissues. Although the actual 
rates of glycolysis or TCA cycle were not detemiined, however marked decrease in 
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MDH activity appears to be due to CP induced damage to mitochondria (Zhang and 
Lindup, 1993; Kuhhnan et al., 1997). An impaired oxidative metabolism of 
glucose/fatty acids due to mitochondrial dysfunction would result to lower ATP 
production by oxidative metabolism which intum would lower the renal transport 
function capabilities (Khan et al., 2009). A marked increase in LDH and to some 
extent HK activity with simultaneous decline in TCA cycle enzyme, MDH appears to 
be adaptive cellular effect in energy metabolism fi-om aerobic metabolism 
alternatively to anaerobic glycolysis due to CP induced mitochondrial dysfunction. 
CP administration as a single or multiple dose caused differential effect on the 
enzymes of gluconeogenesis. The activities of G6Pase and FBPase were significantly 
declined in cortex and medulla by single CP injection and in medulla by multiple CP 
doses. The decline in the gluconeogenesis can be explained by the fact that lower 
TCA enzyme activities especially that of MDH would have resulted in lower 
oxaloacetate production from malate which is required not only for the continuation 
of TCA cycle but also for gluconeogenesis. Thus, CP-induced toxicity appeared to be 
primarily due to renal mitochondrial damage as suggested by morphological studies 
(Zhang and Lindup, 1993; Khulm.ann et al., 1997). The activity of G6PDH, an 
enzyme of HMP-shunt pathway was declined while the activity of NADP malic 
enzyme (ME) was increased in renal cortex and medulla both by single and multiple 
dose CP treatment. The present data indicate that CP caused differential effect on 
different enzymes of carbohydrate metabolism. However, the activities of these 
enzymes in FO group either remained same or were increased in comparison to the 
control group. FO is shown to alter the expression and activities of various enzymes 
of carbohydrate metabolism (Jump et al., 1994; Yoshida et al., 2001; Yilmaz et al., 
2004). Dietary FO supplementation either for 2 or 4 weeks to the CP treated rats 
resulted in overall improvement of carbohydrate metabolism as evident by higher 
activities of LDH, MDH and gluconeogenic enzymes in CPF compared to CP group. 
Taken together, the results indicate that FO supplementation to CP treated rats might 
have lowered the number of damaged mitochondria or affected macromolecules or 
may have increased the number of normally active organelles or macromolecules. 
A balance between production and catabolism of oxidants by cells and tissues is 
critical for the maintenance of biological integrity of the tissues. It has been reported 
Page I 82 
Results & Discussion 
that some toxicants including certain drugs (Banday et al., 2008a) and heavy metals 
(Fatima et al., 2004; Priyamvada et al., 2009) exert their toxic effects by inducing the 
generation of reactive oxygen species (ROS). However, oxidative stress can occur as 
a result of either increased ROS generation and/or decreased antioxidant enzyme 
system comprising SOD, catalase and GSH-Px. These antioxidant enzymes protect 
the cell against cytotoxic ROS. CP has been found to increase mitochondrial 
generation of ROS and oxidative stress and subsequent cell death (Qian et al., 2005). 
CP has been shown to enhance lipid peroxidation (LPO), an indicator of tissue injury 
and deplete GSH and protein thiols (Nakano and Gemba, 1989; Mistry et al., 1991). 
The activities of antioxidant enzymes in kidney were shown to be decreased by CP 
administration (Fatima et al., 2004). In agreement with previous observations, CP 
treatment significantly decreased the activities of SOD, catalase and GSH-Px and 
enhanced LPO in the renal cortex and medulla indicating CP induced oxidative 
damage to the renal tissues. The severity of the damage appeared to be more profound 
by a single dose CP treatment. Enhanced LPO results in protein damage and 
inactivation of membrane bound enzymes either through direct attack by free radicals 
or through chemical modification by its end product (malondialdehyde) (Halliwell 
and Gutteridge, 1999). This fiirther explains the observed decline in BBM enzyme 
activities by CP treatment. In contrast, dietary FO by virtue of its antioxidant 
properties, significantly enhanced antioxidant defense mechanism. As can be seen 
from the "Results lA and IB", feeding of FO either for 2 weeks (short term protocol) 
or for 4 weeks (long term protocol) caused significant increase in SOD, catalase and 
GSH-Px activities in the renal cortex and medulla. These alterations were associated 
with lowering of LPO in both renal tissues. This is in agreement with previous studies 
which have shown that a)-3 PUFA supplementation diet leads to increased plasma 
total antioxidant capabilities (Sarsilmaz et al., 2003; Erdogan et al., 2004). 
FO consumption in combination with CP treatment significantly prevented CP 
induced increase in LPO and decrease in the activities of SOD, catalase and GSH-Px 
in the renal cortex as well as in medulla both in short term (Result-IA) and long term 
(Results-IB) protocols, co-3 PUFA enriched FO supplementation diet seems to offer 
protection against the damage caused by CP in two possible ways: First, it increases 
the levels of SOD, catalase and GSH-Px in the renal tissues resulting in enhanced 
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defense against ROS. Second, (o-3 PUFAs that have been supplemented may be 
replaced with pol5ainsaturated fatty acid components of the membranes that had been 
attacked by oxygen free radicals (Masters, 1996; Ozgocmen et al., 2000) thus 
lessening the damage caused by CP and improving the membrane integrity. Several 
animal and human studies demonstrate that co-3 PUFAs may also act as a free radical 
scavenger (Barbosa et al., 2003; Fisher and Levine, 1991; Chautan et al., 1990; 
Sarsilmaz et al., 2003). FO seems to enhance resistance to free radical attack 
generated by CP similarly as demonstrated in lupus nephritis and other pathologies 
(Chandrasekar and Femandes, 1994; Donadio, 2001). Thus, the protection offered by 
FO against CP induced renal dysfunction can be attributed to its intrinsic 
biochemical/antioxidant properties. 
In conclusion, results of the present study show that CP treatment in single or multiple 
doses induces generation of free radicals that causes oxidative damage to cellular 
organelles, macromolecules and especially to mitochondria and plasma membrane. In 
contrast, FO by virtue of its antioxidant properties reduces oxidative stress thus 
improving the structural integrity of various organelles/macromolecules and 
eventually enhances metabolic capabilities of the kidney. 
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PARTII A 
O HYPOTHESIS-II A: 
a)-3 fatty acids from plant (flaxseed oil, FXO) sources would protect against single 
CP dose induced acute nephrotoxic and other deleterious effects in the rat kidney. 
O EXPERIMENTAL DESIGN-IIA (SHORT TERM PROTOCOL): 
To test the above hypothesis, Adult male Wistar rats (10-12 rats/group) weighing 
between 150-200 g were used in the study. Animals were acclimatized for a week on 
standard rat chow and allowed water ad libitum under controlled conditions of 
25±2°C temperature, 50±15% relative humidity and normal photoperiod (12 hour dark 
and light). Four groups of rats entered the study after acclimatization (Figure 13). 
They were fed on either normal diet (control and CP groups) or diet containing 15% 
flaxseed oil (CP+FXO and FXO groups). After 10 days rats in two groups (CP and 
CP+FXO) were administered a single dose of CP intraperitoneally (6 mg/kg bwt) in 
0.9% saline. Animals in the control and FXO group received an equivalent amount of 
normal saline. Since CP-induced renal injury is gradual and usually occurs 3-5 days 
after CP administration (Arany and Safirstein, 2003), hence the animals were 
sacrificed 4 days after CP administration under light ether anesthesia. Blood was 
withdrawn from left jugular vein and serum was separated by centrifiigation at 2000 x 
g for 10 min. Urine samples were collected for 4 h in standard metabolic cages a day 
before the sacrifice of rats. The kidneys were extracted and processed for the 
preparation of homogenates and brush border membrane vesicles (BBMV) as 
described in "Methods". Each preparation of BBM was made by pooling the cortical 
tissue from 2-3 animals. Thus, the number of animals mentioned above contributed to 
4-5 different preparations for each group. Body weight of rats were recorded at the 
start and completion of the experimental procedures. 
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Results & DiscussioKi 
O RESULTS-II A: 
To test the above hypothesis, the effect of flaxseed oil (FXO) consumption and 
cisplatin (CP) alone and in combination was determined on various parameters in rat 
serum and kidney. In general the rats remained active and alert throughout the study. 
The daily food and fluid intake was similar in various experimental group of rats (data 
not shown). There was significant loss in body weight in CP treated rats (CP and 
CPFXO groups) as compared to control rats (Table 1) 
O Effect of dietary flaxseed oil on single CP dose induced alterations in serum 
and urine parameters: 
CP treatment to control rats resulted in significant increase in serum creatinine (Scr, 
+176%), blood urea nitrogen (BUN, +122%), cholesterol (+13%), phospholipids 
(PLP, +77%i) but decrease in inorganic phosphate (-17%)) and glucose (-79%o) 
compared to control rats (Table 2). These changes were associated with massive 
glucosuria, phosphaturia, proteinuria and polyurea accompanied by decreased 
creatinine clearance (Table 3). In contrast FXO diet alone increased creatinine 
clearance and decreased polyurea, phosphaturia and proteinuria as compared to 
normal diet fed rats. 
Feeding of FXO-diet to CP administered (CPFXO group) rats resulted in amelioration 
of various CP elicited nephrotoxic alterations on serum and urine parameters. CP 
induced increase in Scr, cholestrol and BUN were prevented by FXO supplementation 
diet. However, serum glucose and Pi remained decreased by FXO feeding to CP 
treated rats in comparison to control rats. 
O Effect of dietary flaxseed oil on single CP dose induced alterations in BBM 
enzymes in the renal homogenates and isolated BBMV: 
To assess the structural integrity of plasma membrane (BBM) and certain organelles 
i.e. lysosomes, the effect of CP and FXO alone and in combination was determined on 
biomarker enzymes of BBM and lysosomes in the homogenates of renal cortex and 
medulla and in isolated BBMV preparations from renal cortex. 
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Table 1: Effect of dietary flaxseed oil (FXO) on body weight (in gms) of rats 
with/without single dose CP treatment. 
Groups Before Treatment After Treatment % change 
Control 150 ±5.30 163 ±10.20 +9 
CP 167.85 ±4.20 125 ±6.70 -26 
CPFXO 150 ±7.50 125 ±5.90 -17 
FXO 150 ±8.40 162.89 ±5.10 +9 
Results are expressed as Mean ± SEM for 10-12 rats/group. 
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Results & Discussion 
a) Effect ofCP alone and with FXO diet on biomarkers ofBBM and lysosomes in 
the cortical/medullary homogenates: 
The activities of alkaline phosphatase (ALP), y-glutamyl transpeptidase (GGTase), 
leucine aminopeptidase (LAP) and acid phosphatase (ACPase) were determined under 
n different experimental condition|) in the homogenates of renal cortex and medulla 
(Table 4). 
Single dose CP treatment to control rats caused significant reduction in the specific 
activities of ALP (-43%), GGTase (-46%) and LAP (-43%) in cortical homogenate. 
Feeding of FXO diet alone, however, caused increase in the activities of ALP, 
GGTase and LAP as compared to control rats. FXO diet fed prior to and following 
CP treatment prevented CP elicited decrease in BBM enzyme activities in cortical 
homogenate (Table 4a, Figure 14a). 
The activities of BBM enzymes similar to the cortex were also lowered in the medulla 
by CP administration (Table 4b). The consumption of FXO in combination with CP 
treatment resulted in the prevention of CP induced decrease in ALP (-36%), GGTase 
(-25%) and LAP (-23%) activities in the medulla. The effect of CP and FXO alone 
and in combination was also determined on the activities of lysosomal enzyme, 
ACPase in the cortical and medullary homogenates. The activity of ACPase was 
significantly increased in cortical (+48%) and medullary (+43%) homogenates by CP 
treatment. CP-induced increase in ACPase activity was significantly reduced by FXO 
diet (CPFXO group) both in cortical and medullary homogenates albeit to different 
extent (Table 4a and 4b). 
b) Effect of dietary flaxseed oil on single CP dose induced alterations in BBM 
enzymes in the isolated BBMVpreparations: 
The effect of CP, FXO and their combination was further analyzed on the specific 
activities of BBM marker enzymes in isolated BBMV preparations (Table 5, Figure 
14b). Results show a similar activity pattern of decrease in BBM enzymes as observed 
in cortical homogenates, however the magnitude of the effects under different 
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Table 4: Effect of dietary flaxseed oil (FXO) on biomarkers of BBM and 
lysosomes in homogenates of a) cortex and b) medulla with/without 
single dose CP treatment. 
Groups 
a) Cortex 
Control 
CP 
CPFXO 
FXO 
b) Medulla 
Control 
CP 
CPFXO 
FXO 
ALP 
()amol/mg 
protein/h) 
8.48 ± 0.0846 
4.85 ± 0.390* 
(-43%) 
6.91 ± 0.70^ 
(-19%) 
10.32±1.11* 
(+21%) 
8.30 ±0.485 
5.31 ±0.135* 
(-36%) 
6.51 ±0.140*^ 
(-22%) 
8.68 ±0.312* 
(+5%) 
GGTase 
(l^mol/mg 
protein/h) 
8.17 ±0.367 
4.39 ±0.12* 
(-46%) 
6.70 ± 0.443^ 
(-18%) 
9.26 ±0.15 
(+13%) 
19.26 ±0.364 
14.50 ±0.362* 
(-25%) 
16.30 ±0.35*^ 
(-15%) 
21.54 ±0.72* 
(+12%) 
LAP 
()Limol/mg 
protein/h) 
2.25 + 0.18 
1.29 + 0.075* 
(-43%) 
1.72±0.11^ 
(-24%) 
2.76 + 0.211* 
(+23%) 
25.03 + 0.765 
19.24 + 0.285* 
(-23%) 
22.69 + 0.80' 
(-9%) 
27.03 + 0.921* 
(+8%) 
ACPase 
(fimol/mg 
protein/h) 
1.3 + 0.02 
1.93 + 0.055* 
(+48%) 
1.54 + 0.05^ 
(+18%) 
1.11 +0.034 
(-15%) 
2.23 + 0.075 
3.18 + 0.045* 
(+43%) 
2.58 + 0.055* 
(+16%) 
2.12 + 0.177* 
(-5%) 
Results (specific activity expressed as |Limoles/mg protein/h) are Mean + SEM for five 
different preparations. 
* Significantly different from control,' fsignificantly different from CP at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 5: Effect of dietary flaxseed oil (FXO) on activities of biomarker enzymes 
of BBM in cortical BBMV with/without single dose CP treatment. 
Groups ALP GGTase LAP (|xmol/mg (i^mol/mg ()imol/mg 
protein/h) protein/h) protein/h) 
Control 
CP 
CPFXO 
FXO 
100.36 ±3.03 
28.93 ±1.64* 
(-71%) 
54.16 ±2.59*^ 
(-46%) 
83.97 ±4.42 
(-16%) 
63.05 ±0.635 
19.75 ±1.29* 
(-69%) 
41.27 ±1.21*'' 
(-35%) 
68.92 ± 3.34 
(+9%) 
104.35 ±0.65 
68.27 ±1.10* 
(-35%) 
84.22 ±1.35*^ 
(-19%) 
94.63 ±1.6* 
(-9%) 
Results (specific activity expressed as )jmoles/mg protein/h) are Mean ± SEM for five 
different preparations. 
*Significantly different from control, fsignificantly different from CP at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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ALP GGTase LAP 
Figure 14.Effect of dietary flaxseed oil (FXO) on the activities ALP, GGTase 
and LAP in (a) cortical homogenate (b) cortical BBM with/without 
single dose cisplatin (CP) treatment. 
Above figure is drawn using values from Table 4a and 5. 
*Significantly different from control, tsignificantly different from CP: at 
p<0.05 by one way ANOVA. 
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experimental conditions were more apparent in BBMV than in the respective cortical 
homogenates. The decrease or increase in the activities of ALP, GGTase and LAP by 
CP or FXO respectively was significantly higher in BBMV as compared to renal 
cortical homogenate. The damaging effect of CP on BBM/BBM enzymes was clearly 
ameliorated by FXO, as decrease in the activities of ALP, GGTase and LAP by CP 
was significantly prevented by FXO consumption. 
O Effect of dietary flaxseed oil on single CP dose induced alterations in 
metabolic enzymes in renal cortex and medulla: 
The effect of CP, FXO and CP+FXO was determined on the activities of various 
enzymes of carbohydrate metabolism involved in glycolysis, TCA cycle, 
gluconeogenesis and HMP shunt pathway in renal cortex and medulla (Tables 6, 7). 
(a) Effect on carbohydrate metabolism in renal cortex: 
Single dose CP treatment to control rats significantly increased LDH, a marker of 
anaerobic glycolysis (+38%) and HK (glycolysis) (+15%) whereas decreased MDH, 
an enzyme of TCA cycle (-47%), G6Pase (-21%) and FBPase (-52%) 
(gluconeogenesis). Feeding of FXO to CP treated rats arrested CP-induced decline in 
MDH, FBPase and G6Pase activities and increase in LDH and HK activities. 
However, FXO alone caused increase in MDH, G6Pase and FBPase activities (Table 
6). 
The effect of CP and FXO alone and their combined effect was also determined on 
glucose-6-phosphate dehydrogenase (G6PDH) and NADP-malic enzyme (ME), 
source of NADPH needed in various anabolic reactions (Table 6). CP treatment to 
control rats significantly decreased G6PDH but increased ME activity. However, CP 
treatment to FXO fed rats reduced the severity of CP induced alterations in glucose-6-
phosphate dehydrogenase (G6PDH) and NADP-malic enzyme (ME) activities. 
b) Effect on carbohydrate metabolism in renal medulla: 
The activities of LDH, MDH, HK, G6Pase and FBPase in medullary homogenates 
were similarly affected by CP treatment (Table 7) as in the cortical homogenates. CP 
treatment to control rats significantly increased the activities of lactate dehydrogenase 
(LDH) and hexokinase (HK) but decreased malate dehydrogenase (MDH), glucose-6-
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Results & Discussion 
phosphatase (G6Pase) and fructose-l, 6-bisphosphatase (FBPase) activities in the 
medulla. Feeding of FXO to C? treated rats prevented CP induced alterations in the 
activities of various metabolic enzymes. Similar to cortex, G6PDH activity was 
decreased whereas ME activity was increased by CP treatment in medulla. Dietary 
supplementation of FXO prior to and following CP treatment reduced the decline in 
G6PDH and increase in ME activity. 
O Effect of dietary flaxseed oil on single CP dose induced alterations in 
antioxidant defense parameters in renal cortex and medulla: 
Antioxidant status is a potential biomarker to determine the physiological state of the 
cell, tissue or organ. To ascertain the role of antioxidant system in CP-induced 
toxicity, the effect of CP was observed on oxidative stress parameters. CP enhanced 
lipid peroxidation (LPO) and significantly suppressed antioxidant enzymes both in 
cortex and medulla, albeit to different extents (Table 8). LPO measured in terms of 
malodialdehyde (MDA) levels was significantly enhanced in the cortex (+39%) and 
medulla (+.31%), whereas total-SH declined to the same extent (-24%) in these tissue. 
CP treatment caused significant decrease in superoxide dismutase (SOD,-63%), 
catalase (-67%) and glutathione peroxidase (GSH-Px, -63%)) activities in the renal 
cortex. In medulla also the activities of SOD (-53%), catalase (-37%) and GSH-Px (-
68%) were decreased similarly by CP administration. However, FXO consumption 
either with or without CP treatment significantly enhanced the antioxidant parameters. 
CP administration to FXO fed rats prevented the CP elicited suppression of 
superoxide dismutase, catalase and glutathione peroxidase activities both in cortex 
and medulla. LPO was significantly declined by dietary FXO supplementation to CP 
treated rats and LPO values in CPFXO group were lowered in comparison to CP and 
even control group. Reduction in total-SH group by CP treatment was also prevented 
although to lesser extent by FXO consumption. The results indicate marked protection 
by FXO diet against CP induced oxidative damage to renal tissues. 
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PART - IIB 
O HYPOTHESIS-II B: 
a)-3 fatty acids from plant (flaxseed oil, FXO) sources would also protect against 
multiple CP dose induced nephrotoxic and other deleterious effects in the rat kidney. 
O EXPERIMENTAL DESIGN-II B (LONG TERM PROTOCOLV. 
Since cancer chemotherapy involving cisplatin requires administration of CP in 
multiple doses over a long duration, therefore to investigate whether the protection 
offered by FXO in single dose CP treatment also extends for multiple dose CP 
therapy, the following experiment was designed. 
Adult male Wistar rats (10-12 rats/group) weighing between 150-200 g were used in 
the study. Animals were acclimatized for a week on standard rat chow and allowed 
water ad libitum under controlled conditions of 25±2°C temperature, 50±15% relative 
humidity and normal photoperiod (12 hour dark and light). Four groups of rats entered 
the study after acclimatization (Figure 15). They were fed on either normal diet 
(control and CP groups) or diet containing 15% flaxseed oil (CPF and FXO groups). 
After 10 days rats in two groups (CP and CPFXO) were administered multiple doses 
of CP intraperitoneally (3 mg/kg bwt) in 0.9% saline on every fourth day for 20 days. 
Animals in the control and FXO group received an equivalent amount of normal 
saline. The rats were sacrificed on fifth day after the last CP/saline injection under 
light ether anesthesia. Blood was withdrawn fi^om left jugular vein and serum was 
separated by centrifiigation at 2000 x g for 10 min. Urine samples were collected for 4 
h in standard metabolic cages a day before the sacrifice of rats. The kidneys were 
extracted and processed for the preparation of homogenates and brush border 
membrane vesicles (BBMV) as described in "Methods". Each preparation of BBM 
was made by pooling the cortical tissue from 2-3 animals. Thus, the number of 
animals mentioned above contributed to 4-5 different preparations for each group. 
Body weight of rats were recorded at the start and completion of the experimental 
procedures. 
Page I 100 
+-» 
ID 
c 
(U 
o 
E 
o I 
00 
CO 
(U 
t 
o 
u 
i5 
=) 
01 
^ 
• 
c 
0) 
tJO 
o E 
u 
I 
i-s 
<J rH 
nj T t 
en 
d 
OJ 
u 
u 
u 
a. 
u 
O 
X 
u. 
o. 
U 
T 0) • > .E 
c 
o 
c 
00 
U u 
Q. 
.^ *««•• 
c 
o 
r) ai 
c 
* c 
re 
Q. 
M 
U 
• ! - • 
x; 00 
0) 
? 
> • 
T3 
U 
n 
on 
^ ^ s ^ 
00 
E 
rf) 
-^^  o 
X 
u. 
Q. U 
a 
z 
O 
X 
u. 
O 
X 
to 
>. 
re 
• D 
o 
OJ 
5 
01 
c 
o 
c 
_rt 
"K C/3 
CJ 
+ 
.4__) 
<D • 
Td 
r;:^  
O 
-d (D 
o 
« X 
C3 
q ^ 
6 
X 
IJH 
O^  
U 
rf 
.a 
ja 
"a V3 
o (ii 
O 
•*—> 
a> • i -H 
T3 
,__, O 
T3 
u 
<u 00 
X 
C3 
C5 '-^ 
. . -4-
o ^ X S 
PH .2 
—r o O 1) 
t- i " r f " 
•a C 
c — O 4) 
" .S 
Ci "cs 
M 
ITT '—' U cS 
• ' " ' r-i 
xj S 
"TO Q 
6 •= 
i<S 
. . \*-' 
P c Z O 
m B 
1—' '^r" 
^ .a 
M P H 
•;^  o 
u . , Is 
a b 
a i3 
^ S 
w 4-
1—1 • - -
g -g 
s -a 
.£f S 
ta i: 
T - l 
o 
rH 
01 
00 
TO QL 
Results & Discussiot\ 
O RESULTS-Il B: 
To test the above hypothesis, the effect of dietary flaxseed oil (FXO) consumption and 
cisplatin (CP) treatment alone and in combination was determined on various parameters 
in rat serum and kidney. In general, the rats remained active and alert throughout the 
study. The daily food and fluid intake was similar in various experimental groups of rats 
(data not shown). There was significant loss in body weight in CP treated rats (CP and 
CPFXO groups) as compared to control (Table 1). 
O Effect of dietary flaxseed oil on multiple CP dose induced alterations in serum 
and urine parameters: 
CP treatment to control rats resulted in significant increase in serum creatinine (Scr, 
+102%), blood urea nitrogen (BUN, +126%), cholesterol (+46%), phospholipids (PLP, 
+67%) but decrease in inorganic phosphate (Pi, -31%) and glucose (-61%) compared to 
control rats (Table 2). These changes were associated with massive phosphaturia, 
proteinuria and glucosuria accompanied by decreased creatinine clearance (Table 3). In 
contrast, FXO-diet alone caused decrease in Scr and Serum cholesterol but increase in 
serum glucose and Pi. 
Feeding of FXO-diet to CP administered (CPFXO) rats resulted in amelioration of various 
CP elicited nephrotoxic alterations on serum and urine parameters. FXO prevented CP 
induced increase of Scr, BUN, PLP, cholestrol and decrease in glucose and Pi. 
O Effect of dietary flaxseed oil on multiple CP dose induced alterations in BBM 
enzymes in the homogenates and isolated BBMV: 
To assess the structural integrity of plasma membrane (BBM) and certain organelles i.e. 
lysosomes, the effect of CP and FXO alone and in combination was determined on 
biomarker enzymes of BBM and lysosomes in the homogenates of renal cortex and 
medulla and isolated BBMV preparations from renal cortex. 
a) Effect of CP alone and with FXO diet on biomarkers of BBM and lysosomes in the 
cortical/medullary homogenates: 
The activities of alkaline phosphatase (ALP), y-glutamyl transpeptidase (GGTase), leucine 
aminopeptidase (LAP) and acid phosphatase (ACPase) were determined under different 
experimental conditions in the homogenates of renal cortex and medulla (Table 4). 
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Table 1: Effect of dietary flaxseed oil (FXO) on body weight (in gms) of rats 
with/without multiple dose CP treatment. 
Groups Before Treatment After Treatment % change 
Control 169.44 ±8.30 175 ±10.60 +3 
CP 165 ±6.10 145 ±9.20 -12 
CPFXO 162.5 ±10.60 150 ±4.50 -8 
FXO 168 ±4.50 177 ±5.21 +5 
Results are expressed as Mean ± SEM for 10-12 rats/group. 
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Results & Discussion 
CP treatment to control rats caused significant reduction in the specific activities of 
ALP (-36%), GGTase (-42%) and LAP (-42%) in cortical homogenate. Feeding of 
FXO diet alone, however, caused increase in ALP, GGTase and LAP activities in 
comparison to control rats. FXO diet fed prior to and along with CP treatment 
prevented CP elicited decrease in BBM enzyme activities in renal cortex. The activity 
of acid phosphatase (ACPase) was increased (+90%) by CP in cortical homogenate 
and FXO diet was able to prevent the increase in ACPase activity (Table 4a, Figure 
16a). 
Similar to the cortex, the activities of BBM enzymes were also lowered in the medulla 
by CP administration (Table 4b). The consumption of FXO in combination with CP 
treatment reduced the CP induced decrease in ALP (-28%), GGTase (-75%) and LAP 
(-53%) activities in the medulla. The effect of CP alone and in combination with FXO 
was also determined on the activities of ACPase in medullary homogenates. The 
activity of ACPase was significantly increased (+55%) by CP treatment in medulla 
also, however to lesser extent than the cortex. CP-induced increase in ACPase activity 
in medulla was significantly reduced by dietary FXO supplementation. 
b) Effect of dietary flaxseed oil on multiple CP dose induced alterations in BBM 
enzymes in the isolated BBMVpreparations: 
The effect of CP, FXO and their combination was further analysed on the specific 
activities of BBM marker enzymes in isolated BBMV preparations (Table 5, Figure 
16b). Results show a similar activity pattern of the enzymes as observed in cortical 
homogenates, however the magnitude of the effects under different experimental 
conditions were more apparent in BBMVs than in the respective cortical 
homogenates. The decrease in the activities of ALP, GGTase and LAP by CP 
treatment was significantly higher in BBMV as compared to cortical homogenate. The 
damaging effect of CP was clearly ameliorated by FXO, as decrease in the activities 
of ALP, GGTase and LAP by CP treatment was found to be significantly prevented 
by dietary FXO consumption. 
Page I 106 
Results & Discussiot\ 
Table 4: Effect of dietary flaxseed oil (FXO) on biomarlcers of BBM and 
lysosomes in homogenates of a) cortex and b) medulla with/without 
multiple dose CP treatment. 
Groups 
a) Cortex 
Control 
CP 
CPFXO 
FXO 
b) Medulla 
Control 
CP 
CPFXO 
FXO 
ALP 
(^mol/mg 
protein/h) 
4.41 ± 0.22 
2.80 ±0.350* 
(-36%) 
3.69 ±0.288^ 
(-16%) 
5.12 ±0.196* 
(+16%) 
3.24 ± 0.072 
2.32 ±0.124* 
(-28%) 
3.13 ±0.363 
(-3%) 
4.16 ±0.072* 
(+28%) 
GGTase 
(fxmol/mg 
protein/h) 
6.37 ±1.14 
3.71 ±1.57* 
(-42%) 
6.06 ±0.166^ 
(-5%) 
7.22 ± 0.089 
(+13%) 
24.01 + 1.95 
5.97 ±0.995* 
(-75%) 
14.38 ±0.905*^ 
(-40%) 
24.64 ±0.11 
(+3%) 
LAP 
()imol/mg 
protein/h) 
22.48 + 1.60 
12.95 + 0.501* 
(-42%) 
14.96 ±0.148* 
(-33%) 
23.15 + 0.34 
(+3%) 
39.56 + 0.976 
18.57+1.52* 
(-53%) 
27.53 ± 0.990*^ 
(-30%) 
37.12 + 1.23 
(-6%) 
ACPase 
(|imol/mg 
protein/h) 
4.52 + 0.191 
8.58 + 0.49* 
(+90%) 
5.04 + 0.243^ 
(+11%) 
4.01+0.22 
(-11%) 
2.28 + 0.099 
3.54 + 0.355* 
(+55%) 
2.80 + 0.085* 
(+23%) 
2.52 + 0.062 
(+11%) 
Results (specific activity expressed as pmoles/mg protein/h) are Mean + SEM for five 
different preparations. 
*Significantly different from control, jsignificantly different from CP at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 5: Effect of dietary flaxseed oil (FXO) on activities of biomarker 
enzymes of BBM in cortical BBMV with/without multiple dose CP 
treatment. 
Groups ALP (^mol/mg 
protein/h) 
GGTase 
(|imol/mg 
protein/h) 
LAP 
(|amol/mg 
protein/h) 
Control 
CP 
CPFXO 
FXO 
48.71±3.48 
13.56 ±1.68* 
(-72%) 
23.87 ±1.81* 
(-51%) 
41.68 ±0.19 
(-14%>) 
146.43 ± 5.09 
50.12 ±1.12* 
(-66%) 
97.04 ± 4.24* 
(-34%) 
161.12±2.15* 
(+10%) 
173.80 ±0.955 
79.91 ±0.47* 
(-54%) 
123.33 ±2.11*^ 
(-29%) 
161.23 ±1.17 
(-7%) 
Results (specific activity expressed as |jmoles/mg protein/h) are Mean ± SEM for five 
different preparations. 
*Significantly different from control, fsignificantly different fi-om CP at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Figure 16. Effect of dietary flaxseed oU (FXO) on the activities of ALP, GGTase 
and LAP in (a) cortical homogenate (b) cortical BBMV with/without 
multiple dose cisplatin (CP) treatment. 
Above figure is drawn using values fi-om Table 4a and 5. 
*Significantly different from control, tsignificantly different from CP: at p < 0.05 
by one way ANOVA. 
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O Effect of dietary flaxseed oil on multiple CP dose induced alterations in 
metabolic enzymes in renal cortex and medulla: 
The effect of CP, FXO and CP+FXO was determined on the activities of various 
enzymes of carbohydrate metabohsm in renal tissues (Tables 6, 7). CP treatment to 
control rats significantly increased hexokinase (HK) activity in the cortex (+93%) and 
medulla (+58%). The activity of LDH (a marker of anaerobic glycolysis) also showed 
a significant increase in the activity in both cortex (+49%) and medulla (+36%). The 
effect of CP was also observed on the activities of MDH (an enzyme of TCA cycle) 
and G6Pase, FBPase (enzymes of gluconeogenesis). CP treatment caused decline in 
the activities of MDH, G6Pase and FBPase both in the cortex and medulla albeit to 
different extents. When CP treatment was extended to FXO fed rats, CP induced 
alterations in LDH, HK, MDH, G6Pase and FBPase activities were prevented. 
However, FXO alone caused increase in MDH, G6Pase and FBPase activities in 
comparison to control group in both the renal tissues. 
The effect of CP and FXO was also determined on glucose-6-phosphate 
dehydrogenase (G6PDH) and NADP-malic enzyme (ME), source of NADPH needed 
in various anabolic reactions (Table 6,7). CP significantly decreased the activity of 
G6PDH in cortex (-31%) as well as in medulla (-70%). ME activity on the other hand 
was enhanced by CP in cortex (+65%) and medulla (+44%). Dietary FXO 
supplementation to CP treatment reduced the severity of CP induced alterations in 
glucose-6-phosphate dehydrogenase (G6PDH) activity in renal cortex and medulla. 
However, increase in NADP-malic enzyme (ME) activity by CP treatment was not 
only prevented by dietary FXO consumption rather the ME activity was lowered in 
renal tissues in CPFXO rats as compared to control rats. 
O Effect of dietary flaxseed oil on multiple CP dose induced alterations in 
antioxidant defense parameters in renal cortex and medulla: 
The effect of CP, FXO and CP+FXO was determined on the parameters of antioxidant 
defense system such as lipid peroxidation (LPO), total SH, SOD, catalase and GSH-
Px (Table 8). Antioxidant status is a potential biomarker to determine the 
physiological state of cell, tissue or organ. Multiple dose CP administration to control 
rats resulted in a profound increase in the production of malondialdehyde (MDA), an 
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Results & Discussion 
end product of lipid peroxidation in the renal tissues. There was marked increase in 
LPO in the cortex (+133%) and in medulla (+111%). CP caused marked reduction in 
total SH levels however the decline was much more pronounced in medulla (-68%) 
than in cortex (-26%). These changes in LPO and total SH were associated with the 
decrease in the activities of SOD, catalase and GSH-Px. Marked decrease in 
superoxide dismutase (SOD, -54%), catalase (-46%) and glutathione peroxidase 
(GSH-Px, -35%) activities by CP treatment was found in renal cortex. In medulla the 
activity of SOD (-62%), catalase (-46%) and GSH-Px (-73%) also showed significant 
decline by CP treatment. 
Dietary FXO supplementation prior to and alongwith CP treatment significantly 
prevented CP induced increase in LPO and decrease in total-SH in the renal tissues. 
The activities of SOD, catalase and GSH-Px in both cortex and medulla were 
significantly ameliorated by FXO supplementation to CP treated rats. Dietary FXO 
when fed alone (without CP treatment) caused increase in SOD, catalase and GSH-Px 
activities in cortex while in medulla SOD and catalase activities were increased by 
FXO consumption. 
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DISCUSSION-II 
Worldwide nephrotoxicity poses a considerable health and economic burden. Drug 
induced nephrotoxicity is a major cause for acute renal injury (AKI) cases (Taber and 
Mueller, 2006). For this reason, the search for strategies to prevent nephrotoxicity 
constitutes an active area of investigation. In addition to drug targeting and ped ic^ 
chemistry for new and safer molecules, a line of interest is the identification of 
renoprotective adjuvants for co-administration alongwith potentially nephrotoxic 
drugs, such as platinated antineoplastics. Many different substances including 
antioxidants (Pabla and Dong, 2008) have been investigated for their beneficial 
effects on cisplatin-induced renal injury (Ali and Al-Moundhri, 2006; Chirino and 
Pedraza-Chaverri, 2009). However, most of them have not yet been proved safe for 
clinical application (Ali and Al-Moundhri, 2006; Gamal-el-Din and Al-Bekairi, 
2006). 
The approach of identifying naturally occurring dietary sources and using them as 
cytoprotectants provides a strategy that is of great interest for CP chemotherapy. 
During the past decade interest in co-3 PUFAs has increased considerably because of 
their beneficial health effects. The most common way to consume co-3 fatty acids has 
been in the form of marine oils like fish oil. Recently, flaxseed has been identified as 
a significant alternative source of co-3 fatty acids (Gebauer et al, 2006; Harper et ai, 
2006) . Flaxseed (Linum usitatissimum) meal and flaxseed oil have been used for food 
for centuries in Asia, Europe and Afiica. Flaxseed has three major components 
making it beneficial in human and animal nutrition: a high content of co-3 PUFA 
namely a-linolenic acid (18:3 n-3), a high percentage of dietary fibre, both soluble 
and insoluble; and the highest content of phytoestrogenic lignans, which have been 
reported to have antioxidant and hypolipidemic effects (Lay and Dybing, 1989; Harris 
and Haggerty, 1993; Newairy and Abdou, 2009). Dietary supplementation of 
flaxseed/flaxseed oil has been shown to have numerous health benefits in normal and 
pathological conditions (Chen et al, 2002; Lin et al., 2002; Abdel-Moniem et ai, 
2011). Inclusion of flaxseed in the diet in animal studies has shown that it can inhibit 
arrhythmogenesis during ischemia-reperfusion (Ander et al, 2004), inhibit 
atherogenesis (Prasad, 2000, 2005) and protect during hypercholesterolemic 
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conditions (Dupasquier et ai, 2006). Dietary supplementation of flaxseed was shown 
to inhibit the growth and development of prostate cancer in the transgenic 
adenocarcinoma mouse prostate model (Lin et al., 2002). Flaxseed has also been 
reported to inhibit human breast cancer growth and metastasis and down-regulate 
expression of insulin-like growth factor and epidermal growth receptor (Chen et al., 
2002). Earlier studies showed that flaxseed oil prevents lead induced neuro- and 
nephrotoxicity (Abdel-Moniem et al., 2010; 2011b). FXO was also found to mitigate 
CP induced hepatotoxic effects (Naqshbandi et al., 2012a). However, the 
renoprotective potential of FXO in CP nephropathy has yet not been explored. 
Considering the potential clinical use of CP and numerous health benefits of FXO, the 
present work was undertaken to study the detailed mechanism of CP induced 
nephrotoxic alterations and possible action mechanism of FXO in preventing those 
deleterious changes in rat kidney. Studies were further extended to investigate the 
efficacy of protection offered by FXO for single dose as well as for multiple dose CP 
treatment schedule. The efficacy of FXO supplementation was investigated in terms 
of attenuation of CP-induced nephrotoxic parameters and other deleterious effects on 
BBM, mitochondria and antioxidant sytem. As shown in the "Results 11", two sets of 
experiments were conducted. In the first set (Part IIA), single injection of CP was 
administered, while in the second set (Part IIB), multiple CP injections were 
administered to normal (CP group) and FXO (CPFXO group) diet consuming rats. 
Serum parameters and the activities of various enzymes of carbohydrate metabolism, 
brush border membrane, mitochondria, lysosomes and antioxidant system were 
analyzed to ascertain potential beneficial effects of FXO. The results show that single 
as well as multiple CP injections produced a tj/pical pattern of nephrotoxicity as 
indicated by increased serum creatinine (Scr) and blood urea nitrogen (BUN) 
accompanied by significant decrease in the serum glucose, inorganic phosphate (Pi) 
and increase in serum cholesterol and phospholipids. CP induced tubular damage 
seems to have caused impaired reabsorption resulting in massive proteinuria, 
glucosuria and phosphaturia as reported earlier (BChan et al., 2009). Dietary FXO 
supplementation prior to and following/along with CP administration protected 
against CP induced deleterious effects on various blood/urine parameters. FXO 
consumption significantly lowered CP-elicited increased levels of Scr and BUN. 
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Serum glucose and phosphate were also improved by dietary FXO supplementation. 
FXO when fed alone either for 2 weeks (short term protocol) or 4 weeks (long term 
protocol) was able to increase serum glucose and phosphate and reduce serum 
creatinine and cholesterol. 
Since BBM of renal proximal tubules was shown to be a specific CP target (Arany 
and Safirstein, 2003; Fatima et al, 2004), the integrity of the membrane was assessed 
by the status of its biomarker enzymes ALP, GGTase and LAP. The activities of 
BBM enzymes were determined in cortical and medullary homogenates, as well as in 
isolated BBM preparations. Single as well as multiple dose CP treatment caused 
significant decrease in the activities of ALP, GGTase and LAP in the cortical 
homogenates and to much greater extent in BBM vesicles. Similar to cortex, activities 
of BBM marker enzymes were decreased in medulla, suggesting an overall CP 
induced damage to the kidney. The decrease in BBM enzyme activities could be due 
to the direct modification and consequent inactivation of enzymes by CP generated 
fi-ee radicals and ROS. Increased LPO, which affects membrane structure and 
function, could also have resulted in decreased activities of these enzymes. There 
could have been leakage or loss of BBM enzymes into the tubular lumen followed by 
their excessive excretion in the urine as reported earlier (Banday et al, 2008; Khan et 
al.. 2009). In contrast to CP, FXO consumption alone, however, enhanced the 
activities of BBM enzymes in comparison to the control rats in the homogenate and 
BBMV, indicating an overall improvement in renal BBM integrity by FXO 
supplementation diet. FXO consumption in combination with CP treatment 
prevented/retarded CP-induced decrease in the BBM enzyme activities in renal cortex 
as well as medulla. In both the short (2 weeks FXO feeding) and the long (4 weeks 
FXO feeding) term protocols, the activities of BBM enzymes in cortical/medullary 
homogenates and in BBMV were found to be higher in CPFXO as compared to CP 
group. Reduction in LPO and in the oxidative modification of BBM enzymes might 
have contributed to the efficacy of FXO in attenuating the effects of CP on BBM. The 
activity of lysosomal enzyme, ACPase was significantiy increased in the cortex and 
medulla by CP treatment. Alteration in ACPase activity demonstrate CP-induced loss 
of lysosomal function (Kuhlman et al., 1997; Courjault-Gantier, 1995). Confirming 
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morphologic and earlier biochemical studies (Dobyan et al, 1980; Leibbrant et al, 
1995; Fatima et al, 2004), the present results indicate that renal BBM and lysosomes 
were severely damaged by CP, however, FXO consumption prevented CP effects by 
lessening the damage caused or by increasing the regeneration process or both. 
The major function of kidney is to reabsorb important ions and molecules, that intum 
depends on the structural integrity of BBM and available energy (ATP) supplied by 
various metabolic pathways. Thus, it is imperative that any alteration to these 
metabolic pathways caused by toxic insult or otherwise modified would affect the 
functional capabilities of the kidney. To assess the functional aspects, the activities of 
various enzymes of carbohydrate metabolism were determined simultaneously for 
different experimental groups viz control, CP, CPFXO and FXO. The activities of 
enzymes involved in glycolysis, TCA cycle, gluconeogenesis and HMP-shunt 
pathway were differentially altered by CP treatment and/or by FXO consumption. 
Single as well as multiple dose CP treatment caused significant increase in LDH and 
decrease in the MDH activities in the renal cortex and medulla. A simultaneous 
increase in hexokinase activity was also found in the renal tissues. Although the actual 
rates of glycolysis or TCA cycle were not determined, marked decrease in MDH 
activity appears to be due to CP-induced damage to mitochondria (Zhang and Lindup, 
1993; Kuhlman et al, 1997). A significant increase in LDH and hexokinase activity 
with simultaneous decline in TCA cycle enzyme, MDH appears to be an adaptive 
cellular effect in energy metabolism from aerobic metabolism alternatively to 
anaerobic glycolysis due to CP induced mitochondrial dysfunction. CP also 
differentially altered the activities of enzymes of gluconeogenesis and HMP-shunt 
pathway. The activities of G6Pase and FBPase (gluconeogenesis) and G6PDH (HMP 
shunt) were profoundly decreased both in cortex and medulla albeit to different 
extents by single and multiple dose CP treatments. The observed decline in G6Pase 
and FBPase activities might be due to lowered TCA cycle enzyme viz MDH activity. 
Lowered MDH activity would have resulted in less oxaloacetate production from 
malate which is required not only for the continuation of TCA but also for 
gluconeogenesis. Thus, CP-induced toxicity appeared to be primarily due to renal 
mitochondrial damage as suggested by morphological studies (Zhang and Lindup, 
1993; Khulmann et al, 1997). However, the activity of NADP malic enzyme (ME) 
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variably increased in the renal tissues by both the CP treatment regimes. The present 
data indicate that CP caused differential effect on different enzymes of the 
carbohydrate metabolism. 
It has been shown that dietary fatty acids incorporate in the cellular membranes 
altering structural integrity and functional capacities of plasma membrane and other 
organelles leading to altered cellular metabolic activities and those of membrane 
associated enzymes (Brasitus et ai, 1985; Thakkar et ai, 2000; Carrillo-Tripp and 
Feller, 2005). Dietary FXO enriched in co-3 PUPA when given alone was found to 
increase the activities of MDH, G6Pase and FBPase in the renal tissues. FXO 
supplementation for 2 or 4 weeks in combination with CP-treatment resulted in an 
overall improvement of carbohydrate metabolism as evident by higher activities of 
MDH, LDH and gluconeogenic enzymes in CPFXO compared to CP group. Thus 
dietary FXO supplementation seems to enhance the production and oxidation of 
glucose in renal tissues viz the cortex and medulla. 
Increased production of reactive oxygen species (ROS) and free radicals has been 
implicated in mediating CP induced toxicity (Xiao et al, 2003; Atessahin et ai, 
2005). However, oxidative stress can occur as a result of either increased ROS 
generation and/or decreased antioxidant enzyme system comprisisng SOD, catalase 
and GSH-Px. These antioxidant enzymes protect the cell against cytotoxic ROS. SOD 
and catalase together convert superoxide radicals first to H2O2 and then to molecular 
oxygen and water. Other enzymes e.g GSH-Px use thiol-reducing power of 
glutathione to reduce oxidized lipids and protein targets of ROS. Under ineffective 
antioxidant enzyme status, lipid peroxidation in the cellular and subcellular 
membranes is the inevitable outcome of ROS injury (Yu and Anderson, 1997; Irmak 
et ai, 2001; Fadillioglu et al., 2004). CP has been shown to inhibit antioxidant 
enzymes in renal tissues, enhance lipid peroxidation (LPO) an indicator of tissue 
injury and deplete GSH and protein thiols (Nakano ans Gemba, 1989; Mistry et al., 
1991; Gonzales et al., 2005; Cetin et al., 2006). In agreement with previous 
observations (Fatima et al., 2004; Gonzales et al., 2005; Khan et al., 2009), CP 
significantly decreased the activities of SOD, catalase and GSH-Px and enhanced 
LPO in the renal cortex and medulla indicating CP-induced oxidative damage. 
However, the severity of the damage appeared to be more prominent in the renal 
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cortex than in the medulla. In contrast, a marked increase in the antioxidant enzyme 
activities was seen when rats were fed FXO diet alone either for 2 or 4 weeks without 
CP administration. The feeding of FXO diet to CP treated rats both in the short and 
long term protocols prevented CP induced augmentation of LPO and suppression of 
antioxidant enzyme activities. We suggest that FXO might be ameliorating the 
damage caused by CP in two possible ways: First, FXO supplementation increases the 
levels of SOD, catalase and GSH-Px in the renal epithelial cells resulting in enhanced 
defense against ROS. Second, the constituent ©-3 PUFA of dietary FXO may have 
replaced the polyunsaturated fatty acid components of the membranes that had been 
attacked by oxygen free radicals thereby improving the membrane integrity (Masters, 
1996; Ozgocmen et al, 2000). This explains the observed increase in BBM marker 
enzyme activities in CPFXO as compared to CP group. 
To summarize, the present biochemical studies clearly demonstrate that single or 
multiple CP exposure produces severe nephrotoxicity and causes profound damage to 
plasma membranes, mitochondria, lysosomes, etc. of renal proximal tubules. The 
enzymes of oxidative carbohydrate metabolism and gluconeogenesis; BBM and 
antioxidant defense mechanism appeared to be severely affected by CP treatment. In 
contrast, FXO, a major source of 0)-3 fatty acids appears to accelerate repair and/or 
regeneration of injured organelles e.g. mitochondria and lysosomes and plasma 
membrane viz BBM as evident by increased activities of TCA cycle and BBM 
enzymes. Most importantly, by activating endogenous antioxidant defense 
mechanism, FXO provided protection against CP-induced free radical attack. 
To conclude, the present results show that CP elicited deleterious nephrotoxic and 
other adverse effects appeared to be mediated, at least, in part via CP-induced 
perturbation in antioxidant defense mechanism. FXO by virtue of its intrinsic 
biochemical and antioxidant properties prevented CP-induced nephrotoxicity 
parameters by enhancing energy metabolism, BBM enzymes activities and by 
empowering antioxidant defense mechanism thereby reducing oxidative damage. 
Taken together, the results suggest that a beneficial effect on renal function was found 
when rats were fed FXO diet prior to and following CP administration both in the 
short and long term protocols. Thus, we propose that FXO may maximize the clinical 
use of CP in the treatment of various malignancies without nephrotoxic and other side 
effects. 
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SUMMARY & CONCLUSION 
The kidney is a vital organ, which plays an essential role in health, disease and overall 
development and growth. The main function of kidney is to maintain total body fluid 
volume, its composition and acid base balance. A number of environmental variables 
including certain drugs influence these functions (Mahmood and Water, 1994; Begg 
and Barcaly, 1995; Priyamvada et al, 2009). Platinum-based drugs are widely used 
anticancer agents with a broad range of antitumor activities (Alois et al., 2007). These 
platinum antitumor agents are unique, coordination complexes and the parent 
compound of this class cis-diammine-dichloroplatinum (II) (cisplatin, CP), 
contributes to the curative treatment of various cancers such as testicular teratoma, 
ovarian, head, neck, bladder, cervical and lung cancers. The compound is also highly 
toxic with a list of side effects including renal damage, severe nausea, vomiting, 
myelosuppression, ototoxicity and neurotoxicity (McKeage, 1995, Markman, 2003). 
The optimal use of cisplatin as a chemotherapeutic drug has been limited by its 
nephrotoxicity. Following administration, CP is widely distributed into body fluids 
and tissues. The highest concentration can be seen in the kidney, liver and intestine 
although it has also been found in all other tissues (McEvoy, 1992). Induction of 
nephrotoxicity is assumed to be a rapid process involving reactions with proteins in 
renal tubules. Light and electron microscopy have shown that the CP-induced injury 
and necrosis in rat kidney are predominantly localized in the S3 segment of proximal 
tubules in the corticomedullary region (Townsend et al., 2003). CP toxicity in 
proximal tubular epithelial cells is morphologically characterized by tubular necrosis, 
loss of microvilli, alterations in the number and size of lysosomes and mitochondrial 
vacuolization accompanied by functional disturbances of various cell organelles 
(Kuhlmann et al, 1997). The mechanism by which cisplatin kills the proximal tubule 
cells in the kidney has been the focus of intense investigation for many years. In 
tumors and other dividing cells, cisplatin-DNA crosslinks are thought to be the 
cytotoxic lesion (Fink and Howell, 2000). Nonproliferating cells are less sensitive to 
the toxicity of DNA-damaging agents, yet the quiescent proximal tubules cells are 
selectively killed by cisplatin (Lieberthal et al, 1996). Experimental evidence has 
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suggested that CP deteriorates renal function (Arany and Satirstein, 2003) and 
glomerular filtration rate (GFR) in a dose-dependent manner (Yao et al, 2007). 
The mechanism underlying the side effects induced by cisplatin is not understood 
clearly, however it was considered to be attributed to the combination of multi-ways 
(Hong et al, 2005; Ramesh and Reeves, 2002; Nowmak, 2002; Townsend and 
Hanigen, 2002; Xiao et al, 2003) such as the generation of reactive oxygen species 
(ROS), which could interfere with the antioxidant defense system and result in 
oxidative damage in different tissues (Kuhlman et al, 1997; Matsushima et al, 1998; 
Kuhad et al, 2007; Khan et al, 2009 ) and reaction with thiols in protein and 
glutathione, which could cause cell dysfunction. Various studies have focused on the 
ways for prevention of cisplatin associated side effects via supplementation of 
preventive agents simultaneously. These include antioxidants, modulators of nitric 
oxide, diuretics, and cytoprotective and apoptotic agents (Ali and Al Moundhri, 
2006). However, none of them have been found safe/suitable for clinical practice. 
In past few years, much interest has been centered on the role of naturally occurring 
dietary substances for the control and management of various chronic diseases such as 
cancer and cardiovascular disorders (Connor, 2000; Hardman, 2002; Larsson et al, 
2004; Williams et al, 2007; Kakar et al, 2008; Leaf, 2008). From ancient times the 
physicians and scholars in Asia have understood that food have both preventive and 
therapeutic value and are integral part of health. Omega-3 polyunsaturated fatty acids 
(co-3 PUPA) enriched fish oil provides one such dietary source of biologically active 
components that has been shown to be co-preventative and co-therapeutic in a wide 
variety of ailments (Doughman et al, 2007). 
A number of investigations have already demonstrated that diet supplemented with 
fish oil (FO) enriched in (0-3 PUFA has profound beneficial health effects against 
various pathologies including cancers, cardiovascular disorders, diabetes, depression, 
arthritis, asthma and inflammatory and immune disorders of the kidney and intestine 
(De Caterina et al, 1994; Tsujikawa et al, 2000; Barbosa et al, 2003; Bhattacharya 
et al, 2006). Recently, co-3 PUFA from some plants/seeds e.g. flaxseed oil (FXO) 
showed many similar health benefits as demonstrated by co-3 PUFA from FO (Freese 
and Mutanen 1997; Ide et al, 2000; Kim and Choi, 2001; Nannicini et al, 2006; 
Paschos et al, 2001). Alpha Linolenic acid (ALA, 18:3 n:3, co-3 FA) from vegetable 
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sources including grains and oils, offer an altemative source for those who are unable 
to regularly consume fish for religious or other reasons (Harper and Jacobson, 2001). 
Dietary flaxseed oil affects the biochemistry of fatty acid metabolism and thus the 
balance of proinflammatory mediators and atherogenic lipids, holding a great promise 
for modulating inflammatory diseases (Chilton et al., 2008). 
In view of numerous beneficial health effects of 00-3 PUFA "we hypothesized that: 
dietary FO and FXO enriched in co-3 PUFA would be able to prevent/reduce single 
as well as multiple CP dose induced nephrotoxic and other adverse effects in the rat 
kidney." 
To address this hypothesis the present work was undertaken to study the detailed 
biochemical events/cellular response/mechanism of CP induced nephrotoxic and other 
adverse effects in rat kidney. The effects of dietary ©-3 PUFA enriched FO and FXO 
were also determined to observe any protection provided by them against CP 
nephrotoxicity. The following parameters were determined: 
(a) Certain biochemical parameters in serum/urine. 
(b) The activities of BBM and lysosomal marker enzymes in renal cortical and 
medullary homogenates and BBM marker enzymes in isolated BBM preparations 
fi-om renal cortex. 
(c) The activities of certain enzymes of carbohydrate metabolism involved in 
glycolysis, TCA cycle, gluconeogenesis and HMP-shunt pathway in renal cortex 
and medulla. 
(d) The enzymatic and non-enzymatic parameters of antioxidant defense system in 
renal cortex and medulla. 
# THE RESULTS OBTAINED ARE SUMMARIZED AS FOLLOWS; 
O PART-IA: EFFECT OF DIETARY FISH OIL (FO) ON SINGLE CP DOSE 
INDUCED ACUTE NEPHROTOXIC AND OTHER ADVERSE EFFECTS 
(a) Serum/Urine Parameters: 
Single CP injecdon resulted in marked nephrotoxicity as manifested by increased 
serum creatinine and BUN. However, serum cholesterol, phospholipids, inorganic 
phosphate and glucose were significantly declined by CP treatment compared to 
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control rats. These changes were associated with massive phosphaturia, proteinuria 
and glucosuria accompanied by decreased creatinine clearance. FO supplementation 
alone caused increase in serum glucose and Pi but decrease in BUN, serum creatinine, 
PLP and cholesterol. Urinary glucose. Pi and protein excretions declined significantly 
accompanied by increased creatinine clearance. CP elicited increase in serum 
creatinine and BUN was markedly lowered by dietary FO supplementation to CP co-
administered rats. CP induced alterations in other serum and urine parameters were 
also prevented by FO supplementation. 
(b) Marker enzymes ofBBM and lysosomes: 
CP treatment to control rats caused significant reduction in the specific activities of 
ALP, GGTase and LAP in cortical homogenate. The activities of BBM enzymes as in 
the cortex were also lowered in medulla by CP administration. Feeding of FO diet 
alone, however, caused increase in GGTase activity both in renal cortex and medulla. 
The consumption of FO in combination with CP treatment prevented/reduced CP 
induced decrease in ALP, GGTase and LAP in the cortex as well as in the medulla. 
The effects of CP and FO were more apparent in BBMVs isolated from renal cortex 
than observed in the respective cortical homogenates. The magnitude of enzyme 
activities increased (4-8 folds) in the membrane preparations compared with 
respective values in the homogenates in control and treated groups for renal cortex 
indicating that the quality of the membrane prepared by the procedure was uniform 
for the various experimental groups. 
The effect of CP, FO alone and in combinations was also determined on the activity 
of lysosomal enzyme, ACPase in renal homogenates. The activity of ACPase was 
significantly increased by CP treatment in cortical and medullary homogenates, 
however the increase was significantly reduced/prevented by FO diet. 
(c) Enzymes of carbohydrate metabolism: 
CP treatment to control rats significantly increased LDH, a marker of anaerobic 
glycolysis and HK whereas decreased MDH, an enzyme of TCA cycle, G6Pase, 
FBPase (gluconeogenesis) and G6PDH (source of NADPH). When CP treatment was 
extended to FO-fed rats, CP-induced alterations in the metabolic enzyme activities 
are prevented. FO alone caused increase in MDH, G6Pase, FBPase and G6PDH 
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activities in cortex as well as in medulla. The activities of LDH, MDH, G6Pase and 
FBPase in medullary homogenates were similarly affected by CP treatment albeit to 
different extent than in the cortical homogenates. Similar to cortex, G6PDH activity 
decreased whereas ME and HK activity increased by CP in the medulla. Feeding of 
FO containing diet to CP treated rats prevented CP induced alterations in various 
enzyme activities in the cortex and medulla. 
(d) Enzymatic and non-enzvmatic parameters of antioxidant defense mechanism: 
CP caused significant decrease in the activities of SOD, catalase and GSH-Px in the 
cortex and medulla which was associated with marked increase in LPO and decrease 
in total-SH levels, indicating that CP caused severe damage to the renal tissues by 
generating free radicals and/or by suppressing the activities of antioxidant enzymes. 
CP treatment caused marked decrease in SOD, GSH-Px activities but slight decrease 
in catalase activity in the renal cortex. In medulla the activity of SOD, catalase and 
GSH-Px also showed significant decline by CP administration alone. CP induced 
increase in LPO and decrease in total-SH was prevented by feeding FO diet to CP 
treated rats. Dietary FO consumption protected well against CP induced perturbation 
of oxidants/antioxidants or CP induced oxidative damage. CP induced decrease in 
SOD, catalase and/or GSH-Px activity was markedly reversed/reduced by FO 
consumption in the renal cortex and medulla. CP induced increase in LPO was also 
lowered by FO supplementation in the renal tissues. 
OPART-IB: EFFECT OF DIETARY FISH OIL (FO) ON MULTIPLE CP 
DOSE INDUCED NEPHROTOXIC AND OTHER ADVERSE EFFECTS 
(a) Serum Parameters: 
Multiple dose CP administration caused severe nephrotoxicity as characterised by 
significant increase in serum creatinine, cholesterol, phospholipids and BUN 
accompanied by significant decrease in serum glucose and Pi. Prolonged FO 
consumption prior to and along with CP treatment significantly lowered CP induced 
increase in serum creatinine and BUN, indicating reduction in CP nephropathy. FO 
given to CP treated rats markedly prevented/retarded CP-induced increase of serum 
creatinine, cholesterol, and BUN. 
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(b) Marker enzymes of BBM and lysosomes: 
CP treatment to control rats caused significant decrease in the activity of ALP, 
GGTase and LAP in the homogenates of renal cortex and medulla and in BBMV 
isolated from renal cortex. FO consumption in general significantly increased the 
activities of GGTase and LAP in both cortex and medulla. CP induced decrease in 
most BBM enzymes in the cortex and medulla was markedly prevented/reduced by 
FO supplementation to CP treated rats. The activity of ACPase, a lysosomal enzyme 
was significantly increased by CP treatment. CP-induced increase in ACPase activity 
was significantly reduced by FO diet both in cortical and medullary homogenates 
albeit to different extent. 
(c) Enzymes of carbohydrate metabolism: 
The activities of various enzymes involved in glycolysis, TCA cycle, gluconeogenesis 
and HMP-shunt pathways were variably affected by CP, FO and CP+FO in rat 
kidney. CP treatment to control rats significantly increased LDH, HK and ME 
activities whereas decreased MDH, an enzyme of TCA cycle and G6PDH (source of 
NADPH). When CP treatment was extended to FO-fed rats, CP-induced decrease of 
metabolic enzyme activities was prevented. CP elicited decrease of MDH activity was 
normalized to near control values by FO supplementation. However, FO alone caused 
increase in MDH, G6Pase, FBPase and G6PDH activities. 
The activities of LDH, MDH, G6Pase and FBPase in medullary homogenates were 
similarly affected by CP treatment albeit to different extent than in the cortical 
homogenates. Similar to cortex, G6PDH activity decreased whereas ME and HK 
activities were increased by CP in the medulla. Prolonged feeding of FO 
supplemented diet to CP treated rats prevented CP induced alterations in various 
enzyme activities in medulla. 
(d) Enzymatic and non-enzymatic parameters of antioxidant defense mechanism: 
CP caused significant decrease in the activities of SOD, catalase and GSH-Px in 
cortex and in catalase and GSH-Px in medulla which was associated with marked 
increase in LPO and decrease in total-SH, indicating that CP caused severe damage to 
these tissues by generating free radicals and by suppressing the activities of 
antioxidant enzyiues. Prolonged FO consumption protected well against CP induced 
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perturbation of oxidants/antioxidants or CP induced oxidative damage. CP induced 
decrease in SOD, catalase and GSH-Px was markedly reversed/reduced by FO 
consumption in both renal cortex and medulla. CP induced increase in LPO was also 
lowered by FO in the renal tissues. 
fy" Interpretation: In general, CP caused severe adverse effects on various 
serum/urine parameters and on the enzymes of BBM, carbohydrate metabolism and 
antioxidant defense system in rat kidney. FO similarly protected against single and 
multiple CP dose induced nephrotoxic and other adverse effects most likely due to its 
intrinsic biochemical and antioxidant properties. 
Z> PART-IIA: EFFECT OF DIETARY FLAXSEED OIL (FXO) ON SINGLE 
CP DOSE INDUCED ACUTE NEPHROTOXIC AND OTHER ADVERSE 
EFFECTS 
(a) Serum/Urine Parameters'. 
Single dose CP administration caused severe nephrotoxicity as characterized by 
significant increase in serum creatinine, BUN, cholesterol and PLP but decrsease in 
glucose and inorganic phosphate accompanied by massive glucosuria, proteinuria, 
phosphaturia, polyuria and decreased creatinine clearance.Dietary FXO 
supplementation to CP treated rats markedly prevented/retarded CP-induced increase 
of serum creatinine, cholestrol and BUN. CP-induced polyuria, phosphaturia and 
glucosuria were significantly prevented by FXO diet. 
(b) Marker enzymes of BBM and lysosomes: 
CP treatment to control rats caused significant decrease in the activities of ALP, 
GGTase and LAP in renal cortex and medulla indicating CP induced damage to the 
kidney. However, dietary FXO consumption caused significant reversal in CP induced 
decrease in BBM enzyme activities in the cortex and medulla. The activity of ACPase 
(a lysosomal enzyme) was variably increased by CP in the renal cortex and medulla 
whereas FXO consumption prevented the CP-induced increase in ACPase. 
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(c) Enzymes of carbohydrate metabolism: 
CP treatment caused significant decline in the activities of MDH, G6Pase,FBPase and 
G6PDH whereas activities of LDH,HK and ME increased significantly in renal cortex 
and medulla. However, the effect of CP on HK and LDH activities was more marked 
in medulla while the effect on MDH activity was greater in cortex than medulla. As 
shown in "Part-IIA", some of these enzyme activities were enhanced by FXO alone. 
FXO supplementation similarly prevented/retarded CP-induced decrease of MDH, 
G6Pase and G6PDH activities in the cortex and medulla. 
(d) Enzymatic and non-enzvmatic parameters of antioxidant defense mechanism: 
CP treatment significantly decreased the activities of SOD, catalase and GSH-Px 
activities, accompanied with marked elevation of LPO and decrease in total-SH levels 
in the cortex and medulla. FXO alone significantly increased SOD, catalase and GSH-
Px activities in the renal cortex and catalase activity in the renal medulla. FXO-diet 
when given to CP treated rats significantly ameliorated the CP-induced imbalance in 
the antioxidant defense system. LPO was decreased, whereas total-SH increased and 
the activities of the antioxidant enzymes remained significantly higher in FXO fed-CP 
treated rats compared to CP treated rats. 
O PART-IIB; EFFECT OF DIETARY FLAXSEED OIL (FXO) ON MULTIPLE 
CP DOSE INDUCED NEPHROTOXIC AND OTHER ADVERSE EFFECTS 
(a) Serum/Urine Parameters: 
Multiple dose CP treatment to control rats resulted in significant increase in serum 
creatinine (Scr), BUN, cholesterol and phospholipids but decrease in glucose and 
inorganic phosphate (Pi). These changes where associated with profound 
phosphaturia, proteinuria and glucosuria, accompanied by decrease in creatinine 
clearance. Feeding of FXO diet to CP administered rats resulted in significant reversal 
of various CP elicited deleterious effects on serum and urine parameters. 
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(b) Marker enzymes ofSBMand lysosomes: 
Multiple doses of CP caused significant decrease in the activities of BBM marker 
enzymes viz ALP, GGTase and LAP while FXO supplementation alone increased the 
activities of ALP and GGTase in renal cortical and medullary homogenates. FXO diet 
fed to CP treated rats prevented/reduced the CP induced decrease in the BBM 
enzymes while the activities were significantly higher in CPFXO than the CP group. 
The effect of CP was much more apparent in isolated BBMV preparations than 
observed in the respective homogenates. The activity of ACPase was however 
increased by CP in both cortical and medullary homogenates and FXO diet was able 
to prevent/retard the CP-induced increase in ACPase activity in a similar maimer. 
(c) Enzymes of carbohydrate metabolism: 
CP treatment to control rats significantly increased LDH, HK and ME while 
decreased MDH, G6Pase, FBPase and G6PDH activities. However, FXO alone 
caused increase in MDH, G6Pase and FBPase activities. The activities of LDH, HK, 
MDH, G6Pase and FBPase in medullary homogenates were similarly affected by CP 
treatment albeit to different extent than in the cortical homogenates. Similar to cortex, 
G6PDH activity decreased whereas ME and HK activities were increased by CP in 
the medulla. Prolonged FXO feeding to CP treated rats prevented the CP-induced 
alterations in the metabolic enzyme activities. 
(d) Enzymatic and non-enzymatic parameters of antioxidant defense mechanism: 
Multiple CP doses caused significant decrease in the activities of SOD, catalase and 
GSH-Px in the cortex and medulla which was associated with marked increase in 
LPO and decrease in total-SH levels. The dietary supplementation of FXO was able to 
ameliorate the CP induced oxidative damage in both renal cortex and medulla. CP 
induced increase in LPO and decrease in total-SH were prevented/reduced by feeding 
FXO diet to CP treated rats. The activities of SOD, catalase and GSH-Px both in the 
cortex and medulla were significantly ameliorated by FXO supplementation to CP 
treated rats. These results indicate marked protection by FXO diet against single and 
multiple CP dose induced oxidative damage to renal tissues. 
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^ Interpretation: Single as well as multiple CP dose treatments caused severe 
damage to the kidney as reflected by increase in serum creatinine and BUN and 
decrease in biomarker BBM enzymes: There appeared to be a shift from aerobic to 
anaerobic metabolism most likely due to CP induced mitochondrial damage. CP also 
increased oxidative stress as indicated by increased LPO and decreased total-SH 
levels associated with suppressed antioxidant enzyme activities. FXO supplementation 
diet similarly prevented/retarded single and multiple CP dose induced alterations in 
various biochemical parameters and enzyme activities most likely by empowering the 
antioxidant defense system and improving cellular membrane integrity. 
O CONCLUSION: 
In conclusion, single or multiple dose CP administration elicited deleterious 
nephrotoxic effects by causing major damage to mitochondria, lysosomes and in 
particular to BBM of renal proximal tubules as reflected by significant decrease in the 
activities of the specific biomarker enzymes, confirming the morphologic and 
toxicogenomic observations that showed these organelles as prime CP target. CP 
seems to enhance glycolytic enzyme LDH in order to increase energy dependence on 
glycolysis due to mitochondrial damage and depressed TCA cycle enzymes. 
Gluconeogenic enzymes, G6Pase and FBPase also appeared to decrease due to 
mitochondrial dysftmction as oxaloacetate produced by MDH is not available. These 
nephrotoxic and other adverse effects appeared to be mediated in part due to CP 
elicited oxidative damage. The significant lowering of LPO by FO/FXO in renal 
cortex and medulla suggests that ©-3 PUFA enriched FO/FXO play a major role in 
reducing oxidative damage induced by CP. The decrease in oxidative damage by 
dietary FO/FXO supplementation appears to be due to the synergistic increase in the 
activity of both SOD and catalase and GSH-Px. The present results imply that 
FO/FXO exhibited a nephroprotective effect probably by empowering the biological 
defense system. Dietary co-3 PUFA enriched fish oil and flaxseed oil to a larger extent 
prevented CP-induced nephrotoxicity parameters by enhancing nutrition/energy 
metabolism, by strengthening antioxidant defense mechanism and by altering 
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membrane organization. Further FO and FXO offered renoprotection similarly 
against single and multiple dose CP treatments. Based on our present observations 
and already known numerous health benefits, we propose that co-3 PUFA enriched 
FO/FXO may provide a cushion for a prolonged therapeutic option against .CP 
induced nephropathy without harmfiil side effects. Similar protective effects of FO 
and FXO provide a much needed relief for millions of vegetarians who do not eat 
fish/fish oil for religious or other reasons. 
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A B S T R A C T 
Cisplatin (CP) is a major antineoplastic drug for the treatment of solid tumors, however, dose dependent 
nephrotoxicity remains the major concern for its long term use. Several agents/strategies vwere attempted 
to prevent CP nephrotoxicity but w/ere not found suitable for clinical practice. Dietary fish oil (FO) 
enriched in a)-3 fatty acids has been shown to prevent/reduce the progression of certain types of cancers, 
cardiovascular and renal disorders. The present study was undertaken to see whether FO can prevent CP-
induced nephrotoxic and other deleterious effects. Rats were prefed experimental diets for 10 days and 
then received a single dose of CP (6 mg/kg body weight) intraperitoneally while still on diet Serum/urine 
parameters, enzymes of carbohydrate metabolism, brush border membrane (BBM) and oxidative stress in 
rat kidney were analyzed. CP nephrotoxicity was recorded by increased serum creatinine and blood urea 
nitrogen. CP decreased the activities of metabolic enzymes, antioxidant defense system and BBM 
enzymes. In contrast, FO alone increased enzyme activities of carbohydrate metabolism and brush border 
membrane (BBM). FO feeding to CP treated rats markedly enhanced resistance to CP-elicited deleterious 
effects. Dietary FO supplementation ameliorated CP induced specific metabolic alterations and oxidative 
damage due to its intrinsic biochemical antioxidant properties. 
© 2011 Elsevier Ltd. All rights reserved. 
\. Introduction 
Cisplatin (ris-diamminedichloroplatinum II, CP) one of the most 
effective chemotherapeutic agent that plays a major role in the 
treatment of variety of human solid tumors including those of 
the head, neck, testis, ovary and breast (Lebwohl and Canetta, 
1998). Inspite of its beneficial antitumor action, dose related neph-
rotoxicity and neurotoxicity limits its application in clinical oncol-
ogy (Antonio et al., 2(X32). 
Light and electron microscopy have shown that the CP-induced 
injury and necrosis in the rat kidney are predominantly localized in 
S3 subsegments of proximal tubular epithelial cells (Townsend 
et al., 2003). Morphologically, it is characterized by the loss of 
Abbreviations: ACPase. acid phosphatase; ALP. alkaline phosphatase: ALT. 
alanine aminotranferase: AST, aspartate aminotransferase; BBM, brush border 
membrane: BBMV. brush border membrane vesicles; BUN, blood urea nitrogen: CP, 
cisplatin: CPF. cisplatin-fish oi l ; FO. fish oi l : FBPase. fructose-1,6-bisphosphatase: 
CSPase. glucose-6-phosphatase: C6PDH, glucose-S-phosphate dehydrogenase: 
GCTase, 7-glutamyl transferase; CSH-Px, glutathione peroxidase: HK. hexokinase: 
LAP, leucine aminopeptidase; LDH, lactate dehydrogenase: MDH, malate dehydro-
genase: ME, malic enzyme; NADP*, nicotinamide adenine dinucleotide phosphate; 
PUFA, polyunsaturated fatty acids; ROS, reactive oxygen species; Scr, serum 
creatinine: SOD, superoxide dismutasc. 
* Corresponding author. Tel.: +91 571 2700741; fax: +91 571 2706002. 
E-mail address: drfarah23(g'live.coni (F, Khan). 
0278-6915/$ - see front niattei 3 2011 Elsevier Ltd. M l rights resewed. 
doi:10.1016/j,fct.2Ol 1.10.039 
microvilli, cellular sw^elling, and condensation of nuclear chroma-
tin (Kuhlmann et al., 1997). Mitochondria, lysosomes and micro-
somes are critical CP targets (Zhang and Lindup, 1993; 
Leibbrandt et al., 1995). Functional alterations are characterized 
by change in urine volume, increase in blood urea nitrogen and ser-
um creatinine (Yao et al., 2007). 
The mechanism underlying the side effects induced by cisplatin 
is not understood clearly, however it was considered to be attrib-
uted to the combination of multi-ways (Hong et al., 2005; Ramesh 
and Reeves, 2002; Nowak, 2002; Townsend and Hanigan, 2002; 
Xiao et al., 2003) such as the generation of reactive oxygen species 
(ROS), which could interfere with the antioxidant defense system 
and result in oxidative damage in different tissues (Kuhlmann 
et al., 1997;Matsushima et al., 1998; Kuhad et al., 2007; Khan 
et al., 2009a,b) and reaction with thiols in protein and glutathione, 
which could cause cell dysfunction. 
Various studies have focused on the ways for prevention of cis-
platin associated side effects via supplementation of preventive 
agents simultaneously. These include antioxidants, modulators of 
nitric oxide, diuretics, and cytoprotective and apoptotic agents 
(Ali and Al Moundhri, 2006). However, none of these were found 
to be suitable. 
Renewed interest has been observed in recent years in o)-3 fatty 
acids enriched fish oil (FO) diet that has profound beneficial health 
effects against various pathologies (Simopoulos, 1991) including 
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cardiovascular, respiratory, inflammatory and immune renal dis-
eases: diabetes, depression and cancer (Caterina et al., 1994; 
Aronson et a!., 2001; Donadio, 2001; Hibbein, 1998; Posta et al., 
2006). Previous studies have shown protective role of dietary FO 
against drug induced nephrotoxicity (Abdel-Gayoum et a!., 1995; 
Thakkar et a!., 2000). Hovk^ ever, it is important that the prospective 
nephro protective agent should not affect the drug efficacy while 
reducing its side effects. There is evidence that dietary supplemen-
tation of FO enhances the antitumor effects of CP chemotherapy 
(Yam et al., 2001). Recent study from our lab has shown that die-
tary FO supplementation ameliorates CM induced nephrotoxic ef-
fects (Priyamvada et al., 2008). However, the protective effect of FO 
on CP induced nephrotoxicity remains uninvestigated. 
Considering the potential clinical use of CP and numerous 
health benefits of FO, the present work was undertaken to study 
the biochemical events/cellular response/mechanisms of CP 
nephropathy and its protection by dietary FO. We hypothesized 
that fish oil would prevent CP-induced nephrotoxicity due to its 
intrinsic biochemical and antioxidant properties that would lead 
to improved metabolism and antioxidant defense mechanism of 
the kidney. The results obtained indicate that dietary supplemen-
tation with fish oil markedly ameliorate CP induced nephrotoxicity 
parameters and support a potential therajjeutic use of CP + FO 
combination in combating cancer without nephrotoxic and other 
harmful side effects. 
2. Materials and methods 
2.). Chemicals and drugs 
Fish oil of menliaden and cisplatin from Sigma Chemical Co.. (St. Louis, MO, 
USA). All other chemicals used were of analytical grade and were purchased either 
from Sigma Chemical Co. or SRL (Mumbai. India). 
22. Diet 
A nutritionally adequate laboratory pellet diet was obtained from Aashirwaad 
Industries, Chandigarh (India). Pellets were crushed finely and mixed with 15% fish 
oil and stored in airtight containers. Vitamin E as DL-a-tocopherol (270 mg/kg chow) 
was added to each of the modified rat chows in order to meet the increased meta-
bolic requirement for antioxidants on a diet high in polyunsaturated fatty acids. 
50±15% relative humidity and normal photoperiod (I2h dark and light). Four 
groups of rats entered the study after acclimatization (Fig. 1). They were fed on 
either normal diet (control and CP groups) or diet containing 15% fish oil (CPF 
and FO groups). After 10 days rats in two groups (CP and CPF) were administered 
a single dose of CP intraperitoneally (6 mg/kg body weight) in 0.9% saline. Animals 
in the control and FO group received an equivalent amount of normal saline. The 
rats were sacrificed 4 days after CP administration under light ether anesthesia. 
Blood and urine samples were collected and kidneys were removed and processed 
for the preparation of homogenates and BBMV (brush border membrane vesicles) as 
described below. All the preparations and analyses of vatious parameters were per-
formed simultaneously under similar experimental conditions to avoid any day to 
day variations. Body weight of rats were recorded at the start and completion of 
the experimental procedures. 
2.4. Preparation of homogenates 
After the completion of the experiment, the kidneys were removed, decapsulat-
ed and kept in ice-cold buffered saline (154 mM NaCI. 5 mM Tris-HEPES, pH 7.5). 
The cortex was carefully separated from medulla as described earlier (Khundmiri 
et al.. 2004). A 15% (w/v) homogenate was prepared in 0.1 -M Tris-HCl buffer. pH 
7.5. using Potter-Elvehejem homogenizer (Remi Motors. Mumbai. India): by pass-
ing five pulses. The homogenate was centrifuged at 3000g at 4 °C for 15 min to re-
move cell debris and the supernatant was saved in aliquots and stored at -20 °C for 
assaying the enzymes of carbohydrate metabolism, free-radical scavenging en-
zymes and for estimation of total-SH and lipid peroxidation (LPO). 
2.5. Prcparanon of brush border membrane 
BBMV were prepared from whole cortex using the MgClj precipitation method 
as described previously (Khundmiri et al., 2005). Briefly, freshly minced cortical 
slices were homogenized in 50 mM mannitol and 5 mM Tris-HEPES buffer, pH 
7.0 (20 ml of buffer/g of cortical tissue), in a glass Teflon homogenizer with four 
complete strokes. The homogenate was then subjected to high speed Ultra-Turrex 
homogenizer (Type T-25, Janke & Kunkel GMBH & Co.. KG. Staufen) for three strokes 
of 15 s each with an interval of 15 s between each stroke, MgCli was added to the 
homogenate to a final concentration of 10 mM and the mixture stirred for 20 min 
on ice. The homogenate was centrifuged at 2000g for 10 min in a Beckman centri-
fuge (J2 Ml. Beckman instruments Inc. Palo Alto. C.A. USA) using JA-17 rotor and the 
supernatant was then recentrifuged at 35,000g for 30 min. The pellet was resus-
pended in 300 mM mannitol and 5 mM Tris-HEPES, pH 7.4, with four passes by a 
loose fitting Dounce homogenizer (Wheaton, IL, USA) and centrifuged at 35,OOOg 
for 20 min in a 15 ml corex tube. The outer white fluffy pellet of BBM was resus-
pended in small volume of buffered 300 mM mannitol. Aliquots of homogenates 
and BBM were saved and stored at -20 "C for BBM enzyme analysis. Each sample 
of BBM was prepared by pooling tissues from two to three rats. 
2.6. Serum/urine chemistries 
2.3. Experimental design 
The animal experiments were conducted according to the guidelines of Com-
mittee for Purpose of Control and Supervision of Experiments on Animals (CPCSEA), 
Ministi7 of Environment and Forests, Government of India. Adult male Wistar rats 
(8 rats/group) weighing between ISO and 200g were used in the study. Animals 
were acclimatized to the animal facility for a week on standard rat chow and al-
lowed water ad libitum under controlled conditions of 2 5 1 2 ^ temperature. 
Serum samples were deproteinated with 3% trichloroacetic acid in a ratio of 1:3. 
left for 10 min and then centrifuged at 200Qg for 10 min. The protein free superna-
tant was used to determine inorganic phosphate and creatinine. The precipitate was 
used to quantitate total phospholipids. Blood urea nitrogen (BUN) and cholesterol 
levels were determined directly in serum samples. Glucose was estimated by o-tol-
uidene method using kit from Span diagnostics, Mumbai. India. All these parame-
ters were determined by standard procedures as mentioned in a previous study 
(Khundmiri et al., 2004). 
Saiinetnjection (i.p) (0.9%) 21'*'dav 
Cisplatin injection (i.p) 
6mg/kgbodyweighl 
CPF 
(for todays) ^FO 
t 4 days 
Kidney < 
< . 
Homogenate 
Homogenate 
Fig. 1. Experimental design (ND: normal diet; C: control: FO: fish oil diet: CP: cisplatin; CPF: fish oil + cisplatin; i.p.: intraperitoneal; CP injection ('): normal saline injeaion 
it). 
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2.7. Assay oj carbohydrate metiibolisni enzymes 
The activities of the enzymes involving oxidation of NADH or reduction of NADP 
were determined spectrophotometrically on Cintra 5 fixed for 340 nm using 3 ml of 
assay buffer in a 1-cm cuvette at room temperature (28-30 °C). The enzyme activ-
ities of lactate dehydrogenase (LDH. E.C,1.1.1.27), malate dehydrogenase (MDH, 
E.C.1.1.1.37), malic enzyme (ME, E,C.l.1.1.40), glucose-6-phosphate dehydrogenase 
(C6PDH, E.C. 1.1.1.49), glucose-6-phosphaUse (G6Pase, E,C.3.I,3.3) and fructose-l, 
6-bisphosphatase (FBPase. E.C.3.1.3.11) were assayed as described by Khundmiri 
et al. (2004). Hexoldnase was estimated by the method of Crane and Sols (1953) 
and the remaining glucose was measured by method of Nelson-Somogyi (Nelson. 
1944). 
2.8. Assay oj brush bonier membrane marker eraymes and lysosomal murker enzyme 
The activities of alkaline phosphatase (ALP), leucine amino peptidase (LAP), y-
glutamyl transferase (CCTase) and acid phosphatase (ACPase) were determined 
as described by Farooq et al. (2004). 
2.9. Assay of enzymes involved in free radical scavenging 
Superoxide dismutase (SOD, E.C.1.15.1.1) was assayed by the method of Markl-
und and Marklund (1974). Catalase (CAT, E.C.1.11,1.6) and glutathione peroxidase 
(CSH-Px) activities were determined by the methtxi of Giri et al. (1996) and Flohe 
and Cunzler (1984X respectively 
2.10. Lipid peroxidation and total-SH group estimation 
Total SH groups were determined by the method of Sedlak and Lindsay (1958). 
Lipid peroxidation (LPO) by the method of Ohkawa et al. (1979). 
2.11. Statistical analyses 
All data are expressed as mean ± SEM for at least 4-5 different preparations. 
Statistical evaluation was conducted by one-way ANOVA using Origin 6.1 software. 
A probability level of p< 0.05 was selected as indicating statistical significance. 
Most of the changes between various groups were compared with control values 
for better understanding and clarity. 
3. Results 
The present work was undertaken to study detailed mechanism 
of CP-induced nephrotoxicity and other deleterious effects and its 
possible protection by feeding (n-3 fatty acids enriched fish oil diet 
to the rats. To address our hypothesis, the effect of CP alone and in 
combination with fish oil (FO) was determined on nephrotoxicity 
parameters with serum biomarkers and enzymes of oxidative 
stress, brush border membrane and carbohydrate metabolism in 
rat kidney tissues. 
compared to control rats. These changes were associated with pro-
found phosphaturia, proteinuria and gkicosuria accompanied by 
decreased creatinine clearance. FO diet alone caused significant in-
crease in serum glucose. Pi and creatinine clearance, decrease in 
BUN, urinary Pi and protein excretions. 
Feeding of FO diet to CP administered (CPF) rats resulted in sig-
nificant reversal of various CP elicited deleterious effects on serum 
and urine parameters, FO prevented CP induced increase of Scr, 
BUN and decrease of serum Pi, PLP and glucose. CP-induced phos-
phaturia, proteinuria and glucosuria were absent in CPF compared 
to CP rats. 
3.2. Effect of dietary fish oil (FO) on CP induced alterations in 
biomarker enzymes ofBBM and lysosomes 
To assess the structural integrity of certain organelles e.g., plas-
ma membrane (BBM) and lysosomes, the effect of CP alone and in 
combination with FO diet was determined on biomarker enzymes 
of BBM and lysosomes in the homogenates of renal cortex and me-
dulla and isolated BBM preparations from renal cortex. 
3.2.1. Effect ofCP alone and with FO diet on biomarkers of BBM and 
lysosomes in the homogenates 
The activities of alkaline phosphatase (ALP), y-glutamyl trans-
peptidase (GGTase), leucine aminopeptidase (LAP) and acid 
phosphatase were determined under different experimental condi-
tions in the homogenates of renal cortex and medulla (Table 3). CP 
treatment to control rats caused significant reduction in the spe-
cific activities of ALP (-35.82%), CCTase (-36.73%) and lAP 
(-29.98%) in cortical homogenate. The feeding of FO diet prior to 
CP treatment prevented CP elicited decrease in BBM enzyme activ-
ities. As can be seen from the data CP induced decrease in BBM en-
zyme activities were similarly prevented by FO diet. However, the 
activity of acid phosphatase (ACPase) was increased (+32.15%) by 
CP in cortical homogenates and FO diet was able to prevent the in-
crease in enzyme activity in a similar manner (Table 3). 
The activities of BBM enzymes similar to the cortex were also 
lowered in the medulla by CP administration (Table 3), The con-
sumption of FO in combination with CP treatment resulted in the 
reversal of CP induced decrease in ALP (-42.21%), CCTase 
(-37.10%) and LAP (-23.6%) in the medulla. The activity of ACPase 
(+35.45%) was increased by CP treatment. However, this increase 
was prevented by FO feeding to CP treated rats. 
3.1. Effect of dietary fish oil (FO) on CP induced nephrotoxicity in 
serum and urinary parameters 
Results summarized in Tables 1 and 2 show the effect of CP 
alone and in combination with FO on blood and urine chemistry. 
CP treatment to control rats resulted in significant increase in 
serum creatinine (Scr) and blood urea nitrogen (BUN), but decrease 
in cholesterol, phospholipids (PL), inorganic phosphate and glucose 
3.2.2. Effect ofCP and CP plus FO diet on BBM markers in isolated 
BBMV 
The effect of CP and FO on BBM marker enzymes was further 
analyzed in BBMV preparations isolated from the renal cortex (Ta-
ble 4). The data shows a similar activity pattern of BBM enzymes as 
observed in cortical homogenates However, the magnitude of the 
effect specifically in ALP activity was much more pronounced in 
BBMV than in cortical homogenates (Fig. 2). Activities of ALP 
Table 1 
Effect offish oil (FO) on serum parameters with/without CP treatnient. 
Group Creatinine (mg/dl) BUN (mg/dl) Cholesterol (mg/dl) Phospholipid (mg/dl) Phosphate (nmol/ml) Glucose (mg/dl) 
Control 0.999 ±0.046 14.40 ±0.669 129.2+1.96 114.71 ±0.86 
CP 2.012±0.139 (+101.40%)' 34.24±3.30(+137.7%)' 115.79 + 1.29 (-10.379%)' 80.68 ±0.38 (-29.66%) 
CPF 1.23 ±0.06 (+23%)' 18.25 ± 0.890 (+26.73%)'' 88.40 + 1.33 (-31.57%)'' 98.51 ± 3.58 (-14.12%)'' 
FO 0.965+ 0.046 (-3.40%) 11.79+0.430 (-18.125%)' 108.47 + 2.63 (-15.04%)' 99.5 ± 1.97 (-13.25%)' 
2,3 + 0.047 73.22 + 4.07 
1.92±0.123 (-16.52%)' 19.16 ±0.59 (-73.83%)' 
2 ±0.063 (-13.04%)' 75.74 ± 3.48 (+3.44%)'-' 
2.51 +0.03 (+9.13%) 83.06+ 5.32 (+13.435) 
Results are mean + SEM for five different preparations. 
CP: cisplatin treated: CPF: fish oil + cisplatin treated; FO: fish oil diet; BUN; blood urea nitrogen. 
Values in parentheses represent percent change from control. 
Significantly different from control. 
Significantly different from CP at p < 0.05 by one way ANOVA. 
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TabJe 2 
Effect of fish oil (FO) on urine parameters with/without CP treatment. 
Croup Urine flow rate (UFR) (ml/ 
day) 
Creatinine clearance (ml/min/IOOg body 
weight) 
Phosptiate(jimol/ml) Protein (mg/mmol 
creatinine) 
Glucose (mg/dl) 
Control 1811.73 
CP 24 ±0.57 (+33.33%)' 
CPF 21 ±2.88 (+16.66%) 
FO 20 ±0.57 (+11.11%) 
0.655 ± 0.002 
0.212±0.057 (-67.63%)' 
0.355 ± 0 (-45.80%)' 
0.954 + 0.0012 (+45.64%)' 
1.16±0.023 
1.65 ±0.77 (+42.24%)' 
1.19 ±0.028 (+2.58%)' 
0.644 ± 0 (-44.48%)' 
0.029 ± 0.003 
0.103 ±0.004 (+255.17%)" 
0.064+0.023 (+120.68%) 
0.020 + 0 (-31.03%)' 
13.98 + 1.73 
56.47 + 5.51 (+303.93%)' 
33.16 ±1.69 (+137.19%)'' 
4.66 ±0.715 (-66.66%)' 
Results are mean ± SEM for five different experiments. 
Values in parentheses represent percent change from control. 
CP: cisplatin treated; CPF: fish oil +cisplatin treated; FO: fish oil diet. 
Significantly different from control. 
' Significantly different from CP at p < 0.05 by one way ANOVA. 
Tables 
Effect of fish oil (FO) on biomarkers of BBM and lysosomes in homogenates of (a) cortex and (b) medulla with/without CP treatment. 
Enzyme 
Croups 
(a) Conex 
Control 
CP 
CPF 
FO 
(b) Medulla 
Control 
CP 
CPF 
FO 
ALP (^mol/mg protein/h) 
7.48 + 0.54 
4.8±0.215 (-35.82%)' 
5.50±0.286 (-26.47%)'' 
6.65 ±0.504 (-11.09%) 
5.33 ±0331 
3.08 ±0.246 (-42.21%)' 
3.75 ±0.849 (-29.64%)' 
4.49+ 0.920 (-15.75%) 
CCTase (nmol/mg protein/h) 
10.18 ±5.91 
6.44 ±1.29 (-36.73%) 
6.92 ±1.068 (-32.02%)' 
12.07 ±1 (+18.56%) 
12.91 ±1.205 
8.12 ±0.552 (-37.10%)' 
9.13 ±1.33 (-29.28%)' 
14.61 ±2.66 (+13.17%) 
LAP (jimol/mg protein/h) 
12.34 ±1.45 
8.64 ±1.12 (-29.98%)' 
11.07± 1.36 (-10.29%)' 
11.86 ±2.23 (-3.89%) 
11.8±1.I4 
9.01 ±0.690 (-23.64%)' 
9.19 ±0.503 (-22.11%)' 
9.79±0.173 (-17.03%)' 
ACPase ((imol/mgprotein/h) 
3.39 ±0.088 
4.48 ±0.194 (+32.15%)' 
3.52 ±0.142 (+3.83%)' 
3.03 ±0.314 (-10.61%) 
2.51 ±0.196 
3.40 ±0.096 (+35.45%)' 
2.69 ±0.177 (+7.17%)' 
2.53 ±0.0914 (+0.796%) 
Results (specific activity expressed as nmol/mg protein/h) are mean ± SEM for five different experiments. 
Values in parentheses represent percent change from control. 
CP: cisplatin treated; CPF: fish oil + cisplatin treated: FO: fish oil diet; ALP: alkaline phosphatase; CCTase: y-glutamyl transferase; LAP: leucine aminopeptidase; ACPase: add 
phosphatase; BBM: brush border membrane. 
Significantly different from control. 
' Significantly different from CP at p < 0.05 by one way ANOVA. 
T^le4 
Effect of fish oil (FO) on activities of biomarker enzymes of BBM in cortical BBMV with/without CP treatment. 
Enzyme 
Croups 
ALP ((imol/mg protein/h) CCTase (j imol/mg protein/h) LAP {nmol/mg protein/h) 
Control 
CP 
CPF 
FO 
45.41 + 5.53 
20.76+ 1.46 (-54.28%)' 
23.76 ±2.51 (-47.67%)" 
42.74+ 1.52 (-5.87%) 
81.22±4.19 
56.28 ±3.44 (-30.71%)' 
78.1 ±2.49 (-3.84%)'-' 
94.15 ±0.815 (+15.91%)' 
66.56 ± 2.5 
52.07+ 2.2 (-21.76%) 
66.17 ±9.5 (-0585%)' 
75.38 + 3.01 (+1325%) 
Results (specific activity expressed as nmol/mg protein/h) are mean ± SEM for five different experiments. 
Values in parentheses represent percent change from control. 
CP: cisplatin treated; CPF: fish oil + cisplatin treated; FO; fish oil diet; ALP: alkaline phosphatase: CCTase; y-glutamyl transferase; LAP: leucine aminopeptidase: BBM: brush 
border membrane; BBMV: brush border membrane vesicles. 
Significantly different from control. 
' Significantly different from CP at p < 0.05 by one way ANOVA. 
(-54.28%), GGTase (-30.78%) and LAP (-21.76%) were profoundly 
declined by CP treatment as compared to control rats. Fish oil (FO) 
dietary supplementation similar to the effect in the homogenates 
appeared to lower the severity of the CP treatment. CP-induced de-
crease in BBM enzyme activities was significantly prevented by 
dietary FO. 
33. Effect offish oil (FO) on CP induced alterations in metabolic 
enzymes in renal cortex and medulla 
The effect of CP, FO diet and their combined treatment was 
determined on the activities of various enzymes of carbohydrate 
metabolism in renal cortex and medulla. 
3.3. J. Effect on carbohydrate metabolism in renal cortex 
As shown in Tables 5a and 6a, CP treatment to control rats sig-
nificantly increased the activity of lactate dehydrogenase (LDH) 
and hexokinase (HK) but decreased malate dehydrogenase 
(MDH), glucose-6-phosphatase(G6Pase) and fructose-l,6-bisphos-
phatase (FBPase) activities in the renal cortex. When CP treatment 
was extended to FO fed rats, CP-induced alterations in metabolic 
enzyme activities were not only prevented by FO diet, but G6Pase 
activity remained significantly higher in CPF compared to CP 
groiips. 
The effect of FO, CP and their combined effect was also deter-
mined on glucose-6-phosphate dehydrogenase (G6PDH) and 
NADP-malic enzyme (ME), source of NADPH needed in various 
anabolic reactions (Table 6a). CP treatment to control rats signifi-
cantly decreased G6PDH but increased ME activity. However. CP 
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Rg. 2. Effect of fish oil (FO) consumption on: (a) ALP; (b) CGTase: (c) LAP in cortex 
homogenate and BBM with/without cisplatin (CP) treatment. 
treatment to FO fed rats reduced the CP induced alterations in glu-
cose-6-phosphate dehydrogenase (G6PDH) and NADP-malic en-
zyme (ME) activities. 
3.3.2. Effect on carbohydrate metabolism in renal medulla 
•Tlie activities of LDH. MDH, HK, G6Pase and FBPase in medul-
lary homogenates were similarly affected by CP treatment (Tables 
5b and 6b) as in the cortical homogenates. Feeding of FO to CP trea-
ted rats prevented CP induced alterations in various enzyme activ-
ities. Similar to cortex, C6PDH activity decreased whereas ME 
activity increased by CP treatment in the medulla (Table 6b). Die-
tary supplementation of FO to CP treated rats decreased C6PDH 
and ME activity. 
3.4. Effect of dietary fish oil (FO) on CP induced alterations in 
antioxidant defense parameters in renal cortex and medulla 
It is evident that reactive oxygen species generated by various 
toxicants are important mediators of cellular injury and pathogen-
esis of various diseases (Walker et al., 1999). Antioxidant status is a 
potential biomarker to determine the physiological state of the cell, 
tissue or organ. To ascertain the role of antioxidant system in CP-
induced toxicity, the effect of CP was observed on oxidative stress 
parameters. CP enhanced lipid peroxidation (LPO) and significantly 
altered antioxidant enzymes both in cortex and medulla, albeit dif-
ferently (Table 7). LPO measured in terms of malodialdehyde (MDA 
levels was significantly enhanced in the cortex (+63.73%) and me-
dulla (+28.9%), whereas total-SH declined in these tissue (-30.36%) 
and (-33.33%), respectively. CP treatment caused significant de-
crease in superoxide dismutase (SOD, -45.69%). Glutathione per-
oxidase (GSH-Px, -40.74%) and catalase (-19.96%) activities in 
the renal cortex. In medulla, however the activity of SOD 
(-51.98%), catalase (-59.15%) and GSH-Px (-38.46%) were pro-
foundly decreased by CP administration alone. However, FO con-
sumption significantly enhanced antioxidant parameters. CP 
administration to FO fed rats prevented the decline in superoxide 
dismutase (SOD), Glutathione peroxidase (GSH-Px) and catalase. 
The results indicate marked protection by FO diet against CP in-
duced oxidative damage to renal tissues. 
4. Discussion 
Cisplatin is an effective chemotherapeutic agent that is widely 
used in the treatment of many malignant tumors, including head 
Fable 5 
Effect of fish oil(FO) on activities of HK, LDH and MDH in homogenates of (a) cortex and (b) medulla with/without CP treatment. 
Enzyme 
Croups 
HK (nmol/mg protein/h) LDH ()imol/mg protein/h) MDH (nmol/mg protein/h) 
(a) Cortex 
Control 
CP 
CPF 
FO 
(b) Medulla 
Control 
CP 
CPF 
FO 
1.48+0.155 
2.50 + 0.069 (+68.9U)' 
2.24 + 0.194 (+51.35%) 
1.85+0.005 (+25%) 
5.32 ±0.325 
7.19+0.325 (+35.15%)' 
4.4 + 0.33 (-17.29%)' 
3 ±0.641 (-43.60%)' 
2.54 + 0.32 
4.72 ± 0.08 {+85.82%)' 
4.11 ±2.49 (+61.81%)' 
3.50 ± 0.1-67 (+37.79%)' 
2.33+0.255 
3.92 ±0466 (+68.24%) 
3.76+0.125 (+61.37%)" 
2.69+0.115(+15.45%) 
2.38 ±0.08 
2.01 ±0.04 (-15.54%)' 
2.36 + 0.175{-0.84%) 
3.34+ 0.165 (+40.33%)' 
13.18±0.51 
8.79±0.575 (-33.31%)' 
8.84+ 0.675 (-32.92%)' 
10.88 ±0.68 (-17.45%)' 
Results (specific activity expressed as }imol/mg protein/h) are mean ± SEM for five different experiments. 
Values in parentheses represent percent change from control. 
CP: cisplatin treated; CPF: fish oil + cisplatin treated: FO: fish oil diet; HK: hexokinase; LDH: lactate dehydrogenase: MDH: malate dehydrogenase. 
Significantly different from control. 
' Significantly different from CP at p < 0.05 by one way ANOVA. 
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Table 6 
Effect of fisfi oil (FO) on activities of C6Pase. FBPase, C6PDH and ME in homogenates of (a) cortex and (b) medulla with/witfiout CP treatment. 
Enzyme 
Croups 
(a) Cortex 
Control 
CP 
CPF 
FO 
(b) Medulla 
Control 
CP 
CPF 
FO 
C6Pase (nmol/mg protein/h) 
1.91 + 0.121 
1.536 ±0.046 (-19.58%)' 
1.83 ±0.101 (-4.18%)' 
2.46 ±0.037 (+28.79%) 
2.83 + 0.104 
2.73 ±0.237 (-3.53%) 
2.53 ±0.127 (-10.6%) 
2.05 ±0.641 (-27.56%)' 
FBPase (nmol/mg protein/h) 
3.44 ±0.068 
2.05 ±0.157 (-40.4%)' 
2.26±0.095 (-34.3%)' 
2.60±0.202 (-24.41%)' 
5.82 ±0.635 
3.64 ±0.301 (-37.45%)' 
3.76 ±0.205 (-35.39%) 
5.61 ±0.15 (-3.60%) 
C6PDH (nmol/mg protein/h) 
0.288 + 0.0065 
0.195 + 0.011 (-32.29%)' 
0.223 ±0.024 (-22.56%)' 
0.293+ 0.013 (+1.73%) 
0.922 ±0.063 
0.217 ±0.032 (-75.46%)' 
0.325 ±0.015 (-64.75%)'' 
0.712 ±0.06 (-22.77%)' 
ME (nmol/mg protein/h) 
0215+0.009 
0.265 + 0.01 (+23.72%)' 
0.245 ±0.006 (+13.95%) 
0.226+ 0.009 (+5.11%) 
2.49 ± 0.085 
3.58 ±0.037 (+43.77%)' 
1.57 ±0.275 (-36.94%)' 
0.170 ±0.0029 (-93.17%) 
Results (specific activity expressed as ).imol/mgprotein/h) are mean±SEM for five different experiments. 
Values in parentheses represent percent change from control. 
CP: cisplatin treated: CPF: fish oil + cisplatin treated; FO; fish oil diet; GSPase; glucose-6-phosphatase; FBPase; fructose-1.6- bisphosphatase: C6PDH; glucose-6-phosphatase 
dehydrogenase: ME; malic enzyme. 
Significantly different from control. 
' Significantly different from CP at p < 0.05 by one way ANOVA. 
Table 7 
Effect of fish oil (FO) on enzymatic and non enzymatic antioxidant parameters in homogenates of (a) cortex and (b) medulla with/without CP treatment. 
Parameters 
Croups 
(ajConex 
Control 
CP 
CPF 
FO 
(b) Medulla 
Control 
CP 
CPF 
FO 
Lipid peroxidation 
(nmol/g tissue) 
94.61 ±12.92 
154.91 ±9.2 (+63.73%)' 
111.79±5.42(+18.15%)* 
102.11 ±8.6 (+7.92) 
27.3 ±1.72 
35.19± 1.72 (+28.9%)' 
33.60 ±1.34 (+23.07%)' 
31.27 ±0.25 (+14.54%) 
Total SH 
(|imol/g tissue) 
15.38 ±0.125 
10.71 ±0.237 (-
13.07 ±0.751 (-
15.03+ 1.533 (-
1.47 ±0.078 
0.98 + 0.023 (-
0.105±0.061 (-
1.29 ± 0.005 (-
-30.36%)' 
-15.01%)* 
-2.27%) 
•33.33%)' 
-92.85%)* 
-12.24%) 
SOD 
(pmol/mg protein) 
25.67 + 0.035 
13.94± 1.106 (-45.69%)' 
22.07 ±0.905 (-14.02%)' 
35.68 ±226 (+38.99%)' 
25.16±1.73 
12.08±0.557 (-51.98%)' 
23.82 ±0.935 (-5.32%)' 
34.62 ±1.19 (+37.59%)' 
Catalase 
(pmol/mg protein/min) 
76.13 ±1.01 
60.93 ±1.18 (-19.96%)' 
67.33±144(-11.55%)'' 
83.55+ 1.17 (+9.74%)' 
97.66 ±3.43 
39.89±2.38 (-59.15%)' 
56.09 ±2.76 (-42.56%)'* 
111.69±0.715(+14.36%)' 
CSH-Px 
(pmo!s/mg protein/ min) 
0.0027 ± 0 
0.0016 ±0 (-40.74%)' 
0.0018+0(-33.33%) 
0.003 ±3.84(+11.11%) 
0.013 ±9.27 
0.008 ±4.33'(-38.46%) 
0.0093+4.48''(-28.46X) 
0.015 ±0.002'(+1538%) 
Results are mean + SEM for five different experiments. 
Values in parentheses represent percent change from control. 
CP: cisplatin treated: CPF: fish oil + cisplatin treated: FO: fish oil diet; LPO: lipid peroxidation: total-SH; sulphydryl groups; SOD: superoxide dismutase: CSH-Px; glutathione 
peroxidase. 
Significantly different from control. 
' Significantly different from CP at p < 0.05 by one way ANOVA. 
and neck, ovarian, and testicular cancers. However, tiie most com-
mon adverse effect, nephrotoxicity, limits the use of this drug in 
many cancer patients (Liu et al., 2006). Experimental evidence 
has suggested that CP deteriorates renal function (Arany and Safir-
stein, 2003) and glomerular filtration rate (GFR) in a dose-depen-
dent manner (Yao et al., 2007). The alterations in the kidney 
functions induced by cisplatin are closely associated with an in-
crease in lipid peroxidation and reactive oxygen species (ROS) in 
renal tissue {Baligha et al., 1998; Silicl et al., 2010). In tumors 
and other dividing cells, cisplatin-DNA crosslinks are thought to 
be the cytotoxic lesion (Fink and Howell, 2000). Nonproliferating 
cells are less sensitive to the toxicity of DNA-damaging agents, 
yet the quiescent proximal tubule cells are selectively killed by cis-
platin (Lieberthal et al., 1996). The metabolic activation of CP in 
proximal tubular cells is found to be essential for its nephrotoxi-
city. Both in vivo and cell culture studies provide evidence that cis-
platin is metabolized to a nephrotoxin through a GSH-conjugate 
intermediate. GGTase is the first enzyme in the proposed metabolic 
pathway for activation of cisplatin glutathione conjugates to a 
nephrotoxin (Mistry et al., 1991; Townsend et al., 2003). The ap-
proach of identifying naturally occurring dietary sources and using 
them as cytoprotectants provides a strategy that is of great interest 
for chemotherapy. In fact, a number of studies have evaluated a 
wide range of antioxidants as potential renal cytoprotectors with 
possible application as adjuvants to cisplatin chemotherapy. How-
ever, most of them have not yet been proved safe for clinical appli-
cation (Ali and Al Moundhri, 2006; Carnal el-Din et al., 2006). 
The past three decades have been a period of rapid expansion in 
the scientific knowledge of 0)-3 PUFAs. Recent studies have shown 
that FO enriched in ©-3 fatty acids retard the progression of vari-
ous forms of cancers, depression, arthritis, asthma, cardiovascular 
and renal disorders (Caterina et al., 1994). However, studies on 
possible beneficial effects of FO on drug or chemical induced neph-
rotoxicity are very limited. Recently it has been documented that 
FO protects against gentamicin-induced nephrotoxicity (Priyamva-
da et al., 2008). The present studies were performed to test the 
hypothesis that FO consumption would ameliorate CP-induced 
nephrotoxic and other adverse effects thus maximizing the clinical 
use of CP in the treatment of various malignancies without any ma-
jor side effects. 
Single CP injection was found to cause marked renal dysfunc-
tion as evident by increased serum creatinine and urea, diagnos-
tic indicators of nephrotoxicity, accompanied by the significant 
decrease in serum glucose, inorganic phosphate (Pi), phospholip-
ids and cholesterol. The results show a typical pattern of CP-in-
duced (Khan et al.. 2009a,b) nephrotoxicity as indicated by 
Author's personal copy 
A Naqshbandi et ai/Food and Chemical Toxicology 50 (2012) 265-273 271 
massive proteinuria, glucosuria and phosphaturia. The feeding of 
FO prior to and after CP treatment significantly lowered CP-elic-
ited increased levels of both serum creatinine and BUN. Serum 
glucose and phospholipids were improved upon CP treatment 
to FO consuming rats. 
Since the BBM of renal proximal tubules has been shown as 
the major site of CP-induced renal injury (Arany and Safirstein, 
2003; Fatima et al., 2004), the integrity of the membrane was 
assessed by the status of its biomarker enzymes ALP, CGTase 
and LAP. CP caused significant decrease in the activities of ALP, 
GGTase and LAP in the cortical homogenates as well as in iso-
lated BBM vesicles. A similar decrease was observed in medulla, 
suggesting an overall CP induced damage to the kidney. The de-
crease in BBM enzyme activities might have occurred due to loss 
of BBM enzymes and other proteinic components from damaged 
BBM into the lumen that later appear in urine as reported earlier 
(Khan et al , 2009a,b; Banday et al., 2008; Fatima et al., 2004). In 
contrast to CP, FO consumption, however, enhanced the activities 
of BBM enzymes in homogenate and BBM, indicating an overall 
improvement in renal BBM integrity. FO consumption in combi-
nation with CP treatment prevented/retarded CP-induced de-
crease of BBM enzyme activities in the renal tissues. CP is 
shown to be metabolized to a nephrotoxin by renal proximal tu-
bule cells and the BBM marker enzyme, GGTase plays an essen-
tial role in the pathway involved (Townsend et al., 2003). 
Inhibition of GGtase activity has been shown to block CP toxicity 
(Townsend et al., 2003; Townsend and Hanigan, 2002). We spec-
ulate that FO might be inhibiting the activity of an essential en-
zyme in this pathway thereby preventing formation of 
nephrotoxin and hence reducing CP nephrotoxicity. The activity 
of GGTase was measured in all the experimental groups. GGTase 
activity was found to increase in FO fed rats while it decreased 
in CP treated rats as compared to control suggesting that FO 
might be ameliorating the effect of CP by inhibiting another en-
zyme and not GGTase crucial/essential for the pathway involved 
in metabolic activation of CP to a nephrotoxin. The activity of 
lysosomal enzyme, ACPase was significantly increased in the cor-
tex and medulla by CP treatment. Alteration in ACPase activity 
demonstrates CP-induced loss of lysosomal function (Kuhlmann 
et al., 1997; Courjault-Gautier et al., 1995). 
Since the major function of kidney is to reabsorb important 
ions and molecules, that inturn depends on the structural integ-
rity of BBM and available energy as ATP which is supplied by 
various metabolic pathways, it is imperative that any alterations 
to these metabolic pathways caused by toxic insult or otherwise 
modified would affect the functional capabilities of kidney. To 
assess the functional aspects, the activities of various enzymes 
of carbohydrate metabolism were examined under different 
experimental conditions. The activities of various enzymes in-
volved in glycolysis, TCA cycle, gluconeogenesis and HMP-shunt 
pathway were differentially altered by CP treatment and/or by 
FO consumption. CP caused significant increase in LDH and de-
crease in MDH in the renal cortex and medulla, which was asso-
ciated with simultaneous increase in hexokinase activity in the 
renal tissues. Although the actual rates of glycolysis or TCA cycle 
were not determined, marked decrease in MDH activity appears 
to be due to CP-induced damage to mitochondria (Kuhlmann 
et al., 1997; Zhang and Lindup, 1993). A marked increase in 
LDH and to some extent hexokinase activity with simultaneous 
decline in TCA cycle enzyme, MDH appears to be an adaptive 
cellular effect in energy metabolism from aerobic metabolism 
alternatively to anaerobic glycolysis due to CP induced mito-
chondrial dysfunction. 
CP also differentially altered the activities of enzymes of gluco-
neogenesis and HMP-shunt pathway. The activities of GSPase and 
FBPase (gluconeogenesis) and G6PDH (HMP shunt), however. 
profoundly decreased in both cortex and medulla albeit to different 
extent. However, the activity of NADP malic enzyme (ME) variably 
increased in the renal tissues. The present data indicate that CP 
caused differential effect on different enzymes of the carbohydrate 
metabolism. FO administration to CP-treated rats resulted in over-
all improvement of carbohydrate metabolism as evident by higher 
activities of LDH, MDH and gluconeogenic enzymes in CPF com-
pared to CP alone or control rats. This could be attributed to the 
fact that FO might have lowered the number of damaged mito-
chondria or affected macromolecules or increased the number of 
normally active organelles or macromolecules. 
Earlier reports reveal that heavy metals including CP exert their 
toxic effects by inducing the generation of reactive oxygen species 
(ROS) (Fatima et al., 2004; Baligha et al., 1998; Banday et al., 2008). 
A major cellular defense against ROS is provided by SOD and cata-
lase, which together convert sujieroxide radicals first to H2O2 and 
then to molecular oxygen and water. Other enzymes e.g., GSH-Px 
use thiol-reducing power of glutathione to reduce oxidized lipids 
and protein targets of ROS. CP has been shown to enhance lipid 
peroxidation (LPO), an indicator of tissue injury and deplete GSH 
and protein thiols (Mistry et al., 1991). The present result show 
that CP administration to control rats caused severe damage to re-
nal tissues most likely by ROS generation as apparent by perturba-
tion in the antioxidant enzymes (SOD, Catalase and GPx-SH) and 
total-SH content that lead to increased lipid peroxidation. These 
results were consistent with earlier reports that oxidative stress 
was thought to contribute to the pathogenesis of the tissue in 
which the mechanism of nephrotoxicity in cisplatin-treated mice 
involved the generation of free radicals and reactive oxygen spe-
cies (ROS) (Atessahin et al., 2005; Sueishi et al., 2002) and causing 
depletion of enzymatic and nonenzymatic antioxidants (Ajith et al.. 
2007). The feeding of FO diet to CP treated rats prevented CP in-
duced augmentation of LPO and suppression of antioxidant en-
zyme activities. The protection against CP effect by FO can be 
attributed to its intrinsic biochemical and natural antioxidant 
prof)erties. Thus, it appears that FO enriched in (»-3 fatty acids en-
hanced resistance to free radical attack generated by CP adminis-
tration similarly as demonstrated in lupus nephritis and other 
pathologies (Chandraseka and Femandes, 1994; Xi and Chen, 
2000; Donadio, 2001). 
Although the mechanism involved in cisplatin nephrotoxicity 
have been extensively studied, they are not yet fully elucidated. 
It has been shown that CP induces necrosis of the S3 subseg-
ment of proximal tubule (Townsend et al., 2003; Portilla et al., 
2006). CP has been shown to be activated to a potent nephro-
toxin in renal proximal tubules (Townsend et al., 2003). CP 
nephrotoxicity has been morphologically characterized by loss 
of microvilli, alteration in the number and size of lysosomes 
and mitochondrial vacuolization accompanied by functional dis-
turbances of various cell organelles (Kuhlmann et al., 1997). Dif-
ferent studies have shown that cytotoxicity of CP is probably due 
to combination of insults including peroxidation of cell mem-
brane, mitochondrial dysfuncrion, inhibition of protein synthesis 
and DNA damage in the kidney (Santos et al., 2007). it has been 
suggested that CP induces renal damage by free radical genera-
tion, such as hydroxyl radical and superoxide anion, by altering 
arginine metabolism, by increasing activity of calcium indepen-
dent nitric oxide synthase and more recently by apoptosis (San-
tos et al., 2007; Devipriya and Shyamaladevi, 1999; Arany et al., 
2004). However, CP-induced oxidative stress was shown to be 
strongly involved in acute renal damage (Gonzales et al.. 
2005). The present findings at least in part support above pro-
posed mechanism. To summarize, our results (Fig. 3) indicate 
an overall improvement in metabolic activities, BBM integrity 
and antioxidant defenses upon dietary FO supplementation to 
CP treated rats. 
Author's personal copy 
A Naqsbbandi et ai/Food and Chemical Toxicology 50 (20J2) 265-273 
MUoc-hondrial dysrunctJon 
Loss ol TCA cycle enzyme 
Decrease in tysusunial 
inlcgrily 
Uamuge lu proximal tubular 
membrane 
Eiraccmem oC BBMV 
Decrease in AlkPasc: GGTasc: 
LAP; 
Oxidative stress 
Increase in LPO. Decrease 
in antioxidant cn/ymcs 
KIDNEY RESPONSE 
CP+FO 
Reduced damage to 
proxinial tubidar 
Diminished Oxidative 
stress 
Improved niilochondrial 
functioning 
Increased Ivs^Bomal 
integrity 
Fig. 3. Cispldtin (CP) induced alterations in cell metabolism, membrane integrity and oxidative stress and its amelioration by dietary fish oil (FO): a summary. 
5. Conclusion 
The present results show that CP elicited deleterious nephro-
toxic and other adverse effects as indicated by significant increase 
in serum creatinine, BUN, decrease in the activities of various en-
zymes of BBM, mitochondria and metabolism. The effects appeared 
to be mediated, at least, in part due to CP-induced perturbation in 
antioxidant defense mechanism. FO consumption to a larger extent 
prevented CP-induced nephrotoxicity parameters by enhancing 
energy metabolism, BBM enzymes and by strengthening antioxi-
dant defense mechanism. Taking into account these results, we 
propose that FO may maximize the clinical use of CP in the treat-
ment of various malignancies without nephrotoxic and other side 
effects. 
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Abstract 
Cisplatin (CP) is known as one of the most potent chemotherapeutic antitumor drugs. The tissue-specific toxi-
city of CP in the kidneys is well documented. However, at higher doses less common toxic effects such as hepa-
totoxicity may arise. Since CP remains one of the most effective antineoplastic drug used in chemotherapy, 
strategies to protect tissues against CP toxicity are of clinical interest. Recently, (0-3 polyunsaturated fatty acids 
(PUFAs) from certain plants/seeds notably flaxseed have shown numerous health benefits. In view of this, the 
present study investigates the protective effect of flaxseed oil (FXO) on CP-induced damage in liver. Rats were 
pre-fed normal diet and the diet rich in FXO for 10 days and then a single dose of CP (6 mg/kg body weight) was 
administered intraperitoneally while still on diet Serum/urine parameters, enzymes of carbohydrate metabo-
lism and oxidative stress were analyzed. CP caused perturbation of the antioxidant defense as reflected by the 
decrease in the activities of catalase, superoxide dismutase and glutathione peroxidase. Further the activities of 
various enzymes involved in glycolysis, tricarboxylic acid cycle, gluconeogenesis and hexose monophosphate 
shunt pathways were determined and were found to be differentially altered by CP treatment. However, these 
alterations were ameliorated in CP-treated rats fed on FXO. Present results show that dietary supplementa-
tion of FXO in CP-treated rats ameliorated CP-induced hepatotoxic and other deleterious effects due to its 
intrinsic biochemical/antioxidant properties. 
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via supplementation of preventive agents simultane-
ously.'''" The past 3 decades have been a period of 
rapid expansion in the scientific knowledge of ca-3 
PUFAs. The most common way to consume co-3 fatty 
acids has been in the form of marine oils like fish. 
Studies from our laboratory have shown that dietary 
fish oil (FO) supplementation ameliorates gentamicin 
and CP-induced damage to kidney and liver, respec-
tively.'*'" Vegetable sources including grains and oils 
offer an alternative source for those who are unable to 
regularly consume fish for religious or other rea-
sons.'^ Flaxseed (Linum usitadssimum) is the richest 
dietary sources of Q)-3 among plant sources. Recently 
flaxseed has been identified as a significant alterna-
tive source of ©-3 fatty acids.'^'''' Dietary supplementa-
tion with flaxseed oil (FXO) affects the biochemistry of 
fatty acid metabolism and thus the balance of proinflam-
matory mediators and atherogenic lipids, holding a great 
promise for modulating inflammatory diseases.'^ FXO 
has also been shown to increase the life span of irra-
diated mice, suggesting its prophylactic potential 
against radiation-induced degenerative changes in 
liver.'^ However, the protective effect of FXO on CP-
induced toxicity has not yet been investigated. 
Taking into consideration the potential clinical use 
of CP and numerous health benefits of FXO, the pres-
ent work was undertaken to study the detailed bio-
chemical events/cellular response/mechanisms of 
CP-induced hepatotoxicity and its protection by diet-
ary FXO. We hypothesized that FXO would prevent 
CP-induced hepatotoxicity due to its intrinsic bio-
chemical and antioxidant properties that would lead 
to improved metabolism and antioxidant defense 
mechanism of the liver. The results obtained indicate 
that dietary supplementation with FXO markedly 
ameliorated CP-induced adverse effects in liver. The 
activities of carbohydrate metabolism, membrane and 
antioxidant enzymes were markedly enhanced by 
FXO feeding to CP-administered rats. These studies 
support a potential therapeutic use of CP + FXO com-
bination in combating cancer without hepatotoxic and 
other harmfiil side effects. 
Materials and methods 
ChQmlcah and drugs 
Flaxseed oil: Omega Nutrition Canada Inc., Cisplatin 
(Sigma Chemical Co., USA). All other chemicals 
used were of analytical grade and were purchased 
either from Sigma Chemical Co. (St Louis, MO, 
USA) or from SRL, Mumbai, India. 
Diet 
A nutritionally adequate laboratory pellet diet was 
obtained from Aashirwaad Industries, Chandigarh 
(India). Pellets were crushed finely and mixed with 
15% FXO and stored in airtight containers. Vitamin 
E as DL-a-tocopherol (270 mg/kg chow) was added 
to each of the modified rat chows in order to meet the 
increased metabolic requirement for antioxidants on a 
diet high in PUFAs. 
Experimental design 
The animal experiments were conducted according to 
the guidelines of Committee for Purpose of Control 
and Supervision of Experiments on Animals 
(CPCSEA), Ministry of Environment and Forests, 
Government of India. Adult male Wistar rats (8 rats/ 
group) weighing between 150 and 200 g were used 
in the study. Animals were acclimatized to the animal 
facility for a week on standard rat chow and allowed 
water ad libitum under controlled conditions of 
25 ± 2°C temperature, 50 ± 15% relative humidity 
and normal photoperiod (12 h dark and light). Four 
groups of rats entered the study after acclimatization 
(Figure 1). They were fed on either normal diet (con-
trol and CP groups) or diet containing 15% FXO 
(CPFXO and FXO groups). After 10 days, rats in 2 
groups (CP and CPFXO) were administered a single 
dose of CP intraperitoneally (6 mg/kg body weight) 
in 0.9% saline. Animals in the control and FXO group 
received an equivalent amount of normal saline. The 
rats were killed 4 days after CP administration under 
light ether anesthesia. Blood and urine samples were 
collected and liver was removed and processed for the 
preparation of homogenate as described below. All 
the preparations and analyses of various parameters 
were performed simultaneously under similar experi-
mental conditions to avoid any day-to-day variations. 
Body weights of rats were recorded at the start and 
completion of the experimental procedures. 
Preparation of homogenates 
After the completion of treatment schedule, animals 
were killed, liver was carefully removed from the 
treated and control animals and homogenized in 
0.1 M Tris-HCl buffer (pH 7.5) by a glass-teflon 
homogenizer (Thomas PA, USA) by passing 5 pulses; 
at 4°C to make a 10% (w/v) homogenate. The homo-
genate was then subjected to high-speed Ultra-Turrex 
Kunkel homogenizer (Type T-25, Janke & Kunkel 
Naqshbandi A et al. 
Killed on 
Saline injcction(i.p)(0.9%) 2|"'dav 
ND 
1 week 
C 
CP 
tt 
Cisplatin injection (i,p) 
6 mg/kg bodywcight 
CPFXO-
FXO i. (for todays) ^FXO 
T 4 days 
Blood 
Liver - • Homogenatc 
Killed 
Figure I. Experimental design (ND: normal diet, C: control, FXO: flaxseed oil diet, CP: cisplatin, CPFXO: flaxseed 
oil +• cisplatin treated, i.p.: intraperitoneal; CP injection {if); normal saline injection (J), 
GMBH & Co. KG. Staufen, Germany) for 3 strokes of 
30 s each with an interval of 30 s between each stroke. 
Homogenate was centrifliged at 2000 r/min at 4°C for 
10 min in Beckman J2-M1 (Beckman instruments, Inc 
Palo Alto, CA, USA) high-speed refrigerated centri-
fuge to remove the cell debris. The supernatant was 
transferred to aliquots and stored at -20°C for various 
enzyme activities. 
Serum/urine chemistries 
Serum samples were deproteinated with 3% trichlor-
oacetic acid in a ratio of 1:3, left for 10 min and then 
centrifuged at 2000g for 10 min. The protein free 
supernatant was lised to determine inorganic phos-
phate (Pi) and creatinine. The precipitate was used 
to quantitate total phospholipids (PLs). Blood urea 
nitrogen (BUN) and cholesterol levels were deter-
mined directly in serum samples. These parameters 
were determined by standard procedures as men-
tioned in a previous study." Transaminases, alanine 
aminotransferase (ALT) and aspartate aminotrans-
ferases (AST) were estimated by Reitman and Frankel 
method using kit from span diagnostics. Glucose was 
estimated by o-toluidene method using kit from Span 
diagnostics, Mumbai, India. 
Assay of carbohydrate metabolism enzymes 
The activities of the enzymes involving oxidation of 
nicotinamide adenine dinucleotide or reduction of 
nicotinamide adenine dinucleotide phosphate (NAD?) 
were determined spectrophotometrically on Cintra 5 
fixed for 340 nm using 3 ml of assay in a 1-cm cuvette 
at room temperature (28-30°C). The enzyme activities 
of lactate dehydrogenase (LDH, B.C. 1.1.1.27), malate 
dehydrogenase (MDH, B.C.1.1.1.37), malic enzyme 
(ME, B.C. 1.1.1.40), glucose-6-phosphate dehydrogen-
ase (G6PDH, B.C. 1.1.1.49), glucose-6-phosphatase 
(G6Pase, E.C.3.1.3.3) and fructose-1,6-bisphosphatase 
(FBPase, E.C.3.1.3.11) were assayed as described by 
Khundmiri et al.'^ Hexokinase (HK) was estimated by 
the method of Crane and Sols'* and the remaining glu-
cose was measured by method of Nelson. 
Assay ofmembrar)e enzymes and lysosomal 
marker enzyme 
The activities of membrane marker enzymes, alkaline 
phosphatase (ALP), leucine amino peptidase (LAP), 
y-glutamyl transferase (GGTase) and lysosomal mar-
ker enzyme, acid phosphatase (ACPase) were deter-
mined as described by Farooq et al. 20 
Assay of enzymes involved in free radical 
scavenging 
Superoxide dismutase (SOD, E.G.1.15.1.1) was 
assayed by the method of Marklund and Marklund.^' 
Catalase (CAT, E.C. L11.1.6) and glutathione peroxi-
dase (GSH-Px, E.C. 1.11.1.9) activities were assayed 
Human and Experimental Toxicology 00(0) 
.23 by the method of Giri et al. and Flohe and Gunzler, 
respectively. 
Lipid peroxidation and total -Sl-I group 
estimotion 
Total SH groups were determined by the method of 
Sedlak and Lindsay^ "* and LPO by the method of 
Ohkawa et al 25 
Statistical analyses 
All data are expressed as mean + SEM for at least 
4-5 different preparations. Statistical evaluation was 
conducted by one-way analysis of variance (ANOVA) 
using Origin 6.1 software. A probability level of 
p < 0.05 was selected as indicating statistical signifi-
cance. Most of the changes between various groups 
were compared with control values for better under-
standing and clarity. 
Results 
The present work was undertaken to study detailed 
mechanism of CP-induced hepatotoxicity and other 
deleterious effects and its possible protection by feed-
ing 00-3 fatty acids-enriched diet to the rats. To 
address our hypothesis, the effect of CP alone and 
in combination with FXO, a rich source of (0-3 fatty 
acids, was determined on various enzymatic and 
nonenzymatic parameters of oxidative stress and 
enzymes of carbohydrate metabolism in rat liver. 
Effect of dietary FXO oil on CP-induced altera-
tions in serum and urinary parameters 
Results summarized in Tables 1 and 2 show the effect 
of CP alone and in combination with FXO on blood 
and urine chemistries. 
The liver dysfunction induced by CP was charac-
terized by the elevated levels of serum transaminases, 
ALT and AST. CP treatment to control rats resulted in 
significant increase in serum transaminases (ALT, 
+ 106% and AST, +154%), creatinine (Scr, 
+ 176%), BUN (+122.31%) and PL (+77%) but 
decrease in Pi (-17%) and glucose (-79%) compared 
to control rats. These changes were associated with 
profound phosphaturia, proteinuria and glucosuria 
accompanied by decreased creatinine clearance. FXO 
diet alone caused decrease in Scr, cholesterol and PL 
accompanied by significant increase in creatinine 
clearance. 
Feeding FXO diet prior to and following CP 
administration resulted in significant reversal of vari-
ous CP-elicited deleterious effects on serum and urine 
parameters. FXO prevented CP-induced increase in [T] 
transaminases, Scr and BUN. 
Effect of dietary FXO on CP-induced alterations in 
membrane enzymes and marker enzyme of 
lysosomes 
To assess the structural integrity of plasma membrane 
and lysosomes, the effect of CP alone and in combina-
tion with FXO diet was determined on membrane and 
lysosomal enzymes in the liver homogenate. The 
activities of membrane marker enzymes viz ALP, 
GGTase and LAP and lysosomal marker enzyme, 
ACPase, were determined under different experimen-
tal conditions in the homogenates of liver (Figure 2; 
Table 3). CP treatment to control rats caused signifi- [7] 
cant reduction in the specific activities of ALP 
(-64%), GGTase (-39%) and LAP (-37%) in liver 
homogenate. CP treatment to FXO fed rats prevented 
CP elicited decrease in membrane enzyme activities. 
As can be seen from the data, CP-induced decrease 
in enzyme activities were prevented by FXO diet. 
However, the activity of ACPase was increased 
(+54%) by CP treatment in liver homogenate, while 
FXO diet was able to prevent the increase in ACPase 
activity (Table 3). 
Effect of FXO on CP-induced alterations on 
metabolic enzymes in liver 
The effect of CP, FXO diet and their combined treat-
ment was determined by the activities of various 
enzymes of carbohydrate metabolism in liver. As 
shown in Table 4, CP treatment to control rats signif-
icantly increased the activities of LDH (+104.76%), 
HK (+18%) and ME (+52%) but decreased the activ-
ities of MDH (-33%), G6Pase (-22), FBPase 
(-44%) and G6PDH (-49%). In contrast, FXO con-
sumption enhanced the activities of FBPase and 
G6Pase. Feeding FXO to CP-treated rats arrested 
CP-induced decline in MDH, FBPase, G6Pase, 
G6PDH activities and enhancement in LDH, HK and 
ME activities. 
Effect of dietary FXO on CP-induced alterations in 
antioxidant defense parameters in liver 
It is evident that ROS generated by various toxicants 
are important mediators of cellular injury and 
Noqshbondi A et al. 
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Figure 2. Effect of flaxseed oil (FXO) on the activities of alkaline phosphatase (ALP), y-glutamyl transferase (GGTase), 
leucine amino peptidase (LAP) and acid phosphatase (ACPase) in liver homogenate with CP treatment Results (^mol/mg 
protein/h) are mean + SEM for five different preparations. *Significantly different from control, fsignificantly different 
from CP: at p < 0.05 by one-v/ay analysis of variance (ANOVA). 
pathogenesis of various diseases.'^ ^ Antioxidant status 
is a potential biomarker to determine the physiologi-
cal state of the cell, tissue or organ. To ascertain the 
role of antioxidant system in CP-induced toxicity, the 
effect of CP was observed on oxidative stress para-
meters. CP enhanced LPO and significantly altered 
antioxidant enzymes albeit differently (Table 5). LPO 
measured in terms of malondialdehyde levels signifi-
cantly enhanced in the (+52%), whereas total -SH 
declined in the liver (—30%) in CP group. CP treat-
ment caused decrease in SOD (-15%), GSH-Px 
(-76%) and CAT (-69%) activities. In contrast, 
FXO consumption increased the activities of antioxi-
dant enzymes albeit to different extents. However, 
when CP treatment was extended to FXO fed rats 
(CPFXO group), the decline in SOD, GSH-Px and 
CAT activities was reduced significantly in compari-
son to CP group. The results indicate marked protec-
tion by FXO diet against CP-induced oxidative 
damage to renal tissues. 
Discussion 
CP is a major antineoplastic drug used for the treat-
ment of various forms of cancers."^ '^^ ** The efficacy 
of CP is limited, however, by its dose-limiting 
nephrotoxicity. '^' •^ ' Although CP-induced 
nephrotoxicity has been very well documented in 
clinical oncology, hepatotoxicity has been rarely 
characterized and is less studied. It is known that 
CP is significantly taken up in human liver and that 
high doses of the drug produces hepatotoxicity.^ '^^ ^ 
The treatment of tumor cells with CP provokes 
several responses including membrane peroxidation, 
dysfunction of mitochondria, inhibition of protein 
synthesis and DNA damage.^ '*'^ ^ Formation of free 
radicals leading to oxidative stress has been shown 
to be one of the pathogenic mechanisms of the 
adverse effects of CP in kidney and liver. ^ * CP is 
known to cause histopathological and ultrastructural 
abnormalities in the liver including inflammatory 
infiltration, hyperplasia, periportal fibrosis, marked 
disruption of hepatic cords and dilated blood sinu-
soids. Many hepatocytes showed karyomegaly and 
pyknotic nuclei indicating apoptosis.^ '^^ * Several stra-
tegies and agents were utilized to prevent CP-induced 
toxicity but were not found suitable for clinical prac-
tice."-'' 
The last 3 decades have witnessed a major drift in 
the scientific community toward the roles of naturally 
occurring dietary substances for their ability to confer 
health and physiological benefits. A number of stud-
ies have revealed that (o-3 PUFAs have numerous 
health benefits. The predominant dietary .sources of 
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PUFA are plants/seed namely flaxseed and fish/ 
marine foods. a)-3 PUFA-enriched FO has received 
a great deal of attention as therapeutic options in a 
variety of clinical situations.'*''^'''^ Lately, flaxseed 
(L. usitatissimum) has been the focus of increased 
interest in the field of diet and disease research due 
to the potential health benefits'*'' associated with its 
biologically active component viz co-S PUFA. FXO 
has been shown to prevent lipid disorders and lead-
induced neurotoxicity and nephrotoxicity.''^'''* How-
ever, the role of FXO in preventing drug-induced 
toxicity has not yet been investigated. 
The present work was undertaken to study detailed 
mechanism of CP-induced hepatotoxic alterations and 
possible role of FXO in preventing those deleterious 
changes in rat liver. Single CP injection caused marked 
alterations in serum and urine parameters. The present 
results show that CP administration to control rats 
caused hepatotoxicity as indicated by elevated levels 
of transaminases (ALT and AST). Moreover, Scr and 
BUN were also enhanced with significant decrease in 
creatinine clearance. These results also show a signif-
icant decrease in serum glucose. Pi, PLs and serum 
cholesterol, accompanied by massive proteinuria, glu-
cosuria and phosphaturia. FXO diet given prior to and 
following CP administration prevented CP-induced 
alterations in various serum/urine parameters. CP 
elicited increase in levels of Scr, BUN and transami-
nases were lowered when CP was administered to FXO 
fed rats. Serum glucose, PLs and phosphate were 
improved upon CP treatment to FXO fed rats. 
Since the brush border membrane of renal proximal 
tubules has been shown as the major site of CP-
induced renal injury,''^''* the integrity of the mem-
brane was assessed by the status of its biomarker 
enzymes ALP, GGTase and LAP. CP significantly 
decreased the activities of ALP, GGTase and LAP 
in the liver homogenate. The decrease in membrane 
enzyme activities might have occurred due to the loss 
of membrane enzyme and other proteinic compo-
nents, indicating adverse effects of CP on membrane 
integrity. The present results show that in contrast to 
CP treatment, dietary supplementation of FXO in con-
trol rats caused significant increase in the activities of 
membrane enzymes in the liver homogenate. Dietary 
FXO supplementation prior to and following CP treat-
ment prevented/retarded CP-induced decrease in 
membrane enzymes in the tissue. The activity of lyso-
somal enzyme ACPase was significantly increased in 
liver homogenate by CP treatment. Alteration in 
ACPase activity demonstrate CP-induced loss of 
lysosomal function.'"'^'' However, the CP-induced 
effect on lysosomal enzyme activity appeared to be 
ameliorated by dietary FXO supplementation. 
To assess the functional aspects, the activities of 
various metabolic enzymes were determined under 
different experimental conditions. The activities of 
various enzymes involved in glycolysis, tricarboxylic 
acid (TCA) cycle, gluconeogenesis and hexose mono-
phosphate (HMP)-shunt pathways were differentially 
altered by CP treatment and/or by FXO consumption. 
CP caused significant increase in LDH and decrease 
in MDH which was accompanied with a simultaneous 
increase in HK activity in liver tissue. Although the 
actual rates of glycolysis or TCA cycle were not 
determined, marked decrease in MDH activity appears 
to be due to CP-induced damage to mitochondria.'"'^" 
A marked increase in LDH activity with simultaneous 
decline in TCA cycle enzyme, MDH appears to be an 
adaptive cellular effect in energy metabolism from 
aerobic metabolism alternatively to anaerobic glycoly-
sis due to CP-induced mitochondrial dysfunction.^' 
CP also altered the activities of enzymes of 
gluconeogenesis and HMP-shunt pathway. The activi-
ties of G6Pase, FBPase and G6PDH were profoundly 
decreased albeit to different extent. However, the activ-
ity of NADP ME was increased in the tissue. The present 
data indicate that CP caused differential effects on dif-
ferent enzymes of carbohydrate metabolism. FXO 
administration to CP-treated rats resulted in the overall 
improvement of carbohydrate metabolism as evident 
by higher activities of MDH and gluconeogenic 
enzymes in CPFXO as compared to CP group. FXO 
might have lowered the number of damaged mitochon-
dria or other affected macromolecules or may have 
increased the number of normally active organelles or 
macromolecules. 
Earlier reports reveal that heavy metals including 
^p48,51,52 gj^ gj{ jjjgjj. toxic effects by inducing the gen-
eration of ROS. A major cellular defense against ROS 
is provided by SOD and CAT, which together convert 
superoxide radicals first to H2O2 and then to molecular 
oxygen and water. Other enzymes, e.g. GSH-Px, use 
thiol-reducing power of glutathione to reduce oxidized 
lipids and protein targets of ROS. However, oxidative 
stress can occur as a result of either increased ROS gen-
eration and/or decrease in antioxidant enzyme system. 
These antioxidant enzymes protect the cell against 
cytotoxic ROS. In agreement with the previous stud-
ies'*'^ ^ present results show that CP enhanced LPO, 
an indicator of tissue injury and depleted protein thiols. 
CP administration to control rats caused severe 
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Mitochondrial dysfunction 
Loss ol'TCA cycle enzyme 
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Increase in LPO, decrease 
in antioxidant enzymes 
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Figure 3. Cisplatin (CP)-induced alterations in cell metabolism, lysosomal integrity and oxidative stress and its ameli-
oration by dietary flaxseed oil (FXO): a summary. 
damage to liver tissue most likely by ROS generation 
as apparent by perturbation in the antioxidant enzymes 
(SOD, CAT and GPx-SH) and total-SH content that 
lead to increased LPO. CP-treated rats fed on FXO-
supplemented diet caused significant increase in SOD, 
CAT and GSH-Px activities accompanied by lower 
LPO values in liver tissue. The protection against CP 
by FXO can be attributed to its intrinsic biochemical 
and natural antioxidant properties. It appears that FXO 
enriched with £0-3 fatty acids enhanced resistance to 
fi-ee radical attack generated by CP administration. 
As indicated in Figure 3, our results indicate an overall 
improvement in metabolic activities, lysosomal 
integrity and augmentation of antioxidant defenses in 
CP-treated FXO-fed rats. 
We conclude that while CP elicited deleterious 
hepatotoxic effects by causing severe damage to the 
plasma membrane, mitochondria and other orga-
nelles by suppressing antioxidant defense mechan-
ism, however these effects were ameliorated by 
dietary supplementation with FXO. Present study 
thus support the rationale that <B-3 fatty acids-
enriched FXO may be effective dietary supplemen-
tation to maximize the clinical use of CP in the 
treatment of various malignancies without hepato-
toxic and other side effects. 
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